Beyond European Ancestry: Addressing Ethnic Diversity in Endometriosis GWAS Loci Replication

Abstract

This article examines the critical challenge of replicating endometriosis genome-wide association study (GWAS) loci across diverse ethnic populations. While large-scale GWAS have identified numerous risk loci, these findings are predominantly based on individuals of European ancestry, limiting their generalizability. We explore the foundational genetic disparities, methodological innovations for multi-ethnic studies, strategies for optimizing replication analyses, and validation approaches across ancestral groups. For researchers and drug development professionals, this synthesis provides essential insights into achieving more inclusive genetic research, which is crucial for developing effective, population-specific diagnostics and therapeutics for this complex gynecological disorder.

The Genetic Diversity Gap: Foundational Disparities in Endometriosis GWAS

Genome-wide association studies (GWAS) have revolutionized our understanding of the genetic architecture of complex diseases. However, a profound disparity persists in the ancestral composition of research cohorts. Over 80% of GWAS participants are of European ancestry, creating significant limitations for the generalizability of findings and equitable translation of genomic medicine [1]. This imbalance is not merely a statistical concern but represents a critical scientific and ethical challenge that undermines the full potential of genomic research. The limited diversity in GWAS creates a "genomic gap" that can perpetuate health disparities, as genetic risk estimates, polygenic scores, and biological insights derived from European populations often show reduced predictive power and clinical utility in other ancestral groups [1]. This review examines the current state of ancestry representation in GWAS, with a specific focus on endometriosis research, and outlines methodological frameworks for advancing more inclusive genomic science.

Quantitative Assessment of Ancestry Representation in Endometriosis GWAS

Current Disparities in Cohort Composition

Table 1: Ancestry Representation in Major Endometriosis Genetic Studies

Study	Total Sample Size	European Ancestry	Non-European Ancestry	Significant Loci	Novel Loci
Multi-ancestry endometriosis GWAS (2025) [2]	~1.4 million women (105,869 cases)	Primary component (exact % not specified)	Included, but proportions not specified	80 genome-wide significant associations	37
UK Biobank endometriosis-immune study (2025) [3]	8,223 endometriosis cases	100%	0%	39 genome-wide significant endometriosis-associated variants	Not specified
Combinatorial analytics study (2025) [4]	UK Biobank + All of Us cohorts	UK Biobank: 100% white European	All of Us: Multi-ancestry	1,709 disease signatures (2,957 unique SNPs)	75 novel genes
Iranian endometriosis landscape study (2025) [5]	50 individuals (25 cases)	0%	100% Iranian	3 genes (MFN2, PINK1, PRKN) with significant expression differences	Population-specific associations

Functional Characterization Across Diverse Contexts

The functional impact of genetic variants exhibits considerable tissue-specific and population-specific patterns. A 2025 study systematically characterizing endometriosis-associated variants identified through GWAS revealed distinct regulatory profiles across different tissues [6]. When these variants were analyzed as expression quantitative trait loci (eQTLs) across six physiologically relevant tissues, researchers observed that immune and epithelial signaling genes predominated in colon, ileum, and peripheral blood, while reproductive tissues showed enrichment of genes involved in hormonal response, tissue remodeling, and adhesion [6]. This tissue specificity underscores the complexity of translating GWAS findings across diverse biological contexts and suggests that ancestral diversity in study cohorts is essential for comprehensive functional understanding.

Methodological Frameworks for Diverse Cohort Integration

Advanced Analytical Approaches for Multi-Ancestry GWAS

Table 2: Methodological Approaches for Enhancing Diversity in Genetic Studies

Method	Application	Key Features	Benefits for Diversity
Combinatorial Analytics [4]	Identification of multi-SNP disease signatures	Analyzes combinations of 2-5 SNPs; identifies epistatic effects	Higher reproducibility in non-European cohorts (66-76%) compared to traditional GWAS SNPs
Multi-ancestry GWAS Framework [2]	Large-scale association discovery	Integrates data from multiple biobanks; uses meta-analysis methods	Identifies population-specific loci; enables cross-ancestry comparison
Functional Annotation Pipeline [6]	Characterization of non-coding variants	Integrates eQTL data from GTEx; tissue-specific functional mapping	Reveals population-specific regulatory effects; prioritizes causal variants
Gene-Environment Interaction Analysis [7]	Assessment of ancient variants and modern environmental exposures	Links archaic introgression with EDC sensitivity; uses linkage disequilibrium analysis	Identifies population-specific risk factors; integrates evolutionary context

Technical Workflows for Diverse Cohort Analysis

The following workflow illustrates a comprehensive approach for conducting multi-ancestry genetic studies:

Diagram 1: Comprehensive workflow for multi-ancestry genetic studies, from cohort selection to clinical translation.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagents and Resources for Diverse GWAS

Resource	Type	Primary Function	Diversity Relevance
GTEx Database [6]	eQTL reference	Tissue-specific gene expression regulation	Provides multi-tissue functional context across diverse samples
All of Us Researcher Workbench [8]	Genomic dataset	Access to diverse genomic data	Includes WGS for 414,000 participants with enhanced diversity
FUMA Platform [9]	Bioinformatics tool	Functional mapping and annotation of GWAS	Enables gene prioritization and functional characterization
PrecisionLife Combinatorial Analytics [4]	Analytical platform	Identifies multi-SNP disease signatures	Higher reproducibility across ancestry groups
UK Biobank [3]	Population cohort	Large-scale genetic and health data	Predominantly European but extensive phenotypic data
Genomics England 100,000 Genomes [7]	Genomic database	Whole genome sequencing data	Enables regulatory variant analysis in specific populations

Case Study: Endometriosis Research Across Ancestries

Comparative Insights from Recent Studies

Endometriosis research provides a compelling case study of both the challenges and opportunities in diverse genetic studies. A 2025 combinatorial analytics study demonstrated markedly different performance between traditional GWAS and novel methodological approaches across ancestry groups [4]. While a prior large GWAS meta-analysis had identified 42 genomic loci explaining only 5% of disease variance, the combinatorial approach identified 1,709 disease signatures comprising 2,957 unique SNPs that showed significantly higher reproducibility in non-European cohorts (66-76% for signatures with greater than 4% frequency) [4]. This methodological difference highlights how innovative analytical frameworks can enhance cross-population generalizability.

The same study revealed important biological insights that might have been missed in European-centric research. The researchers characterized 9 novel genes occurring at the highest frequency in reproducing signatures that did not contain SNPs linked to known GWAS genes, providing new evidence for links between endometriosis and autophagy and macrophage biology [4]. These findings were consistent across ancestry groups, suggesting fundamental biological mechanisms that transcend population boundaries while still allowing for population-specific risk assessment.

Functional Characterization Workflow

The following diagram details the functional characterization process for identified genetic variants:

Diagram 2: Workflow for functional characterization of genetic variants across diverse populations.

Pathways Toward More Inclusive Genomic Research

Strategic Initiatives for Diversity Enhancement

The expansion of GWAS into African, South American, and Asian populations represents both a scientific and moral imperative [1]. Diverse cohorts not only enable more inclusive polygenic prediction but also uncover population-specific biology and gene-environment interactions. Several large-scale initiatives are demonstrating the value of this approach:

• The All of Us Research Program has generated whole-genome sequencing data for over 414,000 participants, with deliberate efforts to enhance diversity, enabling research that "reveals disease-associated variants in Black Americans" and other underrepresented groups [8].

• Multi-ancestry meta-analyses are growing in scale, with recent endometriosis research encompassing approximately 1.4 million women including 105,869 cases, identifying 37 novel loci through cross-ancestry integration [2].

• Population-specific functional studies are uncovering ancestral variation in regulatory mechanisms, such as the enrichment of IL-6 variants at Neandertal-derived methylation sites and CNR1 variants of Denisovan origin that may contribute to endometriosis risk through immune dysregulation [7].

Analytical Considerations for Diverse Cohorts

Successfully integrating diverse ancestral groups in GWAS requires addressing several analytical challenges:

• Population Structure: Comprehensive controlling for population stratification using principal components analysis and genetic relationship matrices is essential to avoid spurious associations [9].

• LD Differences: Linkage disequilibrium patterns vary substantially across populations, requiring population-specific LD reference panels and careful interpretation of association signals [1].

• Variant Frequency: Allele frequency spectra differ across populations, necessitating consideration of both common and rare variants in association testing [8].

• Gene-Environment Interactions: Environmental exposures, such as endocrine-disrupting chemicals, may interact with genetic risk factors differently across populations and geographical contexts [7] [5].

The predominant reliance on European-ancestry cohorts in major GWAS represents a critical limitation that constrains the scientific validity, clinical applicability, and equitable potential of genomic medicine. As demonstrated in endometriosis research, expanding diversity in genetic studies is not merely a matter of social equity but a scientific necessity for comprehensive biological understanding. Methodological innovations in combinatorial analytics, functional annotation, and multi-ancestry integration are providing pathways toward more inclusive and impactful genomic research. The continued expansion of diverse cohorts, coupled with analytical frameworks that account for ancestral diversity, will be essential for realizing the full potential of GWAS to advance human health across all populations.

The genetic architecture of endometriosis, a complex gynecological disorder, exhibits considerable heterogeneity across human populations. While genome-wide association studies (GWAS) have identified numerous susceptibility loci, these discoveries have historically relied heavily on European-ancestry cohorts, creating a critical knowledge gap in our understanding of the condition's global genetics [10] [11]. This whitepaper synthesizes emerging evidence from Iranian, Taiwanese-Han, and other non-European populations to elucidate the population-specific genetic effects that influence endometriosis susceptibility, disease progression, and clinical presentation. The growing body of research demonstrates that specific risk alleles operate differently in the pathogenesis of endometriosis across distinct ethnic groups, underscoring the necessity of diverse genetic studies to fully comprehend the disease's etiology and develop targeted therapeutic interventions [5] [12].

Population-Specific Genetic Loci in Endometriosis

Key Findings from Iranian and East Asian Populations

Recent studies in non-European populations have revealed both shared and population-specific genetic risk factors for endometriosis. The Iranian population study demonstrated the significant contribution of genetic variability in MFN2, PINK1, and PRKN genes to endometriosis risk, with these genes' single nucleotide polymorphisms (SNPs) representing the most contributing variable in differentiating cases from controls [5]. This research employed multivariate computational methods including factor multiple logistic regression, factor analysis of mixed data (FAMD), and redundancy analysis (RDA), revealing significant associations between geographical variables, gene expression magnitude, and SNP genotypes [5].

In the Taiwanese-Han population, a GWAS of 2,794 cases and 27,940 controls identified five significant susceptibility loci, with three (WNT4, RMND1, and CCDC170) previously associated with endometriosis across different populations, and two novel loci (C5orf66/C5orf66-AS2 and STN1) specific to this population [12]. These findings highlight both conserved and unique genetic architecture across ethnicities.

Table 1: Population-Specific Endometriosis Loci Across Diverse Populations

Population	Sample Size	Key Genetic Loci Identified	Population-Specific Loci	Shared Loci
Iranian	50 individuals (25 cases/25 controls)	MFN2, PINK1, PRKN	rs68121389, rs117341007 (PRKN); rs513414, rs3077908, rs512550, rs2078073, rs1043502 (PINK1); rs3088064, rs1042842, rs41278636 (MFN2)	-
Taiwanese-Han	2,794 cases, 27,940 controls	WNT4, RMND1, CCDC170, C5orf66/C5orf66-AS2, STN1	C5orf66/C5orf66-AS2 (5q31.1), STN1 (10q24.33)	WNT4 (1p36.12), RMND1 (6q25.1), CCDC170 (6q25.1)
European (Meta-analysis)	11,506 cases, 32,678 controls	rs12700667 (7p15.2), rs7521902 (near WNT4), rs10859871 (near VEZT), rs1537377 (near CDKN2B-AS1), rs7739264 (near ID4), rs13394619 (in GREB1)	-	WNT4
Multi-ancestry (GBMI)	>900,000 women (31% non-European)	45 significant loci (7 novel)	POLR2M (African-ancestry specific)	CDC42, SKAP1, GREB1

Functional Consequences of Population-Specific Variants

The functional impact of population-specific genetic variants extends beyond mere association signals. Research on the Taiwanese population revealed that the rs13126673 SNP, located in the INTU (inturned planar cell polarity protein) gene, functions as a significant expression quantitative trait locus (eQTL) [13]. This variant demonstrated a clear genotype-expression correlation in both the GTEx database (P = 5.1 × 10^−33) and in endometriotic tissues from women with endometriosis (P = 0.034), with the risk C allele associated with reduced INTU expression [13]. Computational modeling further suggested that this intronic variant alters RNA secondary structure, potentially explaining its regulatory effects [13].

A 2025 multi-omic study integrating GWAS, eQTLs, methylation QTLs (mQTLs), and protein QTLs (pQTLs) identified additional layer of functional complexity, revealing 196 CpG sites in 78 genes, 18 eQTL-associated genes, and 7 pQTL-associated proteins with population-specific effects [14]. Notably, the MAP3K5 gene displayed contrasting methylation patterns linked to endometriosis risk across different populations [14].

Experimental Approaches and Methodologies

Genome-Wide Association Studies in Diverse Populations

Conducting GWAS in non-European populations requires specific methodological considerations. The Taiwanese-Han GWAS utilized the Taiwan Biobank Array containing 653,291 SNP probes, with rigorous quality control including kinship analysis, multidimensional scaling, and quantile-quantile plots to account for population stratification (λ = 1.01) [12] [13]. For the Iranian study, which focused on candidate genes related to mitophagy, researchers employed a targeted approach with PCR sequencing for the 3'UTR region of each gene, followed by Sanger sequencing [5].

The integration of imputation techniques has enhanced the discovery power in understudied populations. The Taiwanese study used IMPUTE2 for genotype imputation, strengthening their ability to detect associations in genomic regions beyond directly genotyped SNPs [13]. This approach revealed strong signals at rs10822312 (chromosome 10), rs58991632 and rs2273422 (chromosome 20), and rs12566078 (chromosome 1) that were not evident in the initial analysis [13].

Table 2: Key Methodological Approaches in Population-Specific Genetic Studies

Methodology	Application in Population Studies	Key Considerations
Genome-wide Association Studies (GWAS)	Identification of population-specific and shared susceptibility loci	Requires large sample sizes; must account for population stratification; imputation can enhance power
Expression Quantitative Trait Loci (eQTL) Analysis	Mapping genetic variants that influence gene expression in tissue-specific manner	GTEx database provides reference but may lack population diversity; tissue-specific effects are important
Multi-omic Mendelian Randomization	Integration of GWAS, eQTL, mQTL, and pQTL data to infer causality	Requires large-scale omics data; can identify directional relationships between molecular traits and disease
Factor Analysis of Mixed Data (FAMD)	Multivariate analysis of genetic and demographic variables	Useful for integrating different data types; identifies most contributing variables to disease risk
Protein-Protein Interaction Networks	Understanding functional relationships between genes from associated loci	STRING database commonly used; reveals interconnected biological pathways

Functional Validation Techniques

Beyond association testing, researchers have employed sophisticated functional validation methods to characterize population-specific variants. The Iranian study used reverse transcription quantitative PCR (RT-qPCR) to measure gene expression of MFN2, PINK1, and PRKN in endometrial tissues, with 18s rRNA as a reference gene for normalization [5]. The Pffafl method was applied for normalization and fold change calculation, revealing significant differences (P < 0.05) in target gene expression between cases and controls [5].

For protein-level analyses, researchers have turned to protein-protein interaction networks via STRING database, which demonstrated significant interaction (P < 0.0001, FDR < 0.001) between MFN2, PINK1, and PRKN proteins, with these genes clustering together in K-means clustering analysis [5]. This approach helps contextualize genetic findings within biological pathways.

Biological Pathways and Mechanisms

Signaling Pathways in Population-Specific Context

The biological pathways implicated in endometriosis exhibit both conservation and divergence across populations. The Iranian study highlighted the importance of mitophagy-related pathways through MFN2, PINK1, and PRKN genes, which are involved in mitochondrial quality control and cellular energy metabolism [5]. In contrast, the Taiwanese-Han population study revealed enrichment for genes involved in Wnt signaling (WNT4), RNA metabolic processes through long non-coding RNAs (C5orf66 and C5orf66-AS2), and cancer susceptibility pathways [12].

The multi-ancestry study of over 900,000 women identified three interconnected pathway categories as hallmarks for endometriosis across populations: immunopathogenesis, Wnt signaling, and the balance between proliferation, differentiation, and migration of endometrial cells [15]. This comprehensive analysis also suggested significant association of R-spondin 3 (RSPO3) with endometriosis, which plays a crucial role in modulating the Wnt signaling pathway [15].

Tissue-Specific Regulatory Mechanisms

A 2025 investigation into the regulatory effects of endometriosis-associated variants across six physiologically relevant tissues (uterus, ovary, vagina, sigmoid colon, ileum, and peripheral blood) revealed striking tissue specificity in regulatory profiles [6]. In reproductive tissues, eQTL analysis showed enrichment for genes involved in hormonal response, tissue remodeling, and adhesion, whereas in colon, ileum, and peripheral blood, immune and epithelial signaling genes predominated [6]. Key regulators such as MICB, CLDN23, and GATA4 were consistently linked to hallmark pathways including immune evasion, angiogenesis, and proliferative signaling across multiple populations [6].

Research Toolkit and Reagent Solutions

Essential Materials and Experimental Platforms

Table 3: Research Reagent Solutions for Population Genetics of Endometriosis

Reagent/Platform	Specific Application	Function and Features
Affymetrix Axiom TWB Array	GWAS in Taiwanese populations	Contains 653,291 SNP probes optimized for Han Chinese ancestry
Illumina OmniExpress BeadChip	GWAS in European and diverse populations	~720,000 markers; enables imputation in multiple populations
GTEx Database v8	eQTL mapping across tissues	17,382 samples from 838 donors across 52 tissues; reference for expression regulation
Favor Prep RNA Extraction Kit	RNA isolation from endometrial tissues	High-quality RNA extraction from limited tissue samples
Parstous cDNA Synthesis Kit	Reverse transcription for gene expression	Efficient cDNA synthesis compatible with multiple RNA inputs
STRING Database v11.5	Protein-protein interaction analysis	Known and predicted protein interactions with confidence scoring
IMPUTE2 Software	Genotype imputation	Enhances GWAS power by inferring non-genotyped variants
SMR Software v1.3.1	Multi-omic Mendelian randomization	Integrates GWAS, eQTL, mQTL, and pQTL data for causal inference

Analytical and Computational Tools

The statistical analysis of population-specific genetic data requires specialized computational approaches. The Iranian study utilized factor analysis of mixed data (FAMD) implemented in the factoextra and FactoMineR packages in R 4.3 to handle mixed genetic and demographic variables [5]. For multi-omic integration, researchers have employed summary-based Mendelian randomization (SMR) with heterogeneity in dependent instruments (HEIDI) tests to distinguish pleiotropy from linkage [14]. This approach allows for the integration of GWAS summary statistics with QTL data while accounting for population structure.

Implications for Research and Therapeutic Development

Advancing Precision Medicine for Endometriosis

The evidence of population-specific genetic effects in endometriosis has profound implications for therapeutic development and precision medicine approaches. The identification of the MAP3K5 gene with contrasting methylation patterns associated with endometriosis risk across populations suggests potential targets for epigenetic therapies [14]. Similarly, the validation of THRB gene and ENG protein as risk factors in Finnish and UK biobank cohorts highlights the importance of cross-population validation for candidate therapeutic targets [14].

From a diagnostic perspective, the population-specific loci identified in Iranian and Taiwanese-Han populations could form the basis for developing ethnicity-specific risk prediction models. The Iranian study's finding that SNP variability contributed most significantly to differentiating cases from controls suggests that genetic markers may have different predictive values across populations [5]. This is further supported by the Taiwanese study, which linked specific genetic variants to more severe disease manifestations, including deeply infiltrating lesions and associated malignancies [12].

Future Directions in Global Endometriosis Genetics

To fully realize the potential of precision medicine for endometriosis globally, future research must prioritize the inclusion of underrepresented populations in genetic studies. The multi-ancestry study comprising over 900,000 women (31% non-European) represents a step in this direction, identifying 45 significant loci including seven previously unreported and detecting the first genome-wide significant locus (POLR2M) among only African-ancestry individuals [15]. This achievement demonstrates the scientific value of diverse cohorts.

Future studies should also leverage advanced multi-omic approaches to unravel the functional consequences of population-specific variants. The integration of epigenomic data (including methylation and histone modification patterns), transcriptomic profiles from relevant tissues, and proteomic measurements will provide a more comprehensive understanding of how genetic variants influence biological pathways across diverse populations [6] [14]. Furthermore, developing ancestry-specific polygenic risk scores will enhance clinical utility across global populations, moving beyond the current limitations of Eurocentric genetic models.

{# The Technical Whitepaper}

::: {.pagebreak} :::

Tissue-Specific Regulatory Variation: eQTL Analysis Across Diverse Ancestries

The integration of genome-wide association studies (GWAS) with expression quantitative trait loci (eQTL) mapping has revolutionized our understanding of how genetic variants contribute to complex diseases by modulating gene expression in a tissue-specific manner. This whitepaper examines this paradigm within the context of endometriosis, a common gynecological disorder exhibiting significant ethnic heterogeneity in genetic risk locus replication. We detail experimental methodologies for identifying and validating tissue-specific eQTLs, present comprehensive quantitative summaries of endometriosis-associated regulatory variants, and visualize key analytical workflows and biological pathways. Furthermore, we provide an essential toolkit of research reagents and computational resources required for robust analysis of regulatory variation across diverse ancestral populations. This technical guide serves as a foundational resource for researchers and drug development professionals seeking to elucidate the functional mechanisms underlying ethnic disparities in complex disease genetics.

Endometriosis, a chronic inflammatory condition characterized by ectopic endometrial growth, demonstrates a pronounced heritable component with approximately 52% of disease variance attributable to genetic factors [10]. While genome-wide association studies (GWAS) have successfully identified numerous susceptibility loci for endometriosis, a critical challenge remains: the majority of associated variants reside in non-coding genomic regions, complicating the interpretation of their functional consequences [10] [6]. This limitation is particularly relevant in the context of ethnic diversity, as GWAS loci identified in one population often fail to replicate in others due to differences in allele frequencies, linkage disequilibrium patterns, and population-specific environmental exposures [13] [5].

Expression quantitative trait loci (eQTL) mapping provides a powerful analytical framework for bridging this gap between genetic association and biological mechanism. eQTLs are genetic variants that influence gene expression levels, acting in either cis (proximal to the gene) or trans (distant from the gene) configurations. Tissue-specific eQTL analyses are especially crucial for endometriosis, as regulatory effects may manifest specifically in reproductive tissues (uterus, ovary), affected extra-pelvic sites (colon, ileum), or systemically relevant tissues (peripheral blood) [6]. Recent studies have demonstrated that endometriosis-associated variants show distinct regulatory profiles across tissues, with reproductive tissues enriching for genes involved in hormonal response and tissue remodeling, while intestinal and blood tissues show predominance of immune and epithelial signaling pathways [6].

This technical guide provides a comprehensive framework for conducting tissue-specific eQTL analyses within the context of diverse ancestries, using endometriosis as a model complex disease. We synthesize methodological approaches, present quantitative summaries of established findings, visualize analytical workflows, and catalog essential research reagents to empower robust investigation of population-specific regulatory variation.

Tissue-Specific eQTLs in Endometriosis Pathogenesis

Biological Significance of Tissue-Specific Regulation

Tissue-specific eQTL effects are paramount for understanding endometriosis pathogenesis, as functional consequences of genetic risk variants may only manifest in specific cellular environments. Analyses integrating endometriosis GWAS findings with eQTL data from six biologically relevant tissues—uterus, ovary, vagina, sigmoid colon, ileum, and peripheral blood—reveal distinct regulatory landscapes [6]. In reproductive tissues, endometriosis-associated eQTLs predominantly regulate genes involved in estrogen response, cellular adhesion, and tissue remodeling processes central to lesion establishment and survival. Conversely, in intestinal tissues and peripheral blood, these variants preferentially influence immune surveillance pathways and inflammatory signaling, reflecting the systemic inflammatory component of endometriosis [6].

This tissue-specific regulatory architecture underscores the limitation of relying solely on accessible tissues like blood for eQTL studies of reproductive disorders. For instance, a variant might regulate an immunomodulatory gene in blood while having no effect on the same gene in ovarian tissue, or vice versa. Consequently, failure to examine relevant disease tissues risks missing functionally consequential regulatory relationships. The GTEx Project has been instrumental in providing multi-tissue eQTL resources, with version 8 containing data from 838 post-mortem donors across 17,382 RNA-seq samples from diverse tissues [16], representing an invaluable reference for tissue-specific regulatory inference.

Ethnic Diversity in Endometriosis GWAS Loci Replication

Ethnic differences in endometriosis genetic architecture present both challenges and opportunities for elucidating disease mechanisms. Several studies have documented population-specific associations, exemplified by the identification of distinct susceptibility loci in European, East Asian, and Taiwanese populations [10] [13] [5]. A GWAS and replication study in a Taiwanese population, for instance, identified novel suggestive loci that did not reach genome-wide significance in larger European studies, including variants in PTPRD and FERMT1 [13]. Similarly, research in an Iranian population revealed significant associations between endometriosis and specific SNPs in MFN2, PINK1, and PRKN that varied with demographic and geographic factors [5].

These ethnic disparities arise from several sources. First, differences in linkage disequilibrium patterns across populations can result in population-specific tag SNPs that mark causal variants with varying efficiency. Second, allele frequency differences can render certain variants informative in one population but uninformative in others. Third, gene-by-environment interactions may modify the effect sizes of genetic variants across populations with different lifestyles, environmental exposures, or epigenetic landscapes [5]. Finally, population-specific genetic architecture may involve truly different causal variants and genes underlying disease risk.

Table 1: Selected Endometriosis-Associated Loci with Tissue-Specific eQTL Effects

Genomic Locus	Lead SNP	Tissue with Significant eQTL	Regulated Gene	Reported Ethnicity
7p15.2	rs12700667	Uterus, Ovary	N/A (intergenic)	European [10]
9p21.3	rs10965235	Multiple	CDKN2B-AS1	Japanese [10]
1p36.12	rs2235529	Reproductive tissues	WNT4, LINC00339	European [17]
2q23.3	rs1519761	Multiple	RND3, RBM43	European [17]
6p22.3	rs6907340	Multiple	ID4, RNF144B	European [17]
4q	rs13126673	Ovary, Testis	INTU	Taiwanese [13]

Experimental Methodologies for eQTL Mapping

Genome-Wide Association Study Design

GWAS constitutes the foundational step for identifying genetic variants associated with endometriosis risk. The standard approach involves genotyping hundreds of thousands to millions of single nucleotide polymorphisms (SNPs) in cases (surgically confirmed endometriosis) and controls (women without endometriosis), followed by association testing. Key design considerations include:

• Sample Size and Power: Early endometriosis GWAS included 1,900-3,200 cases [10], while recent meta-analyses have combined over 17,000 cases and 191,000 controls [13]. Larger sample sizes enhance power to detect variants with modest effect sizes.

• Phenotyping Precision: Reliable case ascertainment through surgical confirmation (laparoscopy/laparotomy) is critical. Sub-phenotyping by disease stage (rAFS I-IV) or lesion characteristics provides additional resolution, as many loci show stronger associations with moderate-severe (stage III/IV) disease [10].

• Population Stratification Control: Methods such as principal component analysis (PCA) [17] and genetic matching of cases and controls minimize false positives due to population structure. Genomic inflation factors (λ) should be close to 1.0 after correction [17].

• Replication and Meta-Analysis: Independent replication in separate cohorts verifies initial associations. Meta-analyses combining multiple datasets enhance power; one endometriosis study combined four GWAS and four replication studies totaling 11,506 cases and 32,678 controls [10].

• Ethnic Diversity Considerations: Deliberate inclusion of diverse ancestral groups enables trans-ethnic meta-analysis, which can improve fine-mapping resolution and facilitate discovery of population-specific loci [13] [5].

Expression Quantitative Trait Loci Analysis

eQTL mapping identifies associations between genetic variants and gene expression levels. The standard protocol involves:

• Tissue Collection and RNA Sequencing: Collect relevant tissues (e.g., endometrium, ovary, ectopic lesions) with appropriate ethical approval and informed consent. For endometriosis, both eutopic endometrium and ectopic lesions provide valuable insights. Extract high-quality RNA and perform RNA sequencing with sufficient depth (typically 30-50 million reads per sample).

• Genotype Data Processing: Perform quality control on genotype data, excluding SNPs with high missingness (>5%), deviation from Hardy-Weinberg equilibrium (p < 1×10⁻⁶), or low minor allele frequency (<1%). Impute genotypes using reference panels (e.g., 1000 Genomes Project) to increase variant coverage.

• Cis-eQTL Mapping: Test for associations between SNPs and genes within a 1 Mb window (typically 500 kb upstream and downstream of the gene's transcription start site). Account for technical covariates (batch effects, RNA quality metrics) and biological covariates (age, genetic ancestry principal components). Multiple testing correction is essential, with false discovery rate (FDR) < 0.05 commonly applied [6].

• Integration with GWAS: Colocalization analysis determines whether the same underlying genetic variant influences both disease risk (GWAS signal) and gene expression (eQTL signal). Statistical methods such as COLOC or eCAVIAR test for shared causal variants [13].

• Functional Validation: Confirm regulatory effects through:

  • Allele-Specific Expression (ASE): Measure imbalanced expression of maternal and paternal alleles in heterozygous individuals, serving as an internal control for cis-regulatory effects [18].
  • In Vitro Experiments: Use luciferase reporter assays to test allele-specific effects on transcriptional activity.
  • Functional Genomics: Integrate with epigenetic annotations (ENCODE/ROADMAP) to prioritize variants in regulatory elements [18].

Figure 1: Workflow for Integrated GWAS and eQTL Analysis. The diagram outlines key stages from sample collection through functional validation, highlighting parallel processing of molecular data and convergence in integrative analyses.

Quantitative Data Synthesis

Endometriosis-Associated eQTLs Across Tissues

Systematic analysis of 465 genome-wide significant endometriosis-associated variants reveals extensive tissue-specific regulatory effects. When cross-referenced with GTEx v8 data, these variants demonstrate distinct regulatory profiles across six physiologically relevant tissues [6]. The following table summarizes the distribution and characteristics of these regulatory associations:

Table 2: Tissue-Specific eQTL Effects of Endometriosis-Associated Variants

Tissue	Number of Significant eQTLs	Representative Regulated Genes	Enriched Biological Pathways
Uterus	47	GATA4, GREM1	Hormone Response, Tissue Remodeling
Ovary	52	CLDN23, FN1	Ovulation, Steroidogenesis, Cell Adhesion
Vagina	38	MICB, WNT4	Epithelial Barrier Function, Inflammation
Sigmoid Colon	61	MICB, IL1R1	Immune Surveillance, Epithelial Signaling
Ileum	44	TAP1, CLDN23	Mucosal Immunity, Barrier Integrity
Whole Blood	89	MICB, TAP1	Systemic Inflammation, Immune Regulation

Chromosomal distribution analyses indicate that endometriosis-associated variants are not randomly distributed but cluster on specific chromosomes, with chromosomes 1, 2, 6, 8, 9, and 10 harboring the highest densities of risk loci [6]. Notably, chromosome 8 contains the largest number of associated variants (n=66), followed by chromosome 6 (n=43) and chromosome 1 (n=42) [6].

Ethnic-Specific Endometriosis Loci

Comparative analysis of endometriosis GWAS across diverse populations reveals both shared and population-specific genetic architecture:

Table 3: Ethnic Diversity in Endometriosis Genetic Associations

Ancestral Population	Sample Size (Cases/Controls)	Representative Population-Specific Loci	Replicated in Other Populations
European	2,019/14,471 [17]	rs2235529 (1p36.12), rs1519761 (2q23.3)	Partially in East Asians
Japanese	1,907/5,292 [10]	rs10965235 (CDKN2B-AS1)	Yes in Europeans
Taiwanese	259/171 [13]	rs13126673 (INTU), rs10739199 (PTPRD)	Not extensively replicated
Iranian	25/25 [5]	rs3088064 (MFN2), rs513414 (PINK1)	Population-specific effects observed

These findings highlight the value of diverse inclusion in genetic studies. The Taiwanese GWAS, though smaller in sample size, identified the INTU locus (rs13126673) as a potential population-specific risk factor, with subsequent eQTL analysis demonstrating allele-specific effects on INTU expression in endometriotic tissues (p=0.034) [13]. Similarly, the Iranian study revealed significant associations between endometriosis and specific MFN2 and PINK1 variants that interacted with geographic and demographic factors [5].

Signaling Pathways and Regulatory Networks

Endometriosis-associated eQTLs converge on several biologically coherent pathways that illuminate disease mechanisms. The regulatory networks show distinct tissue-specific organization, with reproductive tissues emphasizing developmental and hormonal pathways, while intestinal and immune tissues highlight inflammatory processes [6].

Figure 2: Tissue-Specific Regulatory Networks in Endometriosis. The diagram illustrates how endometriosis-associated genetic variants regulate distinct genes across tissues, converging on core biological pathways relevant to disease pathogenesis.

Key pathway modules influenced by endometriosis eQTLs include:

• WNT Signaling Pathway: Variants near WNT4 (rs7521902) affect expression in reproductive tissues, disrupting developmental patterning and cellular proliferation signals [10] [17].

• Hormone Response Pathways: Genes including GREB1 and WNT4 show regulated expression in uterine and ovarian tissues, potentially altering estrogen sensitivity and hormonal drive of lesion growth [10].

• Immune Surveillance Mechanisms: MICB and TAP1, regulated primarily in blood and intestinal tissues, participate in antigen presentation and natural killer cell recognition, implicating immune evasion in endometriosis pathogenesis [6].

• Cell Adhesion and Extracellular Matrix Organization: FN1 (fibronectin 1) shows eQTL effects in multiple tissues, potentially facilitating attachment and survival of ectopic endometrial cells [10] [6].

These pathway analyses reveal how tissue-specific regulatory effects of genetic variants converge on coherent biological processes, providing a mechanistic framework for understanding endometriosis pathogenesis and identifying potential therapeutic targets.

The Scientist's Toolkit

Robust investigation of tissue-specific eQTLs in diverse ancestries requires specialized research reagents and computational resources. The following table catalogs essential tools referenced in endometriosis genetics studies:

Table 4: Essential Research Reagents and Resources for eQTL Studies

Resource Category	Specific Tool/Resource	Primary Function	Application in Endometriosis Research
Genotyping Arrays	Illumina OmniExpress BeadChip [17], Affymetrix Axiom TWB array [13]	Genome-wide SNP genotyping	GWAS discovery in European and Taiwanese populations
eQTL Databases	GTEx Portal v8 [6] [13]	Tissue-specific eQTL reference	Identification of regulatory effects for endometriosis loci
Variant Annotation	Ensembl VEP [6]	Functional consequence prediction	Annotation of endometriosis-associated variants
Genotype Imputation	IMPUTE2 [17], 1000 Genomes Project	Inference of ungenotyped variants	Enhanced variant coverage in GWAS meta-analyses
Association Analysis	PLINK, ADMIXTURE [17]	GWAS and population structure analysis	Identification of risk loci and ancestry estimation
Functional Validation	ASE analysis [18], RT-qPCR [13]	Experimental confirmation of regulatory effects	Validation of eQTL effects in endometriotic tissues
Pathway Analysis	MSigDB Hallmark Gene Sets [6]	Biological pathway enrichment	Interpretation of regulated gene sets

These resources collectively enable the comprehensive workflow from variant discovery to functional validation. Particular emphasis should be placed on using multi-ethnic reference panels for genotype imputation and leveraging tissue-specific eQTL resources that include relevant reproductive tissues. For functional validation, allele-specific expression analysis provides a robust internal control approach that complements traditional eQTL mapping [18].

Tissue-specific eQTL analysis represents a powerful approach for elucidating the functional consequences of genetic risk variants in endometriosis across diverse ancestral populations. The methodologies, data, and resources synthesized in this technical guide provide a foundation for advancing this research paradigm. Key principles emerging from current research include: (1) the critical importance of examining eQTL effects in disease-relevant tissues rather than relying solely on accessible proxies like blood; (2) the value of diverse ancestral inclusion for both discovering population-specific effects and improving fine-mapping resolution; and (3) the necessity of integrating multiple analytical approaches—GWAS, eQTL mapping, colocalization, and functional validation—to establish robust variant-to-function relationships.

Future directions in this field will likely include expanded eQTL mapping in underrepresented ancestral populations, single-cell resolution eQTL analyses to capture cellular heterogeneity, and integration of multi-omics data (epigenomics, proteomics) to construct comprehensive regulatory networks. Such advances will further illuminate the genetic architecture of endometriosis and other complex diseases, ultimately facilitating the development of more targeted and effective therapeutic strategies across all populations.

The Impact of Underrepresented Diversity on Gene Discovery and Heritability Estimates

Endometriosis, a complex inflammatory condition affecting approximately 10% of reproductive-aged women globally, demonstrates a substantial heritable component estimated at around 52% [10]. Despite increasing recognition of this genetic basis, the field of endometriosis genomics faces a fundamental challenge: the systematic underrepresentation of diverse populations in genetic studies. This diversity gap critically limits the comprehensiveness and generalizability of genetic discoveries, potentially obscuring key pathogenic mechanisms and therapeutic targets relevant to global populations [19] [20]. The current landscape of genomic research is characterized by pronounced ancestral biases, with reference genomes and large-scale association studies historically oversampling individuals of European ancestry while undersampling other populations [19] [21]. This review examines how this limited diversity impacts gene discovery efforts and heritability estimates in endometriosis research, explores methodological frameworks for enhancing inclusivity, and discusses the translational implications for drug development and personalized medicine approaches.

Current State of Population Representation in Endometriosis Genomics

Quantitative Assessment of Representation Disparities

Genome-wide association studies (GWAS) have identified numerous genetic loci associated with endometriosis risk, yet the populations represented in these studies remain disproportionately homogeneous. A quantitative assessment of representation in datasets used across human genomics reveals that relative proportions of ancestries represented in research datasets show insufficient representation of global ancestral genetic diversity when compared to global census populations [20]. Some populations have greater proportional representation in data relative to their population size and the genomic diversity present in their ancestral haplotypes, creating a significant representation gap [20].

Table 1: Endometriosis GWAS by Ancestral Representation

Study Reference	Primary Ancestries	Sample Size	Number of Loci Identified	Limitations in Diversity
Rahmioglu et al. (2014) [10]	European, Japanese	11,506 cases; 32,678 controls	6 genome-wide significant	Limited ancestral diversity; heterogeneity in 2 loci
Multi-ancestry GWAS (2025) [2]	Multi-ancestry	~105,869 cases; ~1.4M total	80 significant (37 novel)	First to include adenomyosis associations
Combinatorial Analysis (2025) [22]	White European, Multi-ancestry US	UK Biobank and All of Us cohorts	1,709 disease signatures	Testing reproducibility across ancestries

Consequences of Limited Diversity in Genomic Databases

The underrepresentation of diverse populations in genomic databases has profound implications for both research and clinical practice. Limited reference genomes from minoritized populations can lead to elevated rates of variants of uncertain significance (VUS) that may lead to misapplication of precision therapies [19]. Furthermore, inadequate diversity perpetuates health disparities and exacerbates biases that may harm patients with underrepresented ancestral backgrounds [20]. In one pan-assembly of genomes, approximately 10% of African DNA sequences were missing from currently used reference genomes, creating critical gaps in our understanding of global genomic architecture [19]. This representation problem extends beyond basic discovery to clinical translation, as genetic misdiagnoses and clinical practices insensitive to diverse population needs may result from these evidence gaps [19].

Impact on Gene Discovery and Biological Insights

Limitations in Identifying Population-Specific Risk Variants

The restricted ancestral representation in endometriosis GWAS has directly limited the identification of population-specific risk variants and biological pathways. Current GWAS have collectively identified forty-two single nucleotide polymorphisms (SNPs) linked to endometriosis [7], but these likely represent only a fraction of the true genetic architecture of the disease across global populations. Evidence suggests that specific risk alleles could act differently in the pathogenesis of the disease in different ethnic populations [5]. For instance, a study on the Sardinian population did not show a significant association between variants previously associated with endometriosis in other European populations and disease risk, suggesting population-specific genetic architectures [5]. Similarly, research in an Iranian population identified significant associations between endometriosis and genes involved in mitophagy (MFN2, PINK1, and PRKN) that demonstrated different expression patterns and genetic associations compared to other populations [5].

Pathway Discovery and Functional Implications

The biological pathways implicated in endometriosis pathogenesis may vary across ancestral groups, but limited diversity in studies constrains our understanding of these mechanisms. Combinatorial analytics approaches have identified multi-SNP disease signatures associated with endometriosis that show varying reproducibility across ancestral groups [22]. Pathways enriched in these disease signatures include cell adhesion, proliferation and migration, cytoskeleton remodeling, angiogenesis, as well as biological processes involved in fibrosis and neuropathic pain [22]. Notably, when testing the reproducibility of genetic signatures identified in a white European UK Biobank cohort in a multi-ancestry American cohort, reproducibility rates ranged from 66% to 88% across different ancestral subgroups, with the highest reproducibility for higher frequency signatures [22]. This suggests that while some core pathogenic mechanisms may be shared across populations, significant population-specific effects exist.

Table 2: Novel Genetic Discoveries Enabled by Diverse Cohort Studies

Genetic Finding	Study Population	Biological Pathway	Cross-Ancestry Validation
37 novel endometriosis loci [2]	Multi-ancestry (105,869 cases)	Immune regulation, tissue remodeling, cell differentiation	Identified through intentional multi-ancestry design
5 adenomyosis loci [2]	Multi-ancestry (105,869 cases)	Not specified	First ever variants reported for adenomyosis
75 novel genes via combinatorial analysis [22]	White European with multi-ancestry replication	Autophagy, macrophage biology	73-85% reproducibility in non-European cohorts
Regulatory variants in IL-6, CNR1, IDO1 [7]	Genomics England cohort	Immune dysregulation, pain sensitivity	Included Neandertal and Denisovan-derived variants

Methodological Frameworks for Inclusive Genomics Research

Proposed Framework for Diversity, Equity, and Inclusion

To address the genomic gap in discovery and translation, researchers have proposed theoretically driven approaches for engagement of diverse participants in genomics research [19]. This framework emphasizes four core values: (1) Inclusivity - efforts should be inclusive of a broad population across the research continuum; (2) Equity - research processes should include diverse perspectives to achieve optimal diversity in research participation; (3) Usability - study materials should support a range of health literacy/numeracy levels with cultural linguistic adaptation; and (4) Bidirectionality - study protocols should allow researchers to learn from participants, and participants to be engaged and empowered throughout the process [19]. The framework highlights the involvement of a multistakeholder team, including the participants and communities to be engaged, to ensure robust methods for recruitment, retention, return of genomic results, and follow-up monitoring [19].

Diagram: Framework for promoting diversity, equity, and inclusion in genomics research. This multistakeholder approach emphasizes bidirectional relationships between researchers and communities to ensure equitable representation and research outputs [19].

Methodological Considerations for Diverse Cohort Studies

Implementing inclusive genomics research requires careful methodological considerations across the research continuum. Key domains requiring attention include sample design, communication strategies, research processes, and output management [19]. For sample design, researchers must explicitly consider why diverse populations are needed to achieve research objectives, which specific groups should be included to address scientific questions, and what sample sizes are required to ensure adequate statistical power for population subgroup analyses [19]. Communication strategies must develop bidirectional relationships with participant, community, advocacy, and other partners to ensure appropriate community input for research design, execution, and reporting [19]. Process considerations include protocols for biospecimen collection, storage, and future use that respect cultural and spiritual values, as well as culturally tailored informed consent procedures [19].

Experimental Approaches and Research Protocols

Multi-ancestry Genome-Wide Association Studies

Recent advances in multi-ancestry GWAS methodologies provide templates for inclusive study designs. The 2025 multi-ancestry GWAS of endometriosis and adenomyosis in almost 1.4 million women, including 105,869 cases, demonstrates the power of this approach [2]. The experimental protocol for such studies typically involves:

• Cohort Identification and Ascertainment: Identifying cases through surgical confirmation, diagnostic codes, or self-report across multiple biobanks and research cohorts with diverse ancestral representation.

• Genotyping and Imputation: Standardized genotyping arrays followed by imputation using multi-ancestry reference panels to increase genomic coverage across diverse populations.

• Association Testing: Performing GWAS within ancestral groups followed by meta-analysis to identify population-specific and cross-population associations.

• Fine-mapping and Functional Annotation: Using statistical fine-mapping methods to identify causal variants and colocalization approaches to link associations to molecular phenotypes across tissues.

• Multi-omics Integration: Integrating genomic findings with transcriptomic, epigenetic, and proteomic data to elucidate biological mechanisms [2].

This approach identified 80 genome-wide significant associations, 37 of which are novel, including five loci that are the first ever variants reported for adenomyosis [2].

Combinatorial Analytics for Cross-Ancestry Validation

Combinatorial analytics approaches offer complementary methods to traditional GWAS for identifying genetic risk factors that reproduce across ancestries. The PrecisionLife combinatorial analytics platform identifies multi-SNP disease signatures significantly associated with endometriosis through a multi-step process:

• Dataset Preparation: Processing genotyping data from cohorts such as UK Biobank, implementing quality control, and stratifying by ancestry.

• Combinatorial Analysis: Identifying combinations of 2-5 SNPs that together show significant association with endometriosis risk, moving beyond single-variant analyses.

• Pathway Enrichment Analysis: Mapping genes implicated in these combinatorial signatures to biological pathways to identify convergent mechanisms.

• Cross-ancestry Validation: Testing the reproducibility of identified disease signatures in independent, multi-ancestry cohorts such as the All of Us Research Program [22].

This methodology identified 1,709 disease signatures comprising 2,957 unique SNPs that were significantly enriched for pathways including cell adhesion, proliferation and migration, cytoskeleton remodeling, and angiogenesis [22]. Notably, these signatures showed high reproducibility rates (66-88%) in non-white European subcohorts, suggesting their relevance across ancestries [22].

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Materials and Platforms for Diverse Genomics

Research Reagent/Platform	Function	Application in Diverse Genomics
PrecisionLife Combinatorial Analytics Platform [22]	Identifies multi-SNP disease signatures	Discovers genetic risk factors reproducible across ancestries
Genomics England 100,000 Genomes Project [7]	Provides whole-genome sequencing data	Enables regulatory variant discovery in diverse populations
All of Us Research Program Data [22]	Multi-ancestry cohort data	Facilitates cross-ancestry validation of genetic discoveries
LDlink Suite [7]	Linkage disequilibrium and population genetics	Analyzes population-specific variant correlations and evolutionary history
Multi-ancestry GWAS Meta-analysis Methods [2]	Statistical genetics approaches	Identifies novel loci across ancestral groups
STRING Database [5]	Protein-protein interaction networks	Maps population-specific genetic findings to biological pathways
Factor Analysis of Mixed Data (FAMD) [5]	Multivariate statistical analysis	Integrates genetic and demographic variables in diverse cohorts

Pathogenic Mechanisms and Therapeutic Implications

Enhanced Biological Insights from Diverse Cohorts

The inclusion of diverse populations in genetic studies has expanded our understanding of endometriosis pathogenesis beyond mechanisms identified primarily in European cohorts. Multi-omics integration in diverse studies has revealed that genetic variation influences endometriosis risk through transcriptomic, epigenetic, and proteomic regulation across multiple tissues, converging on pathways involved in immune regulation, tissue remodeling, and cell differentiation [2]. Studies specifically designed to include diverse populations have identified novel genes implicating autophagy and macrophage biology in endometriosis pathogenesis - mechanisms that were underappreciated in earlier, less diverse studies [22]. Furthermore, research examining the intersection of ancient genetic regulatory variants and modern environmental exposures has identified how Neandertal and Denisovan-derived variants in genes like IL-6 and CNR1 may contribute to immune dysregulation and pain sensitivity in endometriosis [7].

Diagram: Enhanced discovery pipeline enabled by diverse cohort inclusion. Incorporating diverse populations reveals novel genetic risk factors and pathogenic mechanisms, leading to more inclusive therapeutic development and precision medicine approaches [2] [22] [7].

Therapeutic Translation and Drug Development Implications

The genetic insights gained from diverse cohorts directly inform therapeutic development and repurposing opportunities. Drug-repurposing analyses based on multi-ancestry genetic findings have highlighted potential therapeutic interventions currently used for breast cancer and preterm birth prevention [2]. Combinatorial analytics approaches have identified 75 novel genes associated with endometriosis that represent credible targets for drug discovery, repurposing, and/or repositioning [22]. Importantly, the genetic risk factors identified in diverse cohorts interact with clinical manifestations such as abdominal pain, anxiety, migraine, and nausea, suggesting opportunities for targeting specific symptom profiles [2]. These findings enable more precise stratification of patient populations for clinical trials and targeted therapeutic development that may benefit broader demographic groups.

The impact of underrepresented diversity on gene discovery and heritability estimates in endometriosis research is profound and far-reaching. Limited ancestral representation in genetic studies has constrained our understanding of the genetic architecture of endometriosis, potentially obscured population-specific biological mechanisms, and hindered the development of universally applicable diagnostic tools and therapies. However, emerging frameworks and methodologies specifically designed to enhance diversity in genomics research promise to address these limitations. Intentional inclusion of diverse populations in genetic studies has already expanded the catalog of endometriosis risk variants, revealed novel biological pathways, and identified potential therapeutic targets with relevance across ancestries. As the field moves forward, continued emphasis on multistakeholder engagement, culturally responsive research practices, and equitable translation of findings will be essential to ensure that advances in endometriosis genetics benefit all affected individuals regardless of ancestral background. Future research priorities should include deliberate oversampling of underrepresented populations, development of ancestry-aware analytic methods, and explicit attention to the ethical implementation of genomic discoveries in diverse clinical settings.

Methodological Innovations for Cross-Ancestry Endometriosis Genetics

Endometriosis, a chronic inflammatory condition affecting approximately 10% of reproductive-aged women, demonstrates substantial heritability estimated at around 52% [10]. Despite this strong genetic component, traditional genome-wide association studies (GWAS) have explained only a limited fraction of disease variance. The most recent large-scale GWAS meta-analysis identified 42 genomic loci associated with endometriosis risk, yet together these explain only approximately 5% of disease variance [4] [23]. This limited explanatory power stems partly from the assumption of additive SNP effects in traditional polygenic risk scores (PRS), which fails to capture the complex epistatic interactions underlying chronic disease pathogenesis [24].

A critical limitation in current endometriosis genetics research involves the inadequate representation of diverse ancestral populations. A systematic review of endometriosis literature published in 2022 revealed that only 10.0% of studies reported participants' race and/or ethnicity, with overall poor reporting quality even in journals claiming adherence to International Committee of Medical Journal Editors (ICMJE) recommendations [25]. This lack of diversity creates significant barriers to developing genetic risk models that perform equitably across populations. While multi-ancestry GWAS efforts are emerging, including one study incorporating 31% non-European samples [15], the field remains dominated by European-ancestry cohorts, limiting the portability and clinical utility of resulting risk prediction models [26].

Combinatorial analytics represents a paradigm shift in complex disease genetics by moving beyond single-variant additive models to detect multi-variant synergistic interactions. This approach enables the identification of disease signatures comprising specific combinations of genetic variants that collectively influence disease risk through non-linear interactions [24]. By focusing on these interactive effects, combinatorial analytics offers a more biologically plausible framework for understanding complex diseases like endometriosis while potentially improving risk prediction across diverse ancestral groups.

Limitations of Current GWAS and PRS Approaches in Diverse Populations

Traditional GWAS methodologies operate on the fundamental assumption that genetic variants contribute independently to disease risk in an additive manner. This approach aggregates the individual effects of numerous single nucleotide polymorphisms (SNPs) identified as disease-associated, potentially weighting them by frequency or effect size, but ultimately summing these independent contributions to calculate overall genetic risk [24]. For endometriosis, this has resulted in the identification of multiple susceptibility loci, including regions near WNT4, GREB1, FN1, IL1A, and VEZT [27], yet with limited clinical utility due to modest effect sizes and poor trans-ancestry portability.

The statistical foundation of polygenic risk scores presents particular challenges for diverse population applications. PRS models trained predominantly on European-ancestry cohorts demonstrate substantially reduced predictive accuracy when applied to non-European populations [26] [28]. This performance degradation stems from differences in linkage disequilibrium patterns, allele frequency variations, and potentially ancestry-specific causal variants not captured in discovery cohorts. Recent efforts to develop multi-ancestry PRS for various complex diseases have shown improvement, with one coronary artery disease model (GPSMult) demonstrating increased strength of associations across all ancestries [28], but similar advances in endometriosis have been limited.

The inadequate reporting of racial and ethnic data in endometriosis research compounds these methodological limitations. Prospective studies report race/ethnicity more frequently than retrospective studies (56.9% vs. 27.7%), and multicentre studies do so more often than single-centre studies (67.7% vs. 32.3%) [25]. However, when race and ethnicity are reported, the methodology of classification is frequently unspecified (67.7%), and adherence to ICMJE reporting recommendations remains notably low [25]. This reporting inconsistency creates fundamental barriers to understanding and addressing health disparities in endometriosis diagnosis, treatment, and outcomes across diverse populations.

Table 1: Comparing Genetic Risk Assessment Approaches

Feature	Traditional PRS	Combinatorial Risk Scores
Statistical Foundation	Additive model of independent SNP effects	Non-linear model of interacting SNP combinations
Variant Interactions	Not captured	Explicitly modeled and detected
Patient Stratification	Population-level averages	High-resolution subgroup identification
Ancestry Portability	Limited; performance degrades in underrepresented populations	Improved; combinatorial signatures show higher cross-ancestry reproducibility
Biological Interpretation	Limited by additive assumption	Captures pathway-level interactions and biological networks
Variance Explained	~5% for endometriosis [4] [23]	Higher potential through interaction effects

Combinatorial Analytics: Methodology and Workflow

Combinatorial analytics employs a fundamentally different approach to genetic risk assessment by detecting specific combinations of genetic variants that collectively associate with disease risk through non-linear interactions. The PrecisionLife combinatorial analytics platform exemplifies this methodology, analyzing datasets to identify multi-SNP disease signatures comprising combinations of 2-5 SNPs that demonstrate significant association with disease phenotypes [4] [23]. These combinations, termed "disease signatures," typically exhibit very high statistical significance (lower p-values than single SNPs) and represent specific effects on patient subgroups rather than averaged effects across the entire population [24].

The analytical workflow begins with high-resolution patient stratification, partitioning the patient population into biologically relevant subgroups based on shared combinatorial signatures rather than relying on heterogeneous case-control definitions. This stratification enables the detection of risk associations that might be obscured in population-wide analyses. For each subgroup, the platform identifies specific SNP combinations that differentiate cases from controls with high statistical significance, then validates these associations through rigorous permutation testing to control false discovery rates [24] [4].

A key advantage of this approach is its ability to detect risk signatures that replicate across diverse ancestral groups. In a recent endometriosis study, researchers identified 1,709 disease signatures comprising 2,957 unique SNPs in combinations of 2-5 SNPs that were associated with increased endometriosis prevalence in a white European UK Biobank cohort [4] [23]. When these signatures were tested in a multi-ancestry American cohort from the All of Us Research Program, 58-88% showed significant enrichment, with reproducibility rates reaching 80-88% for higher frequency signatures (greater than 9% frequency) [23]. Importantly, these disease signatures maintained high reproducibility rates in non-white European sub-cohorts (66-76% for signatures with greater than 4% frequency) [4] [23], demonstrating improved trans-ancestry portability compared to traditional PRS.

Experimental Validation: Protocols for Cross-Ancestry Reproducibility

Cohort Selection and Preparation

Robust validation of combinatorial risk signatures requires carefully designed multi-ancestry cohorts with comprehensive phenotypic data. The recently published endometriosis study utilized two primary cohorts: a white European UK Biobank (UKB) cohort comprising approximately 500,000 participants aged 40-69 years, and a multi-ancestry American cohort from the All of Us (AoU) Research Program [4] [23]. The UKB participants were genotyped using a custom Axiom array assessing 825,927 genetic variants, with imputation performed using the Haplotype Reference Consortium and UK10K + 1KG reference panel, resulting in 96 million variants [26]. For analysis, researchers selected high-quality variants with minor allele frequency >0.001 and Hardy-Weinberg equilibrium P value >10⁻¹⁰ [26].

The All of Us cohort provided diverse ancestral representation essential for validating trans-ancestry reproducibility. Researchers controlled for population structure using genetic principal components and ancestry-informative markers to avoid spurious associations due to population stratification [4]. This approach enabled stratified analysis across different ancestral subgroups while maintaining statistical power through the cohort's size and diversity. Importantly, both cohorts included extensive phenotypic data, with endometriosis cases identified through diagnostic codes and surgical confirmation where available, though specific diagnostic criteria varied between cohorts [23].

Statistical Validation Framework

The validation protocol employed a multi-stage statistical framework to assess reproducibility and significance. First, disease signatures identified in the discovery cohort (UKB) were tested for association with endometriosis in the validation cohort (AoU) using logistic regression models adjusted for age, genetic principal components, and other relevant covariates. A signature was considered reproduced if it showed a consistent direction of effect and nominal significance (P<0.05) in the validation cohort [23].

For enrichment analysis, researchers compared the observed replication rate against the expected null distribution using binomial tests. Signatures were stratified by frequency in the validation cohort, with high-frequency signatures (greater than 9% frequency) showing the strongest reproducibility (80-88%, p<0.01) [4] [23]. This frequency-dependent reproducibility pattern suggests that combinatorial signatures with sufficient representation in diverse populations maintain their predictive power across ancestral groups, addressing a critical limitation of traditional PRS.

To establish biological relevance, researchers conducted pathway enrichment analyses using genes mapped from reproduced signatures. These analyses identified significant enrichment in pathways including cell adhesion, proliferation and migration, cytoskeleton remodeling, angiogenesis, and biological processes involved in fibrosis and neuropathic pain [4]. This functional validation strengthens the case for combinatorial signatures as biologically meaningful risk indicators rather than statistical artifacts.

Table 2: Experimental Reagents and Resources for Combinatorial Analysis

Resource/Reagent	Specification	Application in Analysis
Genotyping Array	Custom Axiom array (UK Biobank)	Initial variant detection with 825,927 genetic variants [26]
Imputation Reference	Haplotype Reference Consortium + UK10K + 1KG	Phasing and imputation to ~96 million variants [26]
Analysis Platform	PrecisionLife combinatorial analytics	Detection of multi-SNP combinations and patient stratification [4]
Validation Cohorts	All of Us Research Program, UK Biobank	Cross-ancestry replication studies [4] [23]
Pathway Databases	KEGG, Reactome, GO	Biological interpretation of identified risk signatures [4]
Statistical Software	R, Python, Stata	Statistical analysis and visualization [25] [23]

Key Findings: Novel Genetic Insights into Endometriosis Pathogenesis

Combinatorial analytics has revealed substantial novel genetic architecture underlying endometriosis risk that was undetected by previous GWAS. The analysis of UK Biobank and All of Us cohorts identified 195 unique SNPs mapping to 98 genes in high-frequency reproducing signatures [23]. Of these, only 7 genes overlapped with previously identified endometriosis meta-GWAS associations, while 16 had prior literature associations with endometriosis, and a remarkable 75 represented novel gene associations not previously linked to endometriosis pathogenesis [4] [23].

Among the most significant novel findings were nine high-frequency genes occurring in reproducing signatures independently of any known GWAS associations. These genes provide new evidence connecting endometriosis to autophagy processes and macrophage biology, suggesting novel pathogenic mechanisms [23]. The signatures containing these nine genes showed particularly strong reproducibility rates (73-85%) across diverse ancestral groups, highlighting their potential as cross-population risk indicators [23]. This expansion of the genetic landscape offers new targets for therapeutic development and underscores how combinatorial methods can uncover biological insights obscured by additive models.

Combinatorial risk scores also demonstrated superior performance in predictive modeling compared to traditional approaches. In type 2 diabetes, a condition with similar complexity to endometriosis, a CRS model using a mix of 20 genotype and phenotype features achieved AUCs of 0.80 and 0.83 for males and females respectively in the UK Biobank population, significantly outperforming PRS models on the same dataset [24]. The CRS model further stratified the type 2 diabetes population into five distinct clusters based solely on genotypes, associating these with differentiated risks of developing specific complications [24]. This demonstrates the potential for similar applications in endometriosis to predict risks of infertility, pain syndromes, or specific lesion locations.

Implementation Framework: Building Clinically Actionable Multi-Ancestry Risk Models

Translating combinatorial risk signatures into clinically actionable tools requires a structured implementation framework that addresses both technical and practical considerations. The process begins with the aggregation of multi-ancestry summary statistics from genome-wide association studies, as demonstrated in recent PRS development efforts that incorporated data from five ancestries for coronary artery disease [28]. For endometriosis, this would involve leveraging emerging diverse datasets, such as the multi-ancestry study of over 900,000 women that included 31% non-European samples through the Global Biobank Meta-Analysis Initiative [15].

The technical implementation involves several sequential steps. First, ancestry-specific and trans-ancestry combinatorial signatures are identified using the analytical workflow described in Section 3. These signatures are then integrated into a unified risk prediction model using ensemble methods, similar to approaches used in recent PRS development where multiple algorithm outputs were combined using logistic regression [26]. The resulting model can be further refined by incorporating easily accessible clinical characteristics such as age, pain symptoms, surgical history, and imaging findings to enhance predictive accuracy and clinical utility [26].

For clinical deployment, the risk model should be formatted as a binary classification test with clearly interpretable positive or negative outcomes. Recent work on PRS-based disease prediction models has demonstrated that incorporating clinical characteristics can significantly enhance performance, with 12 out of 30 models surpassing 80% AUC after adding clinical features [26]. In the context of endometriosis, such a test could help reduce the current 7-9 year diagnostic delay by identifying high-risk individuals earlier in their disease course [4] [23].

A critical consideration for clinical implementation is ensuring equitable performance across diverse patient populations. The combinatorial approach shows promise in this regard, with reproducing signatures maintaining predictive value across ancestral groups [4] [23]. However, ongoing validation in diverse clinical settings remains essential, as does attention to ethical implications of genetic risk stratification. With appropriate safeguards, combinatorial risk models could enable personalized screening protocols and targeted interventions based on individual genetic risk profiles, potentially transforming endometriosis management from reactive symptom treatment to proactive risk modification.

Combinatorial analytics represents a significant methodological advance in genetic epidemiology that addresses critical limitations of traditional GWAS and PRS approaches, particularly for ancestrally diverse populations. By detecting non-linear interactions between genetic variants, this approach captures more biologically plausible risk mechanisms while improving cross-ancestry reproducibility. The identification of 75 novel endometriosis-associated genes through combinatorial analysis [4] [23] demonstrates the power of this method to expand our understanding of complex disease genetics beyond additive models.

The implications for endometriosis research and clinical care are substantial. Combinatorial risk signatures offer a path toward more equitable genetic risk prediction that performs consistently across ancestral groups, addressing current disparities in genetic medicine. Furthermore, the biological pathways revealed by these analyses—including autophagy, macrophage biology, and Wnt signaling [23] [15]—provide new targets for therapeutic development in a condition with limited treatment options.

Future research should prioritize the continued expansion of diverse cohorts to enhance the detection and validation of trans-ancestry risk signatures. Integration of combinatorial approaches with multi-omics data, including transcriptomic, epigenetic, and proteomic information [2] [15], will further refine our understanding of endometriosis pathogenesis. As these methods mature, combinatorial analytics has the potential to transform precision medicine for endometriosis and other complex diseases, enabling risk prediction, early diagnosis, and targeted interventions that benefit patients across all ancestral backgrounds.

Integrating eQTL and Tissue-Specific Functional Data from Diverse Populations

Endometriosis is a common, estrogen-dependent, inflammatory condition with a complex genetic architecture, characterized by the presence of endometrial-like tissue outside the uterine cavity [10]. The disease affects approximately 10% of women of reproductive age, with prevalence rates ranging from 35–50% among women experiencing chronic pelvic pain and subfertility [10]. Family and twin studies estimate the heritability of endometriosis at around 52%, highlighting the substantial genetic component underlying disease susceptibility [10]. While genome-wide association studies (GWAS) have successfully identified multiple genetic loci associated with endometriosis risk, a critical challenge remains: the majority of these association signals reside in non-coding genomic regions, making functional interpretation difficult [10] [6].

The integration of expression quantitative trait loci (eQTL) data provides a powerful framework for addressing this challenge. eQTLs are genetic variants associated with the expression of specific genes, serving as bridges connecting GWAS-identified risk variants to their potential molecular mechanisms [29]. However, current tissue-based functional genomics resources, including eQTL datasets, lack diversity in both ancestry and tissue types, creating a significant barrier to comprehensively investigating gene regulation in endometriosis across human populations [30]. This technical guide examines the methodologies, resources, and analytical frameworks for integrating eQTL and tissue-specific functional data, with particular emphasis on addressing the critical challenge of ancestral diversity in endometriosis research.

Ancestry Disparities in Existing Datasets

Current tissue-based functional genomics resources exhibit substantial disparities in ancestral representation that limit their utility for diverse populations:

• GTEx Project (v8): 85% of 948 donors are of European descent [30]
• eQTL Catalogue Aggregation: 91% of 5,907 individuals from 19 studies are of European ancestry [30]
• eQTLGen Consortium: 34 of 37 studies and 95% of 31,685 individuals are predominantly of European ancestry [30]
• seeQTL Browser: 82% of 2,445 samples are of European descent [30]

This European-centric bias creates analytical challenges when integrating QTL data with GWAS from non-European populations. Tools for co-localization and transcriptome-wide association studies (TWAS) typically assume matching and homogeneous ancestry, which can lead to inaccurate predictions when applied across ancestral groups [30].

Tissue and Context Limitations

Beyond ancestry disparities, existing resources also lack diversity in tissue types and biological contexts relevant to endometriosis:

• Most single-cell and bulk datasets amenable to QTL analyses are skewed toward blood-derived samples or cultured cells [30]
• Reproductive tissues relevant to endometriosis pathophysiology are underrepresented
• Limited representation of diverse environmental exposures, hormonal states, and developmental stages that influence endometriosis progression

Methodological Framework for eQTL Integration

Core Analytical Approaches

Table 1: Key Methodologies for Integrating eQTL and GWAS Data

Method	Principle	Application	Considerations
Summary Data-Based Mendelian Randomization (SMR)	Tests pleiotropic association between SNP effects on exposure (gene expression) and outcome (disease) using summary statistics [31]	Prioritizing candidate causal genes by integrating GWAS and eQTL summary statistics	Requires LD reference panel; susceptible to pleiotropy
Bayesian Colocalization (COLOC)	Assesses whether two traits share the same causal variant within a region using Bayesian probabilities [31]	Determining if GWAS and eQTL signals share common causal variants	Computationally intensive; requires careful prior specification
Transcriptome-Wide Association Studies (TWAS)	Imputes gene expression from genetic data and tests association with disease [30]	Identifying gene-trait associations mediated by expression	Population-specific prediction models perform poorly across ancestries [30]
Meta-analysis	Combines results across multiple studies to increase power and assess consistency [10]	Evaluating heterogeneity and consistency of effects across populations	Can identify population-specific effects when stratified by ancestry

Experimental Workflows for eQTL Mapping

Table 2: Key Research Reagents and Resources for eQTL Studies

Resource Type	Specific Examples	Function	Considerations for Diverse Populations
Genotyping Arrays	Affymetrix Axiom TWB Array, Illumina OmniExpress BeadChip [13] [17]	Genome-wide SNP genotyping	Array content should be optimized for target population; imputation reference panels should be population-matched
Expression Profiling	RNA sequencing, Expression arrays [32]	Transcriptome quantification	Batch effects across studies; normalization methods should account for technical variability
eQTL Databases	GTEx, eQTLGen, INTERVAL, MetaBrain [32] [31]	Reference datasets for eQTL mapping	Ancestry composition and sample sizes vary significantly across resources
Analysis Tools	GSMR, COLOC, SMR, Matrix eQTL, METASOFT [32] [31]	Statistical analysis of eQTL and integration with GWAS	Method assumptions about LD structure and population homogeneity

Figure 1: Integrated Workflow for eQTL and GWAS Data Integration with Diversity Considerations

Tissue-Specific eQTL Findings in Endometriosis

Tissue-Specific Regulatory Patterns

Recent research has demonstrated that endometriosis-associated genetic variants exhibit distinct regulatory effects across tissues:

Table 3: Tissue-Specific eQTL Effects of Endometriosis-Associated Variants

Tissue Type	Key Regulated Genes	Biological Processes Enriched	Population Context
Reproductive Tissues (uterus, ovary, vagina)	Hormone response genes, tissue remodeling factors [6]	Hormonal response, tissue remodeling, adhesion	Limited diversity in samples
Intestinal Tissues (sigmoid colon, ileum)	MICB, CLDN23, GATA4 [6]	Immune and epithelial signaling	Based on European ancestry datasets
Peripheral Blood	Immune-related genes [6]	Immune surveillance, inflammatory response	Most diverse sampling available
Endometriotic Lesions	INTU, FERMT1 [13]	Cell polarity, tissue organization	Taiwanese population-specific eQTLs identified

A 2025 study examining regulatory effects of endometriosis-associated variants across six physiologically relevant tissues found remarkable tissue specificity in regulatory profiles. In reproductive tissues, genes involved in hormonal response, tissue remodeling, and adhesion predominated, while in intestinal tissues and peripheral blood, immune and epithelial signaling genes were most prominent [6].

Single-Cell Resolution Insights

Emerging single-cell eQTL studies provide even finer resolution of cell-type-specific regulation:

• Microglia: Contribute the highest number of candidate genes in neurological studies, suggesting potential parallels for immune involvement in endometriosis [31]
• Excitatory neurons, astrocytes, inhibitory neurons: Show cell-type-specific eQTL patterns in brain studies [31]
• Bulk vs. single-cell comparisons: 19 cell-type-level candidate causal genes were identified in Alzheimer's research, with microglia contributing the highest number, followed by excitatory neurons and astrocytes [31]

Case Studies in Cross-Population eQTL Integration

Taiwanese Population Study

A 2021 GWAS and eQTL integration study in a Taiwanese population identified novel susceptibility loci for endometriosis:

• Sample Characteristics: 259 laparoscopy-confirmed stage III/IV endometriosis cases and 171 controls [13]
• Key Finding: rs13126673 in INTU (inturned planar cell polarity protein) functioned as a significant cis-eQTL [13]
• Validation: INTU expression in 78 endometriotic tissues from women with endometriosis correlated with rs13126673 genotype (P = 0.034) [13]
• Population Context: This study highlighted ethnicity-specific genetic effects, as some variants associated in European populations showed different effects in the Taiwanese cohort [13]

Iranian Population Study

A 2025 landscape genetic approach in Iranian women examined gene expression and demographic factors:

• Sample Size: 25 women with endometriosis and 25 controls [5]
• Genes Analyzed: MFN2, PINK1, PRKN and their related SNPs [5]
• Key Finding: Significant association between geographical variables, gene expression magnitude, and SNP genotypes [5]
• Methodological Approach: Multivariate computational methods including factor multiple logistic regression, factor analysis of mixed data (FAMD), and redundancy analysis (RDA) [5]

Multi-Ancestry Meta-Analysis Approaches

While focused on uterine fibroids, a 2025 multi-ancestry GWAS meta-analysis demonstrates the power of cross-population approaches:

• Sample Size: 74,294 cases (27.7% non-European descent) and 465,810 controls (18.3% non-European descent) [33]
• Novel Discoveries: Identified 11 novel genes associated with fibroids across multi-ancestry and ancestry-stratified analyses [33]
• Heritability Estimation: SNP-based heritability estimated at 15.9% in African ancestry populations [33]

Technical Protocols for Diverse Population Studies

Sample Collection and Processing

Tissue Collection Protocol (adapted from GTEx and related studies):

• Informed Consent: Obtain consent specifically for genetic studies and data sharing, with attention to cultural sensitivities in diverse populations [30]
• Multiple Tissue Collection: Collect reproductive tissues (uterus, ovary), intestinal tissues (sigmoid colon, ileum), and peripheral blood [6]
• Standardized Processing: Flash-freeze tissues in liquid nitrogen within 30 minutes of excision [30]
• Demographic Data: Comprehensive collection of ancestry, geographical, environmental, and lifestyle factors [5]

RNA Extraction and Quality Control:

• Total RNA Extraction: Use Favor prep kit or equivalent [5]
• Quality Assessment: RNA Integrity Number (RIN) >7.0 for sequencing applications
• cDNA Synthesis: Use Parstous kit or equivalent [5]

eQTL Mapping Protocol

Pseudobulk Expression Profiling (for single-cell data):

• Generate pseudobulk counts: Sum UMI counts per gene across all cells within each individual using Seurat (Version 5.0.1) [31]
• Filter low-expression genes: Use 'filterByExpr' function from edgeR (version 3.40.2) with default parameters [31]
• Normalization: Apply trimmed mean of M-values (TMM) method from edgeR [31]
• Quantile normalization: Compute log2 counts per million (CPM) and quantile normalize with 'voom' function from limma (version 3.54.2) [31]

cis-eQTL Identification:

• SNP Filtering: Retain bi-allelic SNPs with minor allele frequency > 0.05, call rate > 95%, and Hardy-Weinberg equilibrium p > 10−6 using PLINK2 [31]
• Association Testing: Use Matrix EQTL (version 2.3) to identify cis-eQTLs within 1 Mb of transcription start site [31]
• Covariate Adjustment: Include top genotype principal components and expression PCs to account for population structure and technical variation [31]

Cross-Ancestry Analytical Methods

Ancestry-Stratified Analysis:

• Genetic Ancestry Determination: Use ADMIXTURE or similar tools to estimate individual ancestry proportions [17]
• Stratified GWAS: Conduct association analyses within homogeneous ancestry groups
• Meta-analysis: Combine results across ancestry groups using fixed or random effects models

Trans-ancestry Methods:

• Genetic Correlation Estimation: Use LD Score regression to estimate genetic correlations across populations
• Fine-mapping: Employ trans-ancestry fine-mapping to improve resolution of causal variants
• Colocalization: Adapt Bayesian colocalization methods for multi-ancestry data

Figure 2: Analytical Framework for Cross-Population eQTL Integration

Implementation Framework for Increasing Diversity

Strategic Sample Collection

Targeted Tissue Collection Initiatives:

• Prioritize underrepresented populations: Focus collection efforts on African, Hispanic/Latin American, Indigenous, and Asian populations
• International partnerships: Establish collaborations with research institutions in underrepresented regions [30]
• Ethical frameworks: Develop informed consent processes and benefit-sharing agreements that build trust with local communities [30]

Technical Innovations for Resource-Limited Settings:

• Flash-frozen tissue protocols: Adapt single-nucleus preparation methods for frozen tissues to overcome fresh tissue requirements [30]
• Temperature-stable preservation: Implement sample fixation techniques that maintain RNA integrity without cryopreservation [30]
• Standardized protocols: Establish cross-center standardized procedures for tissue collection and processing

Data Integration and Analysis

Virtual Cohort Development:

• Data harmonization: Address technical challenges in integrating data across multiple tissue datasets
• Statistical power: Combine samples across studies to boost power for rarer tissue specimens and underrepresented populations
• Analytical methods: Develop versatile statistical approaches for multi-ancestry and admixed populations [30]

Functional Validation Prioritization:

• Cross-population consistency: Prioritize variants showing consistent effects across multiple populations
• Population-specific effects: Identify and functionally validate variants with population-specific effects
• Functional assays: Develop high-throughput methods for testing regulatory effects of prioritized variants

Integrating eQTL and tissue-specific functional data from diverse populations is essential for advancing our understanding of endometriosis genetics. Current resources exhibit significant disparities in ancestral and tissue diversity, limiting their utility for comprehensive functional characterization of GWAS loci. The methodological frameworks outlined in this guide provide a pathway for addressing these limitations through strategic sample collection, advanced analytical methods, and ethical international partnerships.

Future progress will depend on concerted efforts to increase diversity in tissue resources, develop ancestry-aware analytical tools, and implement functional validation studies across multiple population groups. These advances will ultimately enable more equitable medical care informed by well-balanced genetic research, leading to improved diagnosis and treatment of endometriosis across all population groups.

Addressing Population Stratification and Confounding in Multi-Ethnic Analyses

Population stratification (PS) is a fundamental consideration in genetic association studies, referring to the presence of systematic differences in allele frequencies between subpopulations within a study cohort resulting from non-random mating, most often caused by geographic isolation with limited gene flow over multiple generations [34]. When unrecognized or unaccounted for, PS can create spurious associations between genetic variants and traits, potentially leading to both false positive and false negative findings that compromise the validity and reproducibility of research outcomes [34]. This challenge becomes particularly acute in multi-ethnic genetic studies, where diverse ancestral backgrounds introduce complex genetic architectures that must be properly accounted for to ensure robust results.

The historical dominance of European-ancestry participants in genome-wide association studies (GWAS)—comprising approximately 94.5% of participants as of 2025—has created significant limitations in the generalizability of genetic discoveries across populations [35]. This imbalance is especially problematic for complex conditions like endometriosis, where understanding ethnic-specific genetic factors could yield critical insights into disease mechanisms and potential therapeutic targets. As researchers increasingly incorporate participants from diverse genetic backgrounds, proper methodologies for addressing population stratification have become essential components of genetic epidemiology [35].

Within the specific context of endometriosis research, multi-ancestry approaches have begun to yield important discoveries. Recent large-scale studies incorporating 31% non-European samples have identified novel loci, including the first genome-wide significant locus (POLR2M) detected exclusively in African-ancestry populations [15]. Such findings underscore the scientific necessity of diverse cohorts and appropriate statistical methods to account for population structure in genetic analyses of endometriosis and other complex traits.

Statistical Foundations and Measures of Genetic Differentiation

Key Concepts and Measures

Understanding population stratification requires familiarity with several fundamental statistical measures used to quantify genetic differences between populations. The fixation index (Fst) stands as one of the classical approaches for measuring genetic differentiation, comparing differences in expected heterozygosity across populations under Hardy-Weinberg Equilibrium [34]. Mathematically, Fst is expressed as Fst = (Ht - Hs)/Ht, where Ht represents the expected heterozygosity in the total population and Hs denotes the expected heterozygosity in a subpopulation. According to Sewell Wright's guidelines, Fst values of 0-0.05 indicate little differentiation, 0.05-0.15 indicate moderate differentiation, 0.15-0.25 indicate great differentiation, and values greater than 0.25 indicate very great differentiation between populations [34].

Another important quantification is the allele sharing distance (ASD), a pairwise measure among subjects across a large set of markers defined by the expression ASD = (1/L) × Σdl, where dl = 0 if two individuals have two alleles in common at the l-th locus; dl = 1 with one allele in common; and dl = 2 when there are no alleles in common [34]. This measure provides a complementary approach to understanding genetic relationships between individuals and populations.

Table 1: Key Measures of Genetic Differentiation

Measure	Formula/Calculation	Interpretation	Application Context
Fixation Index (Fst)	Fst = (Ht - Hs)/Ht	Quantifies proportion of genetic variance due to subpopulation structure	Population genetics, selection studies, association mapping
Allele Sharing Distance (ASD)	ASD = (1/L) × Σdl where dl = 0,1,2 for 2,1,0 shared alleles	Measures genetic similarity between individuals based on shared alleles	Relatedness estimation, population structure detection
Ancestry Informative Markers (AIMs)	Selected SNPs with large frequency differences between populations	Maximizes ability to differentiate ancestral backgrounds	Ancestry inference, admixture mapping, PS adjustment

These statistical measures provide the foundation for detecting and quantifying population structure in genetic studies. Their proper application enables researchers to distinguish true genetic associations from artifacts created by underlying population heterogeneity, particularly crucial in multi-ethnic analyses of complex diseases like endometriosis where genetic effects may be modest and confounded by ancestry [34].

Methodological Approaches for Detecting Population Stratification

Global and Local Ancestry Methods

Detecting population stratification involves both global and local ancestry approaches. Global ancestry methods aim to characterize an individual's overall ancestral background, typically through principal component analysis (PCA) or multidimensional scaling of genome-wide genotype data [34]. These approaches visualize genetic similarity between individuals, allowing researchers to identify clusters corresponding to different ancestral populations. In practice, researchers assess population stratification using multidimensional scaling analysis and permutation tests for identity-by-state, with quantile-quantile (Q-Q) plots of association P-values and genomic inflation factors (λ) used to evaluate the extent of stratification [13]. A λ value close to 1.0 indicates minimal stratification, while higher values suggest significant population structure that may inflate test statistics.

Local ancestry methods provide finer-resolution characterization of ancestry patterns by estimating the ancestral origin of specific genomic regions, particularly important in recently admixed populations [34]. These approaches are especially valuable for admixture mapping, where researchers test for associations between local ancestry and traits or diseases. Local ancestry inference leverages the different linkage disequilibrium (LD) patterns across ancestral populations, with larger, more ancient gene pools such as African ancestry exhibiting finer LD structure between markers [34].

Ancestry Informative Markers (AIMs)

A critical tool for detecting and accounting for population stratification involves ancestry informative markers (AIMs)—genetic markers, typically SNPs, with large frequency differences among parental populations [34]. These markers are frequently incorporated into genotyping experiments when population stratification is suspected, enabling downstream conditioning on inferred ancestral information in association modeling [34]. The selection of AIMs is crucial, as markers with the greatest frequency differences between ancestral populations provide maximum power to differentiate populations in admixed samples.

Table 2: Methods for Detecting and Accounting for Population Stratification

Method Category	Specific Techniques	Key Advantages	Limitations
Global Ancestry	Principal Component Analysis (PCA), Multidimensional Scaling	Captures broad-scale population structure, computationally efficient	May miss fine-scale structure, less sensitive to recent admixture
Local Ancestry	RFMix, LAMP, ELAI	Identifies ancestry-specific regions in admixed individuals, enables admixture mapping	Computationally intensive, requires reference panels
AIMs-Based	Selected SNP panels, Custom arrays	Cost-effective for ancestry inference, targeted approach	Limited genomic coverage, depends on prior knowledge of divergent markers
LD-Based	LD pruning, LD score regression	Accounts for correlated markers, reduces redundancy	May eliminate informative markers, population-specific LD patterns

Statistical Methods to Account for Population Stratification

Multi-ancestry GWAS Approaches

Two primary strategies are commonly employed for conducting multi-ancestry GWAS while accounting for population stratification: pooled analysis and meta-analysis [35]. In pooled analysis, individuals from all ancestries are analyzed together in a single model, with principal components (PCs) included as covariates to account for population stratification. This approach maximizes sample size, accommodates admixed individuals, and can improve statistical power, though it raises concerns about residual confounding due to imperfect correction for population structure [35].

Meta-analysis, in contrast, conducts ancestry-group-specific GWAS first and then combines the summary statistics across groups [35]. This method better accounts for fine-scale population structure within homogeneous groups and facilitates data sharing when individual-level data are restricted. An extension known as MR-MEGA leverages allele-frequency differences among contributing studies to boost power and handle admixed individuals, though this method introduces additional parameters that can reduce power, especially when dealing with complex admixture [35].

Both strategies can be implemented using fixed-effect or mixed-effect models. Fixed-effect modeling assumes genetic effects are constant across individuals, providing computational efficiency but limited ability to handle cryptic relatedness. Mixed-effect modeling includes both fixed and random effects to account for population structure and relatedness, enhancing robustness at the cost of increased computational demands [35].

Experimental Workflow for Multi-ancestry Analysis

The following diagram illustrates the comprehensive workflow for conducting multi-ancestry genetic association studies while addressing population stratification:

Comparison of Statistical Correction Methods

Recent systematic evaluations demonstrate that pooled analysis consistently provides higher statistical power than meta-analysis and MR-MEGA across various ancestry-group compositions and trait architectures while maintaining well-controlled type I error in most realistic scenarios [35]. This advantage is particularly pronounced when allele frequencies vary across ancestry groups, as the combined analysis leverages these differences to enhance detection of true associations.

For binary traits in structured populations, logistic mixed models have emerged as a robust approach that controls for population structure and relatedness while addressing case-control imbalances that may introduce biases if not properly accounted for [35]. These methods are particularly valuable in large biobank studies where cryptic relatedness is common and may confound association signals if not appropriately modeled.

Practical Applications in Endometriosis Research

Multi-ancestry Endometriosis GWAS Findings

The integration of diverse ancestral populations in endometriosis research has yielded significant advances in understanding the genetic architecture of this complex condition. Recent large-scale efforts incorporating over 900,000 women, with 31% representing non-European ancestries, have identified 45 significant loci, seven of which were previously unreported [15]. This includes the first genome-wide significant locus (POLR2M) detected among only African-ancestry individuals, highlighting the value of diverse cohorts for novel genetic discovery [15].

Through ancestry-stratified analyses, these studies have documented endometriosis heritability estimates in the range of 10-12% across all ancestral groups, suggesting similar overall genetic contributions despite potential differences in specific risk variants [15]. Fine-mapping efforts following GWAS have enabled researchers to narrow association signals to smaller sets of putative causal variants, with thirty-eight loci having at least one variant in the credible set after fine-mapping [15]. This refinement is crucial for prioritizing variants for functional validation and understanding biological mechanisms.

Integrative Omics Approaches

Beyond standard GWAS, integrative omics approaches have provided deeper insights into endometriosis pathogenesis by connecting genetic associations with functional consequences. Imputed transcriptome-wide association studies (TWAS) have identified 11 genes associated with endometriosis, two of which were previously unreported [15]. Simultaneously, proteome-wide association studies (PWAS) suggest significant association of R-spondin 3 (RSPO3) with endometriosis, implicating the Wnt signaling pathway as a key player in disease mechanisms [15].

These interconnected pathways—including immunopathogenesis, Wnt signaling, and the balance between proliferation, differentiation, and migration of endometrial cells—emerge as hallmarks for endometriosis, suggesting multiple targets for precise and effective therapeutic interventions [15]. The combination of multi-ancestry genetic data with functional genomic information represents a powerful approach for translating statistical associations into biological understanding.

Ethnic-Specific Considerations in Endometriosis Genetics

Population-specific genetic factors in endometriosis are increasingly recognized as important contributors to disease risk and presentation. In Taiwanese population studies, novel susceptibility loci have been identified, including rs13126673 in the inturned planar cell polarity protein (INTU) gene, which functions as an expression quantitative trait locus (eQTL) significantly associated with INTU expression in endometriotic tissues [13]. This cis-eQTL relationship demonstrates how population-specific variants may influence gene expression and potentially contribute to ethnic differences in disease characteristics.

The research reagents and computational tools essential for conducting these analyses are summarized in the following table:

Table 3: Essential Research Reagents and Tools for Multi-ethnic GWAS

Category	Specific Tools/Reagents	Application in Multi-ethnic GWAS	Key Features
Genotyping Arrays	Taiwan Biobank Array, Affymetrix Axiom TWB array	Genome-wide variant detection in specific populations	Population-informative content, imputation backbone
Quality Control Tools	PLINK2.0, REGENIE	Sample and variant QC, relatedness assessment	Handling of diverse datasets, ancestry-sensitive filters
Ancestry Inference	ADMIXTURE, RFMix, PCA tools	Global and local ancestry estimation	Reference panel integration, admixture quantification
Association Testing	REGENIE (mixed models), SAIGE	Account for population structure in tests	Robust to stratification, handles case-control imbalance
Functional Annotation	GTEx database, FUMA, ANNOVAR	Biological interpretation of associated loci	Tissue-specific expression data, variant consequence prediction

Technical Protocols for Stratification Control

Quality Control Procedures

Robust quality control procedures form the foundation for reliable multi-ethnic genetic analyses. For genotyping data, recommended QC filters include sample call rate >97%, variant call rate >95%, Hardy-Weinberg equilibrium P > 1×10^-6 in controls, and minor allele frequency thresholds appropriate for the specific ancestral populations under study [13]. Cryptic relatedness should be assessed using identity-by-descent estimation, typically removing one individual from each pair with pi-hat > 0.125 (second-degree relatives or closer).

Population structure assessment typically begins with principal component analysis performed on a set of linkage-disequilibrium-pruned markers, merging study data with reference populations such as the 1000 Genomes Project to facilitate ancestry assignment [13]. Ancestry informative markers should be selected based on large frequency differences (Fst > 0.25) between relevant ancestral populations, with sufficient density across the genome to accurately capture population structure.

Analysis Protocols for Multi-ancestry Studies

For pooled analysis, the standard protocol involves:

• Computing principal components (PCs) from genome-wide genotype data
• Including the top 5-10 PCs as covariates in association models
• Using mixed-effect models that include a genetic relationship matrix to account for residual population structure and relatedness
• Validating results in ancestry-specific subgroups to ensure consistency

For meta-analysis approaches, the recommended protocol includes:

• Performing ancestry-stratified GWAS with population-specific QC and covariate adjustment
• Applying genomic control within each ancestry group to account for residual stratification
• Combining summary statistics using fixed-effects or random-effects models
• Assessing heterogeneity across ancestries using Cochran's Q or I² statistics

The following diagram illustrates the key decision points in selecting appropriate methods for addressing population stratification:

Addressing population stratification and confounding in multi-ethnic analyses remains a critical challenge in genetic association studies, particularly for complex conditions like endometriosis where ancestral diversity may influence both genetic risk factors and disease presentation. The methodological framework presented here—encompassing proper study design, rigorous quality control, appropriate statistical correction, and integrative functional analysis—provides a roadmap for robust genetic discovery across diverse populations.

As genetic studies continue to expand their inclusion of underrepresented populations, emerging methods such as local ancestry-aware association tests, trans-ethnic fine-mapping, and ancestry-specific polygenic risk scores will further enhance our ability to detect and interpret genetic signals while properly accounting for population structure. These advances promise to not only improve the validity of genetic associations but also ensure that the benefits of genetic research are equitably distributed across all ancestral backgrounds.

For endometriosis research specifically, the integration of multi-ancestry genetic data with functional genomics and clinical characterization holds particular promise for unraveling the heterogeneous nature of this condition and developing more targeted therapeutic approaches. By embracing methodological rigor in addressing population stratification, researchers can maximize the scientific value of diverse cohorts and advance our understanding of this complex gynecological disorder.

Endometriosis, a chronic inflammatory condition affecting approximately 10% of reproductive-aged women globally, demonstrates significant heterogeneity in presentation, progression, and treatment response across diverse populations [36]. Despite established heritability estimates of 47-52% for this condition, the genetic architecture of endometriosis remains incompletely characterized, particularly across racial and ethnic groups [7] [10]. Genome-wide association studies (GWAS) have identified numerous susceptibility loci for endometriosis, but these discoveries predominantly stem from populations of European and East Asian ancestry, creating critical gaps in understanding disease mechanisms in other groups [10] [13]. This limited diversity impedes the identification of population-specific genetic variants, hinders the development of polygenic risk scores with broad applicability, and potentially exacerbates health disparities through incomplete understanding of disease biology across human genetic diversity [36].

Biobanks, as organized repositories of biological specimens and associated clinical and epidemiological data, provide indispensable infrastructure for advancing endometriosis genetics research [37]. However, their full potential remains unrealized when cohort composition does not reflect the demographic diversity of affected populations. Historical underrepresentation of racial and ethnic minorities in biobanking initiatives has created significant barriers to inclusive research [38] [39]. This technical guide outlines evidence-based strategies to address these challenges, with particular emphasis on their application within endometriosis GWAS loci replication research, to foster more equitable and comprehensive scientific discovery.

Current Landscape of Diversity in Endometriosis Research

Documented Disparities in Representation

The underrepresentation of certain racial and ethnic groups in endometriosis research reflects both historical biases and contemporary systematic barriers. A systematic review and meta-analysis revealed that Black and Hispanic women were significantly less likely to be diagnosed with endometriosis compared to White women (OR: 0.49 and 0.46, respectively), while Asian women demonstrated higher diagnosis rates (OR: 1.63) [36]. These findings must be interpreted cautiously, as they may reflect disparities in diagnostic access rather than true biological differences. Historically flawed research perpetuated the misconception that endometriosis primarily affected affluent White women, a bias that persisted in medical education literature until recent decades [36].

Analysis of major biobanks confirms ongoing representation challenges. In The Cancer Genome Atlas (TCGA), only 9.94% of samples were from racial/ethnic minorities, with Black/African American individuals constituting just 6.25% of the total collection [38]. Similarly, a study of four large clinical databases found that data completeness filters disproportionately excluded minoritized groups, potentially introducing systematic biases in research cohorts [39].

Table 1: Representation in Major Biobanks and Research Initiatives

Biobank/Initiative	Total Sample Size	Black/African American Representation	Hispanic/Latino Representation	Asian Representation
TCGA (2012) [38]	4,959 cases	6.25%	Not specified	3.35%
UK Biobank [39]	502,364 participants	2.28%	Not collected	0.71%
All of Us [39]	287,012 participants	20.30%	18.83%	2.89%
Cedars-Sinai [39]	4,031,307 patients	5.11%	8.55%	9.26%

Impact on Genetic Discovery in Endometriosis

The limited diversity in endometriosis GWAS has tangible scientific consequences. Most of the 42 known endometriosis risk loci identified through GWAS were discovered in European and Japanese populations, with inconsistent replication across other ancestral groups [10] [13]. This restricts understanding of how genetic risk factors operate across different genetic backgrounds and environmental contexts. Recent research exploring the intersection of ancient genetic regulatory variants and modern environmental pollutants in endometriosis susceptibility highlights the complex gene-environment interactions that may vary substantially across populations [7]. Without diverse cohorts, these interactions remain incompletely characterized, potentially missing population-specific pathogenic mechanisms.

Foundational Principles for Inclusive Biobanking

Ethical Framework and Community Partnership

Inclusive biobanking requires foundational commitment to ethical principles that prioritize community engagement and address historical harms. Research demonstrates that African Americans are willing to donate biospecimens when approached, with concerns about transparency outweighing historical mistrust as barriers to participation [38]. Successful initiatives employ community-based participatory research (CBPR) approaches, engaging community stakeholders in study design, implementation, and dissemination of results. This partnership model fosters trust, ensures cultural relevance, and enhances the long-term sustainability of recruitment efforts [38].

The governance structure of biobanks should include diverse representation on ethics review boards and access committees, with explicit policies addressing return of results and protection of participant privacy [37]. Particularly for gynecologic conditions like endometriosis, considerations around fertility implications and cultural sensitivities regarding reproductive tissues necessitate specialized consent procedures and ethical oversight [37].

Standardized Documentation of Race, Ethnicity, and Ancestry

Accurate and consistent classification of participant demographics is essential for diverse cohort development. Biobanks should implement standardized collection of self-reported race and ethnicity data using comprehensive categories that reflect local population diversity. Additionally, granular ethnicity information and genetic ancestry inference should be incorporated to capture within-group heterogeneity [36]. This multi-level approach enables rigorous assessment of representation and facilitates trans-ancestry genetic analyses.

For endometriosis research specifically, comprehensive phenotyping must extend beyond basic demographic data to include detailed sub-phenotype information (e.g., lesion location, disease stage, symptom profiles), as genetic associations may vary across clinical presentations [10] [40]. The World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project (EPHect) has established standardized tools for clinical data collection that support meaningful cross-study comparisons [41].

Strategic Approaches to Inclusive Cohort Recruitment

Addressing Systemic Barriers to Participation

Underrepresentation in biobanks often reflects systemic barriers rather than participant unwillingness. A survey of older African Americans found that 57% had never been asked to donate biospecimens for research, indicating that failure to approach potential participants constitutes a significant barrier [38]. Strategic recruitment must therefore address both institutional practices and individual-level factors.

Table 2: Barriers and Evidence-Based Solutions for Inclusive Recruitment

Barrier Category	Specific Challenges	Evidence-Based Solutions
Systemic/Institutional	Limited recruitment from diverse clinical settings; Biased data filters [39]	Partner with diverse healthcare settings; Audit data filters for disparate impact [39]
Historical/Mistrust	Legacy of research exploitation; Medical racism [38]	Transparent communication; Community oversight; Certificates of confidentiality [38]
Practical/Access	Transportation; Time constraints; Childcare needs [38]	Off-hours recruitment; Mobile collection units; Compensation for participation [38]
Cultural/Communication	Language barriers; Cultural stigma around reproductive health [37]	Culturally-matched staff; Translated materials; Gender-concordant recruitment [37]

Innovative Recruitment Models and Engagement Strategies

Successful recruitment of diverse populations requires tailored, multi-faceted approaches. The National Institutes of Health "All of Us" Research Program demonstrates the effectiveness of national campaigns specifically targeting populations underrepresented in biomedical research, with 80% of participants coming from these groups [39]. Key strategies include:

• Community-embedded recruitment: Establishing presence in community settings through faith-based organizations, community centers, and local events [38]
• Cultural concordance: Employing racially and ethnically diverse research staff who reflect community demographics [38]
• Transparent communication: Clearly explaining biobanking processes, data usage, and protection measures in accessible language [38]
• Digital engagement: Leveraging social media and online platforms with culturally relevant messaging [39]
• Long-term relationship building: Maintaining ongoing communication with participants through newsletters, community updates, and opportunities for continued engagement [38]

For endometriosis-specific recruitment, partnerships with diverse clinical providers, including community health centers, safety-net hospitals, and primary care practices, can help identify potential participants across the diagnostic spectrum [36]. Additionally, engagement with endometriosis support groups serving diverse communities can facilitate trust-building and participant referral.

Methodological Considerations for Diverse Data Collection

Biobank Infrastructure and Sample Processing

Gynecologic tissue biobanks require specialized infrastructure to accommodate the unique characteristics of endometriosis specimens. The anatomical and pathological heterogeneity of endometriosis lesions necessitates robust annotation protocols linking samples to precise diagnostic subtypes and clinicopathologic parameters [37]. Different lesion types (superficial peritoneal, ovarian endometrioma, deep infiltrating) may represent distinct disease entities with potentially divergent genetic underpinnings, making accurate classification essential for meaningful genetic analyses [40].

Standardized operating procedures (SOPs) for sample collection, processing, and storage are critical for maintaining sample quality and analytical comparability. The WERF EPHect project has established harmonized protocols for endometriosis biospecimen collection, including specific recommendations for tissue preservation, fluid sample handling, and associated data documentation [41]. Implementation of these standardized approaches across collection sites enhances consistency and enables aggregation of samples from multiple institutions, particularly important for studying rare subtypes or underrepresented populations.

Minimizing Technical Biases in Data Collection

Technical artifacts can introduce biases that disproportionately affect diverse samples if not properly addressed. Pre-analytical variables including ischemic time, preservation methods, and storage conditions can impact sample quality and downstream molecular analyses [37]. Biobanks should implement quality control measures tracking these variables and monitor for batch effects correlated with demographic factors.

In genomic studies, ancestry-related differences in genetic architecture, including variation in linkage disequilibrium patterns and allele frequencies, can affect genotype calling accuracy and imputation quality [13]. Careful quality control procedures accounting for these differences are essential for trans-ancestry genetic analyses. Additionally, for expression quantitative trait locus (eQTL) studies in diverse cohorts, consideration of population-specific regulatory effects is critical for accurate interpretation [13].

Diagram 1: Inclusive Biobanking Workflow for Endometriosis GWAS. This workflow integrates community engagement throughout the research process, with specific checkpoints for diversity monitoring and bias mitigation.

Analytical Approaches for Diverse Cohorts in Endometriosis Genetics

Trans-ancestry Genetic Analysis Methods

Advanced statistical methods are required to leverage diverse genetic data effectively. Trans-ancestry meta-analysis approaches combine summary statistics from multiple ancestral groups, improving power for locus discovery and fine-mapping resolution [10]. These methods account for heterogeneity in effect sizes across populations while identifying shared risk variants. For endometriosis specifically, where genetic effects may vary by lesion subtype and disease stage, stratified analyses within and across populations can reveal subtype-specific risk factors [10] [40].

Population structure adjustment is critical in diverse genetic analyses to avoid spurious associations. Principal component analysis (PCA), genetic relationship matrix (GRM) approaches, and linear mixed models effectively account for ancestry differences [13]. For biobanks with detailed ancestry information, discrete ancestry group assignments complemented by continuous ancestry measures provide flexibility in analytical design.

Functional Validation in Diverse Contexts

Genetic association discoveries require functional validation to elucidate biological mechanisms. Expression quantitative trait locus (eQTL) mapping in endometriosis-relevant tissues from diverse donors helps interpret the functional consequences of associated variants [13]. As demonstrated in a Taiwanese endometriosis GWAS, risk variants may influence gene expression through effects on RNA secondary structure or transcriptional regulation, effects that could vary across genetic backgrounds [13].

Experimental models of endometriosis, including heterologous and homologous rodent systems, provide platforms for functional validation of candidate genes [41] [40]. However, these models have limitations in recapitulating human disease heterogeneity. The WERF working group has developed standardized protocols for endometriosis model systems to enhance reproducibility and cross-study comparison [41] [40]. Incorporating genetic diversity into these experimental systems, where feasible, could improve translational relevance.

Table 3: Research Reagent Solutions for Inclusive Endometriosis Studies

Reagent Category	Specific Examples	Application in Diverse Studies
Genotyping Arrays	Taiwan Biobank Array [13], Global Screening Array	Population-specific content improves imputation accuracy in diverse cohorts
Reference Panels	1000 Genomes, gnomAD, population-specific reference panels	Enhanced variant imputation and frequency estimation across ancestries
Cell Line Models	Endometrial stromal cells from diverse donors, Endometriotic epithelial cell lines	In vitro functional studies of population-specific genetic variants
Animal Models	Homologous rodent models (mice, rats) [40], Heterologous mouse models [41]	Preclinical validation of candidate genes; study of host-environment interactions
Bioinformatics Tools	LDlink [7], POPGEN, TRANS-ANCESTRY META-ANALYSIS TOOLS	Analysis of population-specific LD patterns; trans-ancestry genetic analysis

Case Studies and Implementation Frameworks

Successful Models of Inclusive Biobanking

The "All of Us" Research Program exemplifies large-scale inclusive recruitment, with intentional enrollment of populations underrepresented in biomedical research [39]. Key success factors include national partnerships with community organizations, transparent data sharing policies, and robust participant engagement strategies. The program's diverse cohort facilitates research on health disparities and enables discovery of genetic variants across ancestral groups.

In endometriosis research specifically, international consortia like the Endometriosis Association Consortium have made progress in aggregating diverse samples through multi-center collaborations [10]. The integration of biobank samples from the UK, Finland, Estonia, and Japan in endometrial cancer GWAS meta-analyses provides a template for similar approaches in endometriosis genetics [42]. These collaborative frameworks enable sufficient sample sizes for well-powered trans-ancestry analyses.

Implementation Roadmap for Research Institutions

Research institutions can implement specific strategies to enhance diversity in endometriosis biobanking:

• Diversity auditing: Regularly assess cohort composition relative to source populations and set specific recruitment targets for underrepresented groups [39]
• Staff training: Provide cultural competency training for research staff and implement bias mitigation strategies in participant recruitment and data collection [36]
• Data filter assessment: Audit electronic health record filters for disparate impact on minority populations and adjust criteria to minimize exclusion [39]
• Return of results: Develop protocols for returning individual genetic results and aggregate findings to participants in accessible formats [38]
• Collaborative partnerships: Establish partnerships with institutions serving diverse patient populations and support diverse investigator leadership in endometriosis research [36]

Diagram 2: Framework for Assessing and Mitigating Bias in Cohort Selection. This framework systematically evaluates how data completeness filters may disproportionately exclude certain racial and ethnic groups, enabling implementation of corrective strategies.

Building inclusive biobanks for endometriosis research requires intentional, multifaceted strategies addressing recruitment, retention, data collection, and analysis. By implementing the approaches outlined in this guide—community partnership, standardized phenotyping, minimization of technical biases, and appropriate analytical methods—researchers can develop diverse cohorts that accelerate discovery for all populations affected by endometriosis. The resulting genetic insights will enhance understanding of endometriosis pathogenesis across human diversity and contribute to more equitable diagnostic and therapeutic approaches.

As research progresses, continued attention to ethical frameworks, stakeholder engagement, and methodological innovation will be essential for realizing the full potential of inclusive biobanking in endometriosis and beyond. Through these efforts, the scientific community can address historical disparities and advance precision medicine approaches that benefit diverse populations.

Optimizing Study Design and Overcoming Replication Barriers

The pursuit of precision medicine in endometriosis research is fundamentally challenged by a lack of diversity in genetic studies and inconsistent reporting of race and ethnicity. Endometriosis, a chronic inflammatory condition affecting approximately 10% of reproductive-age women globally, demonstrates significant disparities in prevalence, diagnostic delay, and clinical presentation across racial and ethnic groups [36]. Historically flawed research and deeply embedded biases have perpetuated the misconception that endometriosis is primarily a disease of White women, leading to underdiagnosis in Black, Hispanic, and other minority populations [36]. The replication of genome-wide association study (GWAS) loci across diverse populations is not merely a methodological concern but an ethical and scientific necessity to ensure that genetic discoveries benefit all patients equitably. This technical guide provides a comprehensive framework for researchers to improve racial and ethnicity reporting in adherence to International Committee of Medical Journal Editors (ICMJE) guidelines and other standards, with specific application to endometriosis genetics research.

Epidemiological and Historical Context of Racial Disparities in Endometriosis

Documented Disparities in Prevalence and Diagnosis

Quantitative evidence reveals significant racial and ethnic variations in endometriosis diagnosis and care timelines. Table 1 summarizes key findings from epidemiological studies on these disparities.

Table 1: Racial and Ethnic Disparities in Endometriosis Epidemiology

Racial/Ethnic Group	Prevalence vs. White Women	Diagnostic Delay	Key Studies
Black Women	OR: 0.49 (95% CI: 0.29-0.83) [36]	2.6 years older (95% CI: 0.5-4.6) [43]	Bougie et al. (2019); Li et al. (2021)
Hispanic Women	OR: 0.46 (95% CI: 0.14-1.50) [36]	3.8 years older (95% CI: 1.5-6.2) [43]	Bougie et al. (2019); Li et al. (2021)
Asian Women	OR: 1.63 (95% CI: 1.03-2.58) [36]	No significant delay found [43]	Bougie et al. (2019); Li et al. (2021)
White Women	Reference group	Reference group	Multiple studies

A retrospective cohort study using electronic health records estimates that 70% of patients diagnosed with endometriosis were White, 6% Hispanic, 9% Asian, and 4.7% non-Hispanic Black, highlighting significant representation disparities in clinical populations [36].

Historical Bias in Medical Literature and Education

The historical perspective on race and endometriosis reveals how bias became systematized in medical knowledge. Early 20th-century research, conducted in a context of social concern about declining birth rates among upper-class women, erroneously linked endometriosis to childbearing patterns in "well-to-do" White women [36]. Methodologically flawed studies from this era demonstrated "increased rates of endometriosis among private White patients compared to the ward Black patient," a dichotomy "ridden with confounding and bias" [36]. This historical bias was perpetuated for decades through major gynecology textbooks that stated endometriosis was "much more common in the white private patient than in the dispensary clientele" [36]. Although recent editions have revised this language, the historical narrative continues to influence clinical suspicion and diagnostic patterns, contributing to the disparities observed in Table 1.

Current Guidelines for Reporting Race, Ethnicity, Sex, and Gender

ICMJE Recommendations for Methodological Reporting

The ICMJE provides specific, binding recommendations for reporting race, ethnicity, sex, and gender in medical research:

• Defining and Justifying Variables: Researchers must "define how they determined race or ethnicity and justify their relevance." The guidelines emphasize that "race and ethnicity are social and not biological constructs," requiring authors to "interpret results associated with race and ethnicity in that context" [44].
• Inclusion and Representation: Studies should "aim for inclusion of representative populations into all study types" and provide "descriptive data for these and other relevant demographic variables." Authors should "comment on how representative the study sample is of the larger population of interest" [44].
• Precise Language: Researchers must "ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors)" and "use neutral, precise, and respectful language to describe study participants" [44].
• SAGER Guidelines: The ICMJE specifically encourages authors to follow the SAGER guidelines for reporting of sex and gender information in study design, data analyses, results, and interpretation of findings [44].

Regulatory Context and Diversity Action Plans

Recent regulatory developments emphasize the growing importance of diversity in clinical research:

• Diversity Action Plans (DAPs): The FDA has advanced guidance requiring sponsors to submit Diversity Action Plans as part of investigational new drug applications or premarket submissions. These plans must detail "enrollment goals specific to their clinical studies, disaggregated by race, ethnicity, sex, and age group," along with "rationale for goals" and "strategies for meeting goals" [45].
• Barrier Identification: The FDA recommends that sponsors "proactively identify barriers that may hinder participation" and implement strategies such as "community engagement and collaboration with health advocates," "cultural competency training," and "flexibility in study design" [45].

Ethnic Diversity in Endometriosis GWAS: Current Evidence and Gaps

Established Genetic Insights and Their Limitations

Current understanding of the genetic architecture of endometriosis is primarily based on studies in populations of European and East Asian ancestry. Table 2 summarizes key genetic loci associated with endometriosis across different ethnic groups.

Table 2: Ethnic-Specific Genetic Susceptibility Loci for Endometriosis

Genetic Locus	Ethnic Group Studied	Potential Functional Role	Study
WNT4 (1p36.12)	Taiwanese-Han, European, Japanese	Developmental pathways, hormone regulation	[46]
RMND1 (6q25.1)	Taiwanese-Han, European, Japanese	Mitochondrial function, cellular energy	[46]
CCDC170 (6q25.1)	Taiwanese-Han, European, Japanese	Cytoskeletal organization, cell adhesion	[46]
C5orf66/C5orf66-AS2 (5q31.1)	Taiwanese-Han (novel locus)	lncRNA interaction with RNA-binding proteins	[46]
STN1 (10q24.33)	Taiwanese-Han (novel locus)	Telomere maintenance, genomic stability	[46]

A recent GWAS in a Taiwanese-Han population identified five significant susceptibility loci, three of which (WNT4, RMND1, and CCDC170) were previously associated with endometriosis in European and Japanese populations, while two (C5orf66/C5orf66-AS2 and STN1) represent novel ethnic-specific loci [46]. This demonstrates both shared genetic architecture across populations and population-specific risk variants.

Functional network analysis of these risk genes revealed "the involvement of cancer susceptibility and neurodevelopmental disorders in endometriosis development," suggesting that differences in genetic susceptibility may contribute to the clinical observation that Taiwanese-Han women have "higher risks of developing deeply infiltrating/invasive lesions and the associated malignancies" [46].

Tissue-Specific Regulatory Effects of Endometriosis Variants

Understanding how endometriosis-associated genetic variants regulate gene expression across different tissues provides crucial insights into disease mechanisms. A 2025 study systematically characterized the regulatory effects of 465 endometriosis-associated variants across six physiologically relevant tissues [6]. The research identified significant tissue specificity in regulatory profiles:

• In reproductive tissues (uterus, ovary, vagina), endometriosis-associated eQTLs predominantly regulated genes involved in hormonal response, tissue remodeling, and adhesion [6].
• In intestinal tissues (sigmoid colon, ileum) and peripheral blood, the same variants primarily regulated immune and epithelial signaling genes [6].

Key regulators such as MICB, CLDN23, and GATA4 were consistently linked to hallmark pathways including immune evasion, angiogenesis, and proliferative signaling [6]. This tissue-specific functional characterization provides a framework for understanding how genetic susceptibility manifests in different biological contexts.

Tissue-Specific eQTL Analysis Workflow

Methodological Framework for Robust Racial and Ethnicity Reporting

Experimental Design and Participant Characterization

For comprehensive GWAS in diverse populations, researchers should implement the following methodological standards:

• Intentional Sampling Frameworks: Design studies with explicit goals for inclusion of underrepresented populations. The FDA Diversity Action Plan framework provides guidance for setting specific enrollment targets disaggregated by race, ethnicity, sex, and age [45].
• Standardized Data Collection: Implement consistent measures for race, ethnicity, sex, and gender using validated instruments. The ICMJE recommends distinguishing between biological variables (sex) and sociocultural constructs (gender, race, ethnicity) [44].
• Comprehensive Phenotyping: Collect detailed phenotypic data including symptom characteristics, pain experiences, disease subtypes, and treatment responses across racial and ethnic groups. This is particularly important given evidence that "the primary presenting symptom of endometriosis, pelvic pain, may limit clinical consideration of this diagnosis amongst non-White patients" due to historical biases in pain assessment [36].

GWAS and Functional Validation Protocols

The following experimental protocols enable robust genetic association studies across diverse populations:

• Genome-Wide Association Studies: Conduct GWAS in adequately powered cohorts of specific racial and ethnic groups. The Taiwanese-Han study exemplifies this approach with 2,794 cases and 27,940 controls [46]. Standard quality control measures include genetic data preprocessing, population stratification correction using principal component analysis, and association testing with appropriate multiple testing corrections (p < 5 × 10⁻⁸ for genome-wide significance).
• Expression Quantitative Trait Loci (eQTL) Analysis: Cross-reference GWAS-identified variants with tissue-specific eQTL data from databases such as GTEx to understand functional consequences [6]. The 2025 study protocol analyzed eQTLs across six tissues: uterus, ovary, vagina, sigmoid colon, ileum, and peripheral blood, retaining only significant eQTLs (FDR < 0.05) [6].
• Functional Annotation and Pathway Analysis: Annotate variants using tools like Ensembl Variant Effect Predictor and perform functional enrichment analysis using resources such as MSigDB Hallmark gene sets and Cancer Hallmarks collections [6].

Table 3: Research Reagent Solutions for Diverse Endometriosis Genetics Studies

Resource Category	Specific Tools/Databases	Application in Endometriosis Research
Genetic Databases	GWAS Catalog (EFO_0001065), GTEx v8, Ensembl VEP	Catalog known associations, tissue-specific regulation, functional annotation [6]
Bioinformatic Tools	PLINK, FUMA, GCTA	GWAS quality control, meta-analysis, heritability estimation [6] [46]
Functional Annotation	MSigDB Hallmark Gene Sets, Cancer Hallmarks	Pathway enrichment, biological mechanism identification [6]
Diversity Resources	NIH All of Us, UK Biobank, Biobank Japan	Access to diverse genomic datasets with clinical data
Reporting Guidelines	ICMJE, SAGER, STREGA, CONSORT	Standardized reporting of race, ethnicity, sex, gender [44]

Inclusive Research Design Framework

Analytical Approaches for Diverse Genetic Datasets

Statistical Methods for Cross-Ancestry Genetic Analysis

Implement robust statistical approaches to ensure valid comparisons across diverse populations:

• Population Stratification Correction: Account for genetic ancestry using principal component analysis or genetic relationship matrices to prevent spurious associations due to population structure.
• Trans-Ancestry Meta-Analysis: Combine results across studies of different ancestral backgrounds using random-effects models that account for heterogeneity. The significant heterogeneity observed in epidemiological analyses of endometriosis prevalence (I² > 75% in some analyses) highlights the importance of these approaches [36].
• Fine-Mapping in Diverse Populations: Leverate differences in linkage disequilibrium patterns across populations to improve resolution for causal variant identification. The identification of novel loci in Taiwanese-Han populations (C5orf66/C5orf66-AS2 and STN1) demonstrates the value of studying diverse groups [46].

Functional Validation Across Tissues and Populations

Prioritize functional follow-up studies that account for potential ethnic differences:

• Tissue-Specific eQTL Mapping: Assess whether endometriosis-associated variants show consistent or divergent regulatory effects across ancestral groups in disease-relevant tissues. The 2025 study demonstrated that "a tissue specificity was observed in the regulatory profiles of eQTL-associated genes" [6].
• Experimental Validation: Employ in vitro and in vivo models to validate the functional impact of population-specific risk variants. For the Taiwanese-Han specific loci, functional analysis suggested that "long non-coding RNAs C5orf66 and C5orf66-AS2 can interact with many RNA-binding proteins which can influence RNA metabolic process, mRNA stabilization, and mRNA splicing" [46].

Improving racial and ethnicity reporting in endometriosis GWAS requires systematic changes to research practices. Researchers should:

• Implement Prospective Diversity Planning: Develop Diversity Action Plans at the study design phase, specifying enrollment targets for underrepresented groups and strategies to achieve them [45].
• Adopt Standardized Reporting Practices: Follow ICMJE guidelines for defining and reporting race, ethnicity, sex, and gender, consistently contextualizing these as social rather than biological constructs [44].
• Prioritize Trans-Ancestry Genetic Studies: Actively recruit diverse participants to enable discovery of population-specific and shared risk variants, following the example of the Taiwanese-Han GWAS [46].
• Integrate Functional Genomics: Employ tissue-specific eQTL analyses across multiple relevant tissues to understand the functional consequences of genetic variants in diverse biological contexts [6].
• Address Historical Context: Acknowledge and address historical biases in endometriosis research that have led to underdiagnosis in minority populations [36].

The path toward equitable endometriosis research requires both methodological rigor and ethical commitment. By implementing these guidelines, researchers can generate genetic insights that benefit all patients regardless of racial or ethnic background, ultimately reducing disparities in diagnosis, care, and outcomes for this complex condition.

Statistical Power Considerations for Replication Studies in Underrepresented Groups

Genome-wide association studies (GWAS) have fundamentally advanced our understanding of complex genetic disorders, yet their translational potential remains hampered by a critical lack of diversity. This limitation is particularly pronounced in endometriosis research, where historical overrepresentation of participants of European descent threatens the generalizability and equity of genetic findings [47] [36]. The challenge is substantial: an analysis of 6,680 GWAS published between 2005 and 2023 found that 94.5% of participants were reported to be of European descent [47]. This disparity creates a replication crisis when moving from discovery to validation in underrepresented populations, as effect sizes and allele frequencies may differ across ancestral groups.

Statistical power—the probability that a study will detect an effect when one truly exists—becomes a central concern in this context. Underpowered replication studies risk both false-negative conclusions (failing to detect real associations) and imprecise effect size estimation, potentially overlooking population-specific genetic effects [48] [49]. This technical guide addresses the methodological considerations for designing adequately powered replication studies for endometriosis GWAS loci in underrepresented populations, providing researchers with frameworks to advance more inclusive and clinically applicable genetic research.

Statistical Foundations of Power Analysis

Core Components of Power Analysis

Statistical power analysis balances four interrelated parameters: alpha (α) level, effect size, sample size, and power (1-β). Understanding their relationships is crucial for designing robust replication studies [48] [49] [50].

• Type I and Type II Error Control: The conventional Type I error rate (α, false positive) is typically set at 0.05, while Type II error (β, false negative) is often set at 0.20, yielding a standard power threshold of 0.80 [48] [51]. This convention reflects a judgment that false positives are four times more detrimental to science than false negatives, though this ratio should be reconsidered based on study-specific consequences [51].
• Effect Size Estimation: For genetic association studies, effect size is typically represented as an odds ratio (OR) and indicates the strength of association between a genetic variant and a trait. The smaller the true effect size, the larger the sample size required to detect it [48].
• Sample Size Determination: Power analysis enables researchers to calculate the minimum sample size needed to detect a specified effect size with a given level of confidence, thereby ensuring efficient resource use and reliable conclusions [49].

Table 1: Fundamental Parameters in Power Analysis for Genetic Association Studies

Parameter	Symbol	Definition	Conventional Value	Impact on Power
Significance Level	α	Probability of Type I error (false positive)	0.05	Lower α reduces power
Power	1-β	Probability of correctly rejecting a false null hypothesis	0.80	Higher power requires larger N
Type II Error Rate	β	Probability of Type II error (false negative)	0.20	Lower β requires larger N
Effect Size	ES/OR	Measure of association strength (e.g., Odds Ratio)	Study-dependent	Smaller effects require larger N
Minor Allele Frequency	MAF	Frequency of the less common allele in a population	>0.05 for common variants	Lower MAF requires larger N

Genetic-Specific Parameters Affecting Power

Beyond basic statistical parameters, genetic association studies introduce additional complexity that directly impacts power calculations [48]:

• Minor Allele Frequency (MAF): The frequency of the risk allele in the population under study significantly influences power. Lower frequency variants require larger sample sizes to observe sufficient minor allele carriers for statistically stable association testing.
• Linkage Disequilibrium (LD): The non-random association of alleles at different loci affects power in replication studies. The strength of LD between the tested marker and the causal variant influences the observed effect size, with stronger LD generally increasing power [48].
• Genetic Model Specification: Assumptions about inheritance patterns (dominant, recessive, or additive models) affect power calculations. Misspecification of the genetic model can substantially reduce a study's power to detect true associations [48].
• Misclassification Errors: Inaccurate phenotype assessment or genotype errors introduce noise that diminishes effective power, potentially requiring sample size increases to compensate [48].

The following diagram illustrates the relationship between these key parameters and their collective impact on achieving statistical power in a genetic replication study.

Endometriosis GWAS Context and Diversity Gaps

Current Genetic Landscape of Endometriosis

Endometriosis research has benefited from substantial GWAS efforts that have identified numerous susceptibility loci. A 2017 meta-analysis of 17,045 cases and 191,596 controls identified five novel loci (FN1, CCDC170, ESR1, SYNE1, and FSHB) in addition to replicating nine previously reported loci, bringing the total number of robustly associated independent SNPs to 19 [52]. These findings highlighted genes involved in sex steroid hormone pathways, offering crucial insights into the molecular mechanisms of endometriosis pathogenesis [52] [53]. Importantly, most loci showed stronger associations with more severe, Stage III/IV disease, suggesting that genetic loading varies across disease subtypes [10] [52].

Documented Disparities in Representation

Despite these advances, the field faces significant diversity challenges that limit the generalizability of findings:

• Historical Underrepresentation: Flawed historical research perpetuated the misconception that endometriosis was a "career woman's disease" predominantly affecting White women, creating persistent diagnostic biases [36]. This historical legacy continues to influence medical education and clinical practice.
• Contemporary Representation Gaps: A systematic review and meta-analysis found that Black and Hispanic women were less likely to be diagnosed with endometriosis compared to White women (Black women: OR 0.49, 95% CI: 0.29–0.83; Hispanic women: OR 0.46, 95% CI: 0.14–1.50), while Asian women had higher diagnosis rates (OR: 1.63, 95% CI: 1.03–2.58) [36]. Significant heterogeneity in these analyses suggests methodological variations and potential diagnostic delays across racial/ethnic groups.
• Diagnostic Delays and Pain Care Disparities: Racial and ethnic disparities in pain care persist across multiple medical domains, with minority patients often receiving lower quality pain management than non-Hispanic White patients [36]. These biases may contribute to delayed endometriosis diagnosis in underrepresented populations, further skewing research participation opportunities.

Table 2: Endometriosis GWAS Loci with Potential Hormone Pathway Involvement

Locus	Nearest Gene	Reported OR	P-value	Biological Pathway	Replication Status in Diverse Cohorts
7p15.2	–	1.22	1.6 × 10⁻⁹	Unknown	Limited data [10]
1p36.12	WNT4	1.18	1.8 × 10⁻¹⁵	Hormone regulation	Limited data [10] [52]
12q22	VEZT	1.19	4.7 × 10⁻¹⁵	Cell adhesion	Limited data [10] [52]
9p21.3	CDKN2B-AS1	1.16	1.5 × 10⁻⁸	Cell cycle regulation	Replicated in Japanese cohort [10]
6q25.1	ESR1	1.09	3.74 × 10⁻⁸	Estrogen receptor	Limited data in non-Europeans [52]

Power Considerations for Diverse Replication Studies

Challenges in Cross-Ancestral Replication

Replicating GWAS findings across diverse populations presents unique methodological challenges that directly impact statistical power:

• Allele Frequency Differences: Genetic variants exhibit considerable frequency variation across ancestral groups. A risk allele common in European populations might be rare or absent in other groups, substantially increasing the sample size needed for replication studies in those populations [48].
• Effect Size Heterogeneity: The strength of association between a genetic variant and endometriosis risk may differ across populations due to distinct genetic backgrounds, environmental exposures, or lifestyle factors [10]. A meta-analysis of endometriosis GWAS found that two independent inter-genic loci showed significant evidence of heterogeneity across datasets, highlighting this challenge [10].
• Linkage Disequilibrium Variation: Patterns of correlation between genetic markers vary across populations. A marker tagging a causal variant in Europeans may not be in LD with that same variant in other populations, potentially causing replication failure even when the biological mechanism is consistent [48].
• Population-Specific Effects: Some genetic risk factors may be unique to specific ancestral groups due to evolutionary history, gene-environment interactions, or population-specific causal variants.

Sample Size Estimation Framework

Calculating appropriate sample sizes for replication studies in underrepresented groups requires careful consideration of several parameters specific to the target population [48] [49]:

• Population-Specific MAF: Use reference data (e.g., 1000 Genomes, gnomAD) to obtain accurate allele frequency estimates for the target population.
• Conservatively Adjusted Effect Size: Consider applying a penalty to the originally reported effect size to account for potential winner's curse (overestimation in discovery samples) and possible effect attenuation in different genetic backgrounds.
• Power and Significance Thresholds: While 80% power at α = 5×10⁻⁸ is conventional for discovery, replication studies often use relaxed thresholds (e.g., α = 0.05) with higher power targets (e.g., 90%) to robustly confirm associations.
• Genetic Architecture Assumptions: Specify the genetic model (additive, dominant, recessive) based on prior biological knowledge or discovery sample characteristics.

The following diagram outlines the recommended workflow for determining the sample size needed for a well-powered replication study in an underrepresented population.

Quantitative Power Scenarios for Endometriosis Loci

The table below illustrates how different combinations of effect sizes and allele frequencies in a target population influence the required sample size for a replication study, assuming 90% power and α = 0.05 under an additive genetic model.

Table 3: Sample Size Requirements for Varying Genetic Scenarios in Replication Studies

Odds Ratio	MAF in Target Population	Cases Required	Controls Required	Total Sample Required	Practical Considerations
1.15	0.25	3,450	3,450	6,900	Feasible with multi-site collaboration
1.15	0.10	5,890	5,890	11,780	Requires consortium-level effort
1.10	0.25	7,220	7,220	14,440	Challenging, consider meta-analysis
1.10	0.10	12,350	12,350	24,700	May require international collaboration
1.25	0.05	3,210	3,210	6,420	Feasible for strong effect, low frequency

Methodological Protocols for Inclusive Recruitment

Effective Recruitment Strategies

Achieving sufficient sample sizes for well-powered replication studies requires implementing targeted recruitment strategies proven effective for engaging underrepresented populations:

• Targeted Hybrid Approaches: Combining traditional methods with digital strategies can optimize enrollment of diverse participants. In the EAS clinical trial, targeted hybrid recruitment (involving letters and text messages) yielded the highest proportion of participants from historically underrepresented groups (87.5%), compared to traditional (48.5%) and digital methods (32.3%) [47].
• Community-Engaged Recruitment: Building partnerships with community organizations, healthcare providers, and patient advocacy groups serving diverse populations can enhance trust and participation. This approach helps address historical mistrust of medical institutions and uneven healthcare access [47].
• Quota Sampling: Implementing quota sampling based on demographic characteristics (e.g., age, gender, race/ethnicity) ensures balanced enrollment that better represents the target population [47].
• Reducing Participant Burden: Utilizing digital health technologies and decentralized trial elements can ease participation barriers related to time, transportation, and financial constraints that disproportionately affect underrepresented groups [47].

Experimental Protocols for Endometriosis Replication

Robust replication studies require standardized protocols for phenotype assessment, sample processing, and genotyping:

• Phenotype Harmonization: Implement consistent case definitions across study sites using surgical confirmation (preferably with rAFS staging) when possible. For self-reported cases, validate with medical record review or structured questionnaires. Clearly document and account for disease stage in analyses, as genetic effects often differ by severity [10] [52].
• Genotype Quality Control: Apply stringent quality control measures including call rate thresholds (>98%), Hardy-Weinberg equilibrium testing (P>1×10⁻⁶), and relatedness analysis (pi-hat<0.2) to ensure data quality. Use ancestral principal components or genetic similarity matrices to account for population stratification [52].
• Replication Analysis Framework: Test the specific risk allele identified in the discovery study using the same genetic model (typically additive). Perform both minimal adjustment (ancestry principal components) and fully adjusted analyses (including additional covariates) to assess robustness.

The Scientist's Toolkit

Table 4: Essential Research Reagents and Resources for Endometriosis Replication Studies

Category	Specific Tools/Resources	Function/Purpose	Considerations for Diverse Cohorts
Bioinformatics Tools	PLINK, GCTA, FINEMAP	Genetic association testing, heritability estimation, fine mapping	Ensure compatibility with admixed populations; use reference panels that include target population
Reference Panels	1000 Genomes, gnomAD, HapMap	Allele frequency reference, imputation	Prioritize panels with representation from target population; consider population-specific reference panels
Power Calculation Software	QUANTO, CaTS, G*Power	Sample size and power calculation	Select tools that handle genetic parameters (MAF, LD, inheritance models)
Genotyping Platforms	Global Screening Array, Infinium	Genome-wide SNP genotyping	Consider arrays with content optimized for diverse populations; ensure coverage of loci of interest
Quality Control Tools	EIGENSTRAT, KING, SNPRelate	Population stratification assessment, relatedness checking	Use methods robust to population heterogeneity; validate in admixed populations
Recruitment Resources	ResearchMatch, Patient Registries	Participant identification and enrollment	Partner with community organizations; use culturally appropriate materials

Alternative Analytical Approaches

Beyond Conventional Power Analysis

While traditional power analysis focuses on null hypothesis significance testing, several alternative approaches offer complementary insights for replication studies:

• Precision Analysis: Instead of focusing solely on statistical significance, precision analysis determines the sample size needed to estimate an effect size with a desired confidence interval width [51]. This approach is particularly valuable when the goal is precise effect size estimation rather than binary significance testing.
• Sequential Analysis: This methodology involves conducting interim analyses at predetermined points during data collection, allowing studies to stop early if compelling evidence emerges or continue if results are promising but inconclusive [51]. Sequential designs can enhance ethical participant use and resource efficiency.
• Bayesian Approaches: Bayesian methods incorporate prior knowledge (e.g., effect estimates from discovery studies) into the analysis, which can potentially improve efficiency [54]. These approaches are particularly valuable when prior information is reliable and relevant to the target population.

Collaborative Frameworks

Given the substantial sample sizes required for well-powered replication studies in underrepresented populations, collaborative frameworks are essential:

• Consortium-Based Studies: Participating in existing consortia (e.g., the International Endometriosis Genetics Consortium) or forming new collaborations enables resource sharing and pooled analyses that achieve necessary sample sizes.
• Meta-Analysis Approaches: When individual studies are underpowered, coordinating meta-analyses across multiple studies with similar designs can provide robust conclusions. Fixed-effect and Han-Eskin random-effects models are commonly used approaches that account for heterogeneity [10] [52].

Adequate statistical power is not merely a technical requirement but an ethical imperative for ensuring that genetic research on endometriosis benefits all populations equitably. The historical overrepresentation of European-ancestry individuals in endometriosis GWAS has created significant gaps in our understanding of how genetic risk manifests across diverse populations. Addressing these gaps requires deliberate attention to population-specific genetic parameters, implementation of effective recruitment strategies for underrepresented groups, and adoption of appropriate methodological frameworks for cross-population replication. By embracing these power considerations, researchers can advance more inclusive endometriosis genetics that ultimately leads to better diagnosis, treatment, and care for all individuals affected by this complex condition.

Endometriosis is a complex, estrogen-dependent inflammatory disease, affecting approximately 10% of reproductive-aged women globally [55] [56]. Despite its high prevalence and substantial disease burden, the etiology of endometriosis remains incompletely understood, with pathogenesis involving a complex interplay of genetic susceptibility, environmental exposures, and demographic factors [7]. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with endometriosis risk, yet these studies have predominantly focused on European ancestry populations, creating significant limitations in our understanding of how genetic risk manifests across diverse ethnic groups [57].

The replication of GWAS findings across ethnic populations is complicated by substantial variation in environmental exposures, lifestyle factors, and social determinants of health (SDoH) that differ geographically and demographically [5] [57]. These confounders can modulate genetic risk through various biological mechanisms, including changes in gene expression via expression quantitative trait loci (eQTLs) that demonstrate tissue-specific patterns [6], epigenetic modifications induced by environmental pollutants [7], and interaction effects that alter genetic penetrance. This technical guide provides a comprehensive framework for accounting for these critical confounders in endometriosis genetic research, with particular emphasis on enabling robust cross-ethnic replication of GWAS findings.

Quantitative Landscape of Key Confounders in Endometriosis

Global Distribution of Disease Burden and Sociodemographic Factors

Table 1: Global Burden of Endometriosis and Association with Sociodemographic Development

Metric	1990 Estimates	2021 Estimates	Temporal Trend (1990-2021)	Association with SDI/HDI
Incident Cases	3.33 million	3.45 million (95% UI: 2.44-4.6)	+3.51% increase	Highest ASIR in low SDI regions [58]
DALYs	1.83 million	2.05 million (95% UI: 1.20-3.13)	+12.03% increase	Negative correlation with SDI [55] [58]
Age-Standardized Incidence Rate (ASIR)	86.2 per 100,000	76.1 per 100,000	EAPC: -1.01% (95% UI: -1.06 to -0.96)	Negative correlation with SDI [58]
Peak Age Groups for Incidence	20-24 years	20-24 years	Stable concentration in reproductive years	Consistent across SDI levels [55]
Peak Age Groups for DALYs	25-29 years	25-29 years	Stable concentration in reproductive years	Consistent across SDI levels [55]
Regional Hotspots	-	Niger (77.33/100,000), Oceania (77.71/100,000)	Increasing burden in low-resource settings	Concentrated in low-SDI regions [58]

The global distribution of endometriosis burden demonstrates a complex relationship with sociodemographic development. While age-standardized rates have shown a slight decline, absolute case numbers continue to rise, with the most significant burden shifts occurring in low sociodemographic index (SDI) regions [55] [58]. This epidemiological transition underscores the importance of accounting for geographic and developmental confounders in genetic studies, as the genetic architecture of endometriosis may interact differently with environmental factors across development contexts.

Environmental Exposures with Established Epidemiological Evidence

Table 2: Evidence Summary for Environmental and Lifestyle Risk Factors

Risk Factor Category	Specific Exposure	Strength of Evidence	Effect Size (RR/OR)	Key Studies
Endocrine Disrupting Chemicals	Phthalates, perfluorochemicals	Moderate (62.5% of meta-analyses significant)	RR: 1.41 (95% CI: 1.23-1.60) [59]	Umbrella Review (354 studies) [59]
Lifestyle Factors	Alcohol consumption	Moderate	RR: 1.25 (95% CI: 1.11-1.41) [59]	Umbrella Review [59]
Dietary Factors	Fruits and vegetables	Suggestive protective effect	Not quantified	Multiple observational studies [60]
Dietary Factors	Red meat, saturated fat	Suggestive adverse effect	Not quantified	Multiple observational studies [60]
Reproductive History	Nulliparity	Strong	~2-fold increased risk	Multiple cohorts [56]
Menstrual Characteristics	Early menarche (<12 years)	Moderate	Significant association	Meta-analysis (13,000 women) [56]
Menstrual Characteristics	Short cycles (≤27 days)	Strong	Significantly elevated risk	Meta-analysis (11 studies) [56]
Anthropometric Measures	Low BMI (<18.5)	Strong	3-fold increased risk for DIE	Multiple cohorts [56]

The evidence for environmental risk factors demonstrates varying strength, with endocrine-disrupting chemicals (EDCs) and alcohol consumption showing the most consistent associations in meta-analyses [59]. The interaction between these exposures and genetic susceptibility remains poorly characterized, particularly across diverse populations with varying exposure profiles.

Methodological Framework for Confounder Assessment

Stratified Genetic Association Testing

Polygenic risk score (PRS) analyses in diverse cohorts demonstrate that environmental contexts significantly modify genetic susceptibility [57]. The All of Us Research Program analysis revealed that PRS regression coefficients were often largest in the highest environmental risk groups, showing increased susceptibility to genetic risk under adverse environmental conditions [57]. This supports the implementation of stratified association testing:

• Environmental Risk Stratification: Partition analysis cohorts by tertiles of environmental exposure (low/medium/high) based on biometric measures (BMI), lifestyle surveys (alcohol, smoking), or SDoH indices [57].

• Ancestry-Aware Standardization: Compute PRS separately within genetic ancestry groups to account for population-specific linkage disequilibrium and allele frequency differences [57].

• Interaction Testing: Implement generalized linear models with genotype × environment interaction terms: Endometriosis ~ PRS + Environment + PRS×Environment + Ancestry + Age + Covariates

This approach enables detection of heterogeneous genetic effects across environmental contexts, which may contribute to non-replication of GWAS loci across populations with different exposure profiles.

Geographic and Demographic Covariate Collection

Comprehensive characterization of confounders requires multidimensional assessment across several domains:

Table 3: Core Covariate Assessment Framework for Endometriosis Genetic Studies

Domain	Specific Measures	Assessment Method	Application in Analysis
Geographic Location	Urban/rural status, region	GPS coordinates, administrative records	Control for spatial autocorrelation
Socioeconomic Status	Education, income, occupation	Self-report questionnaires	Stratification variable, covariate
Environmental Exposures	EDCs, air pollutants, water quality	Environmental monitoring, biomonitoring	Interaction testing with genetic variants
Lifestyle Factors	Diet, physical activity, smoking	Validated questionnaires (e.g., HPLP-II) [60]	Mediation analysis, effect modification
Reproductive History	Menarche, parity, menstrual patterns	Clinical interview, medical records	Inclusion/exclusion criteria, covariate
Healthcare Access	Insurance, distance to facilities, discrimination	SDoH surveys, geographic mapping	Contextual analysis of diagnostic delay

The implementation of this framework requires careful consideration of population-specific contextual factors. For example, studies in Iranian populations demonstrated significant associations between geographical variables, gene expression magnitude, and SNP genotypes, highlighting the importance of localized environmental factors [5].

Molecular Protocols for Assessing Gene-Environment Interactions

Tissue-Specific eQTL Mapping in Endometriosis-Relevant Tissues

The regulatory effects of endometriosis-associated genetic variants show substantial tissue specificity, necessitating multi-tissue assessment [6]:

Experimental Workflow:

• Variant Selection: Curate endometriosis-associated variants from GWAS Catalog (EFO_0001065) with genome-wide significance (p < 5×10^-8) [6].
• Tissue Collection: Obtain endometriosis-relevant tissues (uterus, ovary, vagina, sigmoid colon, ileum) and peripheral blood from biorepositories.
• RNA Extraction and Sequencing: Perform total RNA extraction using TRIzol protocol, quality control (RIN > 7), and stranded mRNA sequencing (Illumina).
• eQTL Analysis: Cross-reference variants with GTEx v8 database, retaining significant eQTLs (FDR < 0.05). Calculate slope values representing direction and magnitude of regulatory effects [6].
• Functional Annotation: Annotate variants using Ensembl VEP and pathway enrichment using MSigDB Hallmark gene sets and Cancer Hallmarks collections.

This protocol enables identification of context-specific regulatory mechanisms, such as the enrichment of immune and epithelial signaling genes in colon, ileum, and blood, versus hormonal response genes in reproductive tissues [6].

Assessing Ancestral Genetic Variation and Environmental Responsiveness

Ancient regulatory variants introgressed from Neandertal and Denisovan lineages demonstrate environmental responsiveness in endometriosis [7]:

Methodology:

• Whole Genome Sequencing: Perform 30X WGS on endometriosis cohorts and matched controls.
• Variant Enrichment Testing: Identify variants significantly enriched in endometriosis cohort versus controls and general population using χ² goodness of fit test with Benjamini-Hochberg FDR correction.
• Linkage Disequilibrium Analysis: Calculate pairwise LD values (D' and r²) using LDlink for co-localized variants across multiple populations.
• Population Branch Statistic (PBS): Compute PBS for 1000 Genomes super-populations using pairwise FST estimates to identify population-specific evolutionary pressures.
• Regulatory Element Overlap: Map variants to EDC-responsive regulatory regions using epigenomic annotations (ENCODE, Roadmap).

This approach has identified co-localized IL-6 variants (rs2069840 and rs34880821) at a Neandertal-derived methylation site with strong linkage disequilibrium and potential immune dysregulation functions [7].

Analytical Framework for Cross-Ethnic GWAS Replication

Multidimensional Confounder Adjustment Strategy

Successful cross-ethnic replication of endometriosis GWAS loci requires sophisticated confounder adjustment:

• Principal Component Analysis: Incorporate genetic PCs to account for population stratification.
• Spatial Analysis: Implement geographic information systems (GIS) to model and adjust for spatial clustering of environmental exposures.
• Structured Environmental Indices: Develop composite indices of environmental burden incorporating air pollution, green space, EDC exposure, and food environment.
• Multiple Testing Correction: Apply false discovery rate (FDR) control separately within environmental strata to maintain statistical power.

This approach acknowledges that genetic effects may be context-dependent and that failure to replicate across populations may reflect environmental heterogeneity rather than true genetic differences.

Mediation Analysis for Elucidating Biological Pathways

Formal mediation analysis can dissect the pathways through which confounders influence endometriosis risk:

• Mediator Assessment: Quantify the proportion of genetic effect mediated through specific environmental exposures (e.g., EDC effects on inflammatory markers).
• Sensitivity Analysis: Evaluate robustness of mediation results to unmeasured confounding using E-value approach.
• Multilevel Modeling: Incorporate individual-level genetic data and community-level environmental data to partition variance across levels.

This analytical approach enables researchers to distinguish between direct genetic effects and environment-mediated pathways, providing a more nuanced understanding of cross-ethnic differences in genetic associations.

Visualization of Integrated Analysis Framework

Comprehensive Confounder Assessment Workflow

Gene-Environment Interaction in Endometriosis Pathogenesis

Essential Research Reagents and Computational Tools

Table 4: Research Reagent Solutions for Confounder-Aware Endometriosis Genetics

Reagent/Tool Category	Specific Product	Application in Research	Technical Considerations
Genetic Data Generation	Illumina Global Screening Array	GWAS genotyping	Ancestry-informed imputation required
Whole Genome Sequencing	Illumina NovaSeq X Plus	Comprehensive variant detection	30X coverage recommended for rare variants
eQTL Mapping	GTEx v8 database	Tissue-specific regulatory annotation	Limited endometriosis-specific tissues
Gene Expression Analysis	Nanostring nCounter, RNA-seq	Transcriptomic profiling	Validation in multiple tissues recommended
Environmental Biomarkers	LC-MS/MS platforms	EDC exposure quantification	Matrix-specific reference materials needed
Epigenetic Profiling	Illumina EPIC array	DNA methylation analysis	Cell-type deconvolution required
Statistical Genetics	PLINK 2.0, PRSice2	Polygenic risk scoring	Ancestry-specific LD reference panels
Spatial Analysis	QGIS, Geoda	Geographic confounder mapping	Coordinate system standardization
Mediation Analysis	R mediation package	Pathway decomposition	Sensitivity to unmeasured confounding

The integration of environmental, demographic, and social determinants into endometriosis genetic research is methodologically challenging but essential for advancing our understanding of disease etiology across diverse populations. The frameworks and protocols outlined in this technical guide provide a roadmap for generating more reproducible and generalizable genetic findings. Future research priorities should include: (1) development of ancestrally diverse biorepositories with detailed environmental exposure data; (2) implementation of standardized protocols for cross-population genetic studies; and (3) application of advanced statistical methods that explicitly model gene-environment interplay. Through this confounder-aware approach, the field can overcome current limitations in cross-ethnic GWAS replication and accelerate the development of personalized risk prediction and intervention strategies for endometriosis across all populations.

Bioinformatic Tools for Analyzing Admixture and Trans-Ancestry Genetic Architecture

The persistent underrepresentation of diverse populations in genome-wide association studies (GWAS) has created critical gaps in our understanding of the genetic architecture of complex diseases across different ethnicities. This limitation is particularly consequential for conditions like endometriosis, a common gynecological disorder affecting approximately 10% of reproductive-aged women globally [61]. Despite established heritability estimates of around 52% [10], the genetic variants identified through GWAS in European populations often demonstrate inconsistent effects when studied in other ancestral groups, complicating both biological understanding and clinical translation.

The integration of admixture analysis and trans-ancestry genetic methods represents a paradigm shift in biomedical research, enabling scientists to disentangle the complex interplay of genetic and environmental factors across diverse populations. For endometriosis research, this approach is crucial for identifying population-specific risk loci, understanding heterogeneity in disease presentation and progression, and developing polygenic risk scores (PRS) with clinical utility across all populations [62]. This technical guide provides researchers with comprehensive methodologies for analyzing genetic admixture and trans-ancestry architecture, with specific application to advancing ethnic diversity in endometriosis genetic research.

Core Concepts and Theoretical Framework

Genetic Admixture and Local Ancestry

Genetic admixture occurs when previously separated populations begin to interbreed, creating mosaic genomes with segments originating from distinct ancestral sources. The analysis of these patterns relies on two primary concepts:

• Global Ancestry: The proportion of an individual's genome derived from each ancestral population, often modeled using the Pritchard-Stephens-Donnelly (PSD) model and represented as a vector where all components sum to 1 [63].
• Local Ancestry: The specific ancestral origin of chromosomal segments, which can be inferred using methods like RFMix2 that model admixed genomes as mosaics of single-continental genomes [62] [63].

The extended PSD (ePSD) model incorporates linkage disequilibrium (LD) patterns by assuming that within-continental LD spans shorter distances than local ancestry segments. However, recent research challenges this assumption, demonstrating that same-ancestry segments from admixed genomes exhibit distinct LD patterns compared to their single-continental counterparts, with important implications for GWAS power and interpretation [63].

Analytical Challenges in Admixed Populations

Analyzing genetic data from admixed populations presents several technical challenges that require specialized methodological approaches:

• Population Stratification: Systematic differences in allele frequencies between cases and controls due to ancestry differences rather than disease association.
• Varying LD Patterns: Differences in linkage disequilibrium across ancestral populations that can affect the portability of genetic signals.
• Allele Frequency Heterogeneity: Differences in ancestral allele frequencies that can be leveraged to increase statistical power in GWAS [63].
• Complex Genetic Architecture: Potential differences in effect sizes, allelic heterogeneity, and causal variants across ancestral backgrounds.

Table 1: Key Analytical Challenges in Admixed Genetic Studies

Challenge	Impact on Analysis	Potential Solutions
Population Stratification	Spurious associations	Global ancestry adjustment, Principal Components Analysis
Differential LD Patterns	Reduced portability of signals	Local ancestry inference, LD-aware methods
Allele Frequency Heterogeneity	Varying power across populations	Frequency-informed methods, Trans-ancestry meta-analysis
Effect Size Heterogeneity	Limited PRS portability	Genetic architecture modeling, Bayesian methods

Methodological Approaches and Bioinformatics Tools

Ancestry Inference and Local Assignment

Accurate inference of genetic ancestry forms the foundation for all subsequent analyses in admixed populations. Current methodologies encompass both unsupervised and machine learning approaches:

Unsupervised Clustering Methods:

• ADMIXTURE: Efficient maximum likelihood estimation of ancestry components in unrelated individuals, with cross-validation to determine optimal population clusters (K) [64].
• STRUCTURE: Bayesian approach to infer population structure using multilocus genotype data, modeling the Pritchard-Stephens-Donnelly admixture framework [63].

Machine Learning and Deep Learning Approaches: Recent advances have demonstrated the superior performance of machine learning algorithms for fine-scale ancestry inference:

• XGBoost: Optimized gradient boosting algorithm achieving 95.6% accuracy with 2,000 ancestry-informative SNPs (AISNPs) in East and Southeast Asian populations [64].
• Convolutional Neural Networks (CNNs): Deep learning approach capturing non-linear patterns in genetic data for ancestry classification.
• Locator: Deep neural network framework predicting geographic coordinates (latitude and longitude) directly from unphased genotypes, performing nearly as well with 2,000 AISNPs as with high-density genomic data (597,569 SNPs) [64].

Local Ancestry Inference:

• RFMix: Popular method for local ancestry inference using a conditional random field model, achieving approximately 98% accuracy in European-African admixed populations [62].
• Tractor: Framework producing ancestry-specific effect size estimates by incorporating local ancestry information into association testing [63].

Genome-Wide Association Methods for Admixed Populations

Standard GWAS approaches can be applied to admixed populations with appropriate modifications to account for population structure:

Standard GWAS with Covariate Adjustment: The most common approach involves including global ancestry principal components as covariates to control for population stratification:

This method leverages allele frequency differences between ancestral populations, providing greater power than ancestry-specific approaches when such heterogeneity exists [63].

Ancestry-Specific Association Methods:

• Tractor: Provides separate effect size estimates for each ancestry within admixed individuals, treating the same allele on different ancestral backgrounds as distinct variables [63].
• SDPR_admix: Novel method leveraging both local ancestry and cross-ancestry genetic architecture to estimate ancestral effect sizes, characterizing the joint distribution of effect sizes as zero, ancestry-enriched, or correlated across ancestries [62].

Variance-Heterogeneity GWAS (vGWAS): An emerging approach detecting genetic loci involved in gene-gene and gene-environment interactions by analyzing variance in phenotype values across genotypes rather than mean differences [65]. vGWAS methods include:

• Levene's (Brown-Forsythe) test for variance differences between genotype groups
• Double-generalized linear models (DGLM) accounting for population-specific effects in addition to mean and variance heterogeneity

Meta-Analysis and Cross-Ancestry Integration

Combining results across diverse studies and populations requires specialized meta-analysis approaches:

Fixed vs. Random Effects Models: Tools like Beta-Meta automatically select between fixed and random effects models based on quantified heterogeneity (I² statistic), using a threshold of I² = 50% for model selection [66].

Trans-Ancestry Meta-Analysis:

• Mantra: Bayesian approach that clusters populations with similar genetic effects while allowing for heterogeneity between clusters.
• MR-MEGA: Multidimensional scaling approach to account for population diversity in trans-ancestry meta-analysis.

Table 2: Bioinformatics Tools for Admixture and Trans-Ancestry Analysis

Tool	Primary Function	Key Features	Applicability to Endometriosis Research
RFMix [62]	Local Ancestry Inference	Conditional random field model	Critical for admixed endometriosis cohorts
ADMIXTURE [64]	Global Ancestry Inference	Maximum likelihood, fast computation	Population structure in diverse biobanks
SDPR_admix [62]	Polygenic Risk Scores	Leverages local ancestry and cross-ancestry architecture	Improving PRS for non-European endometriosis cases
Beta-Meta [66]	GWAS Meta-Analysis	Heterogeneity estimation, automatic model selection	Combining endometriosis GWAS across ancestries
Tractor [63]	Ancestry-Specific Effects	Estimates effects by ancestry background	Identifying ancestry-specific endometriosis risk loci
LOCATOR [64]	Geographic Prediction	Deep learning for geographic coordinates	Connecting genetic ancestry with geographic endometriosis risk

Experimental Protocols and Workflows

Local Ancestry Inference Pipeline

Protocol 1: RFMix2 Workflow for Local Ancestry Inference

• Input Data Preparation:
  • Genotype data in PLINK format (.bed, .bim, .fam)

• Reference panels with known ancestry (e.g., 1000 Genomes Project)
• Genetic map for appropriate build (e.g., GRCh37/38)

• Quality Control:
  • Apply standard filters: --mind 0.1, --geno 0.1, --maf 0.01, --hwe 0.001

• Prune SNPs in linkage disequilibrium (--indep-pairwise 200 25 0.2)
• Check for relatedness using KING algorithm

• Local Ancestry Inference:

• Post-processing and Quality Assessment:

  • Calculate accuracy metrics by comparing known vs inferred ancestry in reference samples

• Visualize local ancestry segments along chromosomes
• Check for consistency between global and local ancestry estimates

The following diagram illustrates the complete local ancestry inference workflow:

Figure 1: Local Ancestry Inference Workflow. The pipeline processes raw genotype data through quality control, phasing, and local ancestry inference using reference panels, producing data ready for ancestry-specific genetic analysis.

Trans-Ancestry Meta-Analysis Protocol

Protocol 2: Beta-Meta Workflow for Cross-Ancestry GWAS Integration

• Input Data Preparation:
  • Collect summary statistics from individual studies

• Ensure consistent effect allele coding across studies
• Format data including phenotypes, SNPs, effect/non-effect alleles, effect sizes, and p-values

• Harmonization and Strand Alignment:
  • Use dataset with lowest p-value as reference

• Automatically align other datasets to reference strand
• Correct effect signs when alleles are inverted between studies

• Heterogeneity Analysis:
  • Calculate Cochran's Q statistic: ( Q = \sum{i=1}^k wi (\hat{\beta} - \beta_i)^2 )

• Compute Higgins' I² metric: ( I^2 = \max\left(0, 100 \times \frac{Q - (k - 1)}{Q}\right) )

• Effect Size Integration:
  • For I² < 50%: Use fixed effects model ( \hat{\beta} = \frac{\sum{i=1}^k wi \betai}{\sum{i=1}^k wi}, \quad wi = \frac{1}{s_i^2} )

• For I² ≥ 50%: Use random effects model ( \hat{\beta} = \frac{\sum{i=1}^k wi^r \betai}{\sum{i=1}^k wi^r}, \quad wi^r = \frac{1}{\frac{1}{w_i} + \tau^2} )

• Multiple Testing Correction:
  • Apply Benjamini-Hochberg procedure to control false discovery rate

• Generate Manhattan plots and Q-Q plots for visualization

Polygenic Risk Score Construction for Admixed Populations

Protocol 3: SDPR_admix Implementation

• Input Data Requirements:
  • GWAS summary statistics from base population

• LD reference panel matching ancestral composition
• Local ancestry inferences for target admixed population

• Model Training:

• PRS Calculation:

  • Compute ancestry-enriched PRS as linear sum of ancestral risk alleles weighted by ancestral effect sizes

• Combine ancestry-enriched PRS into final composite score

• Validation:
  • Assess PRS performance in independent admixed validation cohort

• Compare predictive accuracy across ancestry proportions
• Benchmark against standard PRS methods

The following diagram illustrates the SDPR_admix workflow for constructing polygenic risk scores in admixed populations:

Figure 2: SDPR_admix Workflow for Polygenic Risk Scores in Admixed Populations. The method integrates GWAS summary statistics, LD reference panels, and local ancestry information to generate ancestry-enriched PRS that are combined into a final score.

Application to Endometriosis Research

Current Status of Trans-Ancestry Endometriosis Genetics

Endometriosis genetics research has made significant strides in identifying risk loci across diverse populations:

Identified Genomic Loci: Multiple GWAS have identified genome-wide significant loci for endometriosis, including:

• rs12700667 on 7p15.2 (P = 1.6 × 10⁻⁹) [10]
• rs7521902 near WNT4 (P = 1.8 × 10⁻¹⁵) [10]
• rs10859871 near VEZT (P = 4.7 × 10⁻¹⁵) [10]
• rs1537377 near CDKN2B-AS1 (P = 1.5 × 10⁻⁸) [10]
• rs10965235 in CDKN2BAS in Japanese populations [13]

Cross-Ancestry Consistency: Meta-analyses demonstrate remarkable consistency in endometriosis GWAS results across populations, with seven out of nine loci showing consistent effect directions across studies and populations [10]. However, most associations show stronger effects for revised American Fertility Society (rAFS) Stage III/IV disease, emphasizing the importance of detailed sub-phenotype information in future studies.

Implementation Framework for Diverse Endometriosis Cohorts

Study Design Considerations:

• Power Calculations: Account for varying allele frequencies and LD patterns across ancestral groups
• Phenotyping: Standardize endometriosis classification using rAFS staging and molecular subtyping
• Covariate Collection: Document relevant environmental and hormonal factors that may interact with genetic effects

Analytical Approaches for Endometriosis:

• Ancestry-Specific Association Testing: Apply Tractor or similar methods to identify ancestry-specific risk variants
• Genetic Correlation Analysis: Use LD score regression to estimate genetic correlations between ancestries
• Pleiotropy Analysis: Implement PLACO (Pleiotropic analysis under composite null hypothesis) to identify shared loci with related conditions like PCOS [67]

Table 3: Research Reagent Solutions for Endometriosis Admixture Studies

Reagent/Resource	Function	Example Sources	Application Notes
TWB Array [13]	Genotyping	Taiwan Biobank	653,291 SNPs, optimized for East Asian populations
GTEx Database [13]	eQTL Reference	GTEx Portal	Tissue-specific expression data for functional annotation
HaploReg [66]	LD Reference	haplotreg.org	Query tool for linkage disequilibrium and functional annotation
RFMix2 [62]	Local Ancestry	GitHub Repository	Critical for ancestry inference in admixed endometriosis cohorts
BioVU	Biobank Resource	Vanderbilt University	Linked EHR and genetic data from diverse populations
FinnGen [67]	GWAS Summary Statistics	finngen.fi	European population data for cross-ancestry comparison

Case Study: Trans-Ancestry Meta-Analysis of Endometriosis

Study Design:

• Discovery: 21,779 cases and 449,087 controls of European ancestry [67]
• Replication: 1,907 cases and 5,292 controls of Japanese ancestry [10]
• Validation: Independent cohorts including Taiwanese population (259 cases, 171 controls) [13]

Methodological Approach:

• Quality Control: Standardized QC pipeline across all cohorts
• Imputation: Unified imputation using TOPMed or 1000 Genomes reference panels
• Association Testing: Ancestry-stratified analysis with appropriate population structure adjustment
• Meta-Analysis: Trans-ancestry meta-analysis using Beta-Meta or similar tool
• Functional Annotation: Integration with GTEx and ENCODE data for functional insights

Key Findings:

• Identification of 12 significant pleiotropic loci shared between endometriosis and PCOS [67]
• Evidence for positive genetic correlation between endometriosis and PCOS (rg = 0.26, P = 0.015)
• Tissue-specific enrichment of genetic associations in uterus, endometrium, and fallopian tube
• Potential causal relationships between endometriosis and PCOS supported by Mendelian randomization

Emerging Methodologies and Technologies

The field of admixture and trans-ancestry genetic analysis is rapidly evolving, with several promising directions:

Advanced Modeling Approaches:

• Deep Learning Models: Convolutional neural networks and transformer architectures for fine-scale ancestry inference and association testing
• Biobank-Scale Methods: Efficient algorithms for analyzing mega-biobanks with diverse participants
• Integrative Omics Approaches: Combining genomic, transcriptomic, epigenomic, and proteomic data in multi-ancestry frameworks

Technical Innovations:

• Long-Read Sequencing: Improved phasing and local ancestry inference through long-range genomic information
• Single-Cell Multi-omics: Cell-type-specific QTL mapping across diverse ancestries
• Digital Phenotyping: Integration of EHR-derived phenotypes for increased sample sizes and power

Implementation Recommendations for Endometriosis Research

To advance ethnic diversity in endometriosis genetic research, we recommend:

• Priority Actions:
  • Systematically include diverse populations in new endometriosis genetic studies

• Apply local ancestry inference in existing admixed cohorts
• Develop optimized polygenic risk scores for non-European populations
• Implement trans-ancestry meta-analysis of all available endometriosis GWAS data

• Methodological Standards:
  • Adopt standardized QC pipelines across studies

• Implement robust population structure control in all analyses
• Apply both fixed and random effects models with heterogeneity estimation
• Perform comprehensive functional follow-up of identified loci

• Data Sharing and Collaboration:
  • Establish consortia for trans-ancestry endometriosis genetics

• Develop shared computational resources and reference panels
• Create federated analysis platforms for secure cross-institutional collaboration

The integration of admixture analysis and trans-ancestry methods represents a crucial advancement in endometriosis genetics, addressing longstanding disparities in genetic research while providing deeper insights into disease etiology. The bioinformatic tools and methodologies outlined in this technical guide provide researchers with a comprehensive framework for conducting rigorous, inclusive genetic studies of endometriosis across diverse populations. As these approaches continue to evolve, they hold tremendous promise for developing more effective, personalized approaches for endometriosis diagnosis, treatment, and prevention that benefit all women, regardless of their genetic ancestry.

Validation Frameworks and Comparative Genomics in Endometriosis

The replication of genome-wide association study (GWAS) findings across diverse populations remains a significant challenge in endometriosis research. This technical review benchmarks the replication rates of traditional GWAS methodologies against emerging combinatorial approaches that integrate multi-omics data. Traditional single-layer GWAS have identified numerous loci, yet these findings frequently demonstrate limited transferability across ethnic groups, compromising their utility for drug development. Combinatorial frameworks that systematically integrate genomic, transcriptomic, and epigenomic data show enhanced prioritization of robust, cross-population targets. Within endometriosis research, these advanced methods recover existing proof-of-concept therapeutic targets and reveal novel biological pathways, while simultaneously quantifying and addressing ethnic diversity in locus replication. This review provides experimental protocols, analytical workflows, and benchmarking metrics to guide researchers in implementing these approaches for more globally applicable genetic discovery.

Endometriosis, a chronic inflammatory condition affecting an estimated 176 million women worldwide, demonstrates substantial heritability estimated at 47-52% [68]. This genetic complexity has made it a prime target for GWAS, which have successfully identified multiple risk loci. However, the clinical translation of these discoveries has been hampered by inconsistent replication across diverse ethnic populations [69]. Traditional GWAS approaches, which test genetic variants across the genome in a hypothesis-free manner, face fundamental limitations regarding cross-population generalizability.

The traditional GWAS paradigm relies on genotyping hundreds of thousands of single nucleotide polymorphisms (SNPs) in large case-control cohorts, identifying variants meeting genome-wide significance (typically p < 5 × 10⁻⁸) [68]. While this approach has identified 12 SNPs at 10 independent loci associated with endometriosis, most show stronger associations with more severe disease stages (rAFS III/IV) and are predominantly located in non-coding regulatory regions [68] [10]. This traditional framework is complicated by population-specific linkage disequilibrium (LD) patterns, allele frequency differences, and heterogeneous environmental exposures across ethnic groups.

Combinatorial approaches represent a paradigm shift, leveraging multiple genomic data layers—including expression quantitative trait loci (eQTLs), chromatin interactions, and protein interactomes—to prioritize candidate genes and pathways with enhanced cross-population stability [70] [6]. These methods address a critical need in endometriosis research, where the heterogeneous nature of the disease and varying genetic backgrounds contribute to disparate findings across populations [69]. For drug development professionals, this transition from single-dimension association studies to multi-omics integration offers promising avenues for identifying therapeutic targets with broader efficacy across diverse patient populations.

Traditional GWAS: Achievements and Replication Limitations

Traditional GWAS have fundamentally advanced our understanding of endometriosis genetics through large-scale international efforts. The first endometriosis GWAS in 2010 identified a significant association in CDKN2B-AS1 (rs10965235; OR = 1.44, P = 5.57 × 10⁻¹²) in a Japanese cohort [68] [10]. This was followed by the first European-ancestry GWAS, which revealed an intergenic locus on chromosome 7 (rs12700667; OR = 1.22) [68]. Meta-analyses consolidating multiple studies have confirmed six genome-wide significant loci with consistent directional effects across populations, including rs7521902 near WNT4, rs10859871 near VEZT, and rs13394619 in GREB1 [10].

Key Experimental Protocols for Traditional GWAS

The standard workflow for traditional GWAS follows a rigorous, established protocol:

• Sample Collection and Phenotyping: Recruit surgically confirmed endometriosis cases and controls with detailed demographic and clinical data. The WERF Endometriosis Phenome and Biobanking Harmonization Project (EPHect) provides standardized protocols for consistent phenotyping across studies [68].
• Genotyping and Quality Control: Process DNA samples using genome-wide arrays (e.g., Illumina or Affymetrix platforms). Apply quality control filters: remove samples with >5% missingness, exclude SNPs with call rate <98%, Hardy-Weinberg equilibrium p < 10⁻⁶, and minor allele frequency <1% [71].
• Imputation: Increase genomic coverage using reference panels (1000 Genomes or HRC) to infer ungenotyped variants. Apply INFO score threshold >0.8 for high-quality imputed SNPs [68].
• Association Testing: Perform logistic regression assuming an additive genetic model, adjusting for principal components to account for population stratification. Apply genome-wide significance threshold of p < 5 × 10⁻⁸ [10].
• Replication Analysis: Test significant associations in independent cohorts from diverse ethnic backgrounds using identical SNP effects or proxy variants in high LD (r² > 0.8).

Quantitative Assessment of Replication Rates

Table 1: Replication Rates of Traditional Endometriosis GWAS Loci Across Ethnicities

Locus	Lead SNP	Discovery Population	European Replication	East Asian Replication	Other Populations	Effect Size (OR)
WNT4	rs7521902	European	Yes (P = 1.8×10⁻¹⁵)	Yes (P < 0.05)	Not replicated in Sardinian [69]	1.20
VEZT	rs10859871	European	Yes (P = 4.7×10⁻¹⁵)	Mixed	Not replicated in Sardinian [69]	1.15
CDKN2B-AS1	rs10965235	Japanese	Yes (P < 0.05)	Yes (P = 5.57×10⁻¹²)	Not assessed	1.44
FSHB	rs11031006	European	Mixed	Not replicated	Not replicated in Sardinian [69]	1.12

Table 2: Limitations in Traditional GWAS Contributing to Poor Replication

Factor	Impact on Replication	Empirical Example
Population-Specific LD	Causal variant tagged in one population not tagged in another	Differences in WNT4 locus LD between European and East Asian [10]
Allele Frequency Differences	Risk allele less frequent or monomorphic in some populations	Variant frequency spectrum differences in Sardinian population [69]
Sample Size Disparities	Limited power in understudied populations	Most large GWAS in European and East Asian ancestries [10]
Phenotypic Heterogeneity	Varying case definitions across studies	Stronger associations with rAFS Stage III/IV vs. all stages [68]

The Sardinian population study exemplifies the replication challenge, where neither WNT4 (rs7521902) nor FSHB (rs11031006) showed significant association with endometriosis risk, despite strong signals in other European populations [69]. This highlights how even within broadly defined ethnic groups, regional genetic substructure can significantly impact replication rates.

Combinatorial Approaches: Multi-Omics Integration for Enhanced Discovery

Combinatorial approaches address fundamental limitations of traditional GWAS by integrating multiple biological data layers to prioritize functionally relevant genes and pathways. These methods leverage the insight that GWAS-identified variants predominantly reside in non-coding regulatory regions, suggesting their primary mechanism involves modulating gene expression rather than altering protein structure [68] [6].

Core Methodological Framework

The combinatorial framework employs systematic integration of diverse genomic datasets:

• GWAS Summary Statistics: Curate associations from large-scale meta-analyses (p < 5 × 10⁻⁸) [70]
• Regulatory Genomics: Incorporate promoter capture Hi-C data defining chromosomal conformation genes (cGenes) [70]
• Expression Quantitative Trait Loci (eQTLs): Integrate tissue-specific eQTL data from relevant tissues (uterus, ovary, blood) [6]
• Protein-Protein Interactions: Utilize high-quality interaction networks from databases like STRING (experimental and database evidence only) [70]

The 'END' method exemplifies this approach, applying machine learning (random forest) to evaluate predictor importance and combining evidence through direct (sum, max, harmonic) or indirect (Fisher's, logistic) methods to prioritize target genes [70]. This multi-evidence framework significantly outperforms naïve prioritization based solely on GWAS p-values or Open Targets aggregation.

Experimental Protocols for Combinatorial Approaches

Protocol 1: Genomics-Led Target Prioritization

• Data Preparation:

  • Obtain GWAS summary statistics for endometriosis
  • Download tissue-specific eQTL data from GTEx v8 for uterus, ovary, vagina, colon, ileum, and whole blood [6]
  • Acquire promoter capture Hi-C data for endometrial cell lines
  • Extract protein-protein interactions from STRING database (high-confidence interactions only)

• Predictor Evaluation:

  • Apply random forest to evaluate importance of each genomic predictor (nGene, cGene, eGene)
  • Retain predictors with importance no less than the conventional nGene baseline

• Evidence Combination:

  • Implement multiple combination strategies (direct: sum, max, harmonic; indirect: Fisher's, logistic)
  • Calculate priority scores for each candidate gene across combination methods

• Benchmarking:

  • Validate against known proof-of-concept targets (drug targets reaching clinical phase 2+)
  • Compare performance with alternative approaches using AUC metrics [70]

Protocol 2: Cross-Disease Prioritization Mapping

• Target Selection: Extract top 5% prioritized genes from endometriosis analysis
• Matrix Construction: Create prioritization matrix across multiple immune-mediated diseases
• Map Training: Apply supra-hexagonal map training to identify shared and distinct targets [70]
• Repurposing Analysis: Identify opportunities for drug repurposing based on shared targets

Visualization of Combinatorial Workflow

Diagram 1: Combinatorial GWAS Analysis Workflow. This integrated approach systematically combines multiple data types with quality control to generate robust, functionally validated outputs.

Benchmarking Replication Performance

Quantitative Comparison of Replication Rates

Table 3: Direct Performance Comparison Between Traditional and Combinatorial GWAS

Metric	Traditional GWAS	Combinatorial Approach	Improvement
Proof-of-Concept Target Recovery	Limited	Recovers existing therapeutic targets [70]	Significant (AUC > 0.8)
Cross-Population Stability	30-60% replication rate [69]	Enhanced through functional prioritization	~40% increase
Drug Target Prioritization	Incidental	Systematic identification of repurposing opportunities [70]	Qualitative advance
Ethnic Diversity Capture	Limited to well-represented populations	Can leverage diverse functional genomics data	Moderate improvement

Table 4: Tissue-Specific Regulatory Effects of Endometriosis Loci [6]

Tissue	Number of eQTLs	Primary Biological Pathways	Ethnic Specificity Notes
Uterus	127	Hormonal response, Tissue remodeling	Consistent across European and East Asian
Ovary	98	Steroidogenesis, Cell adhesion	Moderate population differences
Vagina	76	Extracellular matrix organization	Limited multi-ethnic data
Whole Blood	215	Immune response, Inflammation	Highly consistent across populations
Sigmoid Colon	84	Epithelial signaling, Immune function	Population-specific effects observed

Combinatorial approaches demonstrate superior performance in benchmark analyses, with the 'END' prioritization achieving AUC >0.8 in separating clinical proof-of-concept targets from simulated controls, significantly outperforming both naïve prioritization and Open Targets [70]. This enhanced performance directly translates to improved replication rates, as functionally validated targets show greater cross-population stability.

Ethnic Diversity Integration in Combinatorial Frameworks

The tissue-specific eQTL analysis reveals both opportunities and challenges for multi-ethnic research. While many regulatory effects are consistent across populations (e.g., immune pathways in whole blood), reproductive tissues demonstrate greater inter-individual variability [6]. This suggests combinatorial approaches must incorporate population-specific regulatory data for optimal performance across diverse groups.

Pathway analysis of prioritized targets reveals both shared and population-specific therapeutic opportunities. Notably, combinatorial analyses identify neutrophil degranulation as an endometriosis-specific pathway, while simultaneously revealing shared targets with immune-mediated diseases (TNF, IL6, IL6R) suitable for drug repurposing [70]. This dual capability enhances the translational potential of genetic findings across diverse patient populations.

Research Reagent Solutions

Table 5: Essential Research Reagents and Computational Tools

Category	Specific Resource	Application	Key Features
Data QC Tools	DENTIST [71]	Detect errors in GWAS summary statistics	Reduces false positives from 28% to <2% for rare variants
Summary Statistics Rehabilitation	SumStatsRehab [72]	Restore missing data columns in GWAS files	Recovers rsID, alleles, frequencies, association statistics
Prioritization Framework	END Method [70]	Multi-omics target prioritization	Integrates GWAS, eQTL, Hi-C, PPI with random forest
eQTL Resources	GTEx v8 [6]	Tissue-specific expression QTLs	Includes uterus, ovary, blood relevant to endometriosis
Pathway Analysis	XGR [70]	Functional enrichment and crosstalk	Identifies critical pathway nodes for targeting
Cross-Disease Mapping	supraHex [70]	Compare prioritization across diseases	Enables drug repurposing analysis

Combinatorial GWAS approaches represent a substantive methodological advance over traditional single-dimension association studies, demonstrating superior replication rates and enhanced capacity for identifying therapeutically relevant targets. By systematically integrating multiple omics data layers, these methods address fundamental limitations in cross-ethnic generalizability while providing mechanistic insights into endometriosis pathogenesis.

For researchers and drug development professionals, the implementation of combinatorial frameworks offers a path to more globally applicable genetic discoveries. Future developments should focus on expanding diverse population representation in both GWAS and functional genomics resources, refining multi-omics integration algorithms, and establishing standardized benchmarking protocols for replication rate assessment across ethnic groups. These advances will accelerate the translation of genetic discoveries into targeted therapies effective across diverse patient populations.

Cross-Population Genetic Correlation and Polygenic Risk Score Transferability

This technical guide examines the transferability of polygenic risk scores (PRSs) and genetic correlations across diverse populations, with a specific focus on endometriosis research. Despite endometriosis affecting individuals globally, genome-wide association studies (GWAS) remain predominantly based on European-ancestry populations, creating significant limitations for equitable precision medicine. We synthesize current methodologies for assessing cross-population genetic architecture, evaluate the performance of endometriosis PRSs in underrepresented populations, and provide experimental protocols for improving transferability. Evidence indicates that PRSs developed in European populations demonstrate substantially reduced predictive accuracy when applied to non-European groups, potentially exacerbating health disparities. This whitepaper underscores the critical need for more diverse genetic studies to ensure all populations benefit equally from advances in genetic medicine, particularly in complex gynecological conditions like endometriosis where diagnostic delays already disproportionately affect minority groups.

Endometriosis, a debilitating gynecological condition affecting approximately one in nine reproductive-aged women, demonstrates significant diagnostic delays of 7-11 years, with emerging evidence suggesting these delays disproportionately affect Hispanic and Black women [73] [25]. Despite its global prevalence, genetic research on endometriosis faces a critical diversity gap. Recent analyses reveal that only 10.0% of human-based endometriosis research articles report participants' race and/or ethnicity, with poor quality of reporting even in these limited cases [25]. This underrepresentation in primary research directly impacts the development and applicability of genetic tools like polygenic risk scores (PRSs).

PRSs aggregate the effects of many genetic variants into a single measure of genetic predisposition for complex traits or diseases [74]. While holding promise for revolutionizing precision medicine, their clinical translation is hampered by limited transferability across ancestries. More than 80% of GWAS participants are of European descent, and PRSs developed from these populations typically lose 40-60% of their predictive accuracy when applied to African, South Asian, or East Asian cohorts [75] [74]. This performance disparity stems from fundamental genetic differences including allele frequency variations, linkage disequilibrium (LD) pattern differences, and effect size heterogeneity [74].

The implications for endometriosis research are profound. Without diverse genetic representation, PRSs and genetic correlation estimates may fail to capture the full spectrum of disease biology across populations, potentially exacerbating existing health disparities in endometriosis diagnosis and treatment.

Fundamental Principles of Cross-Population Genetic Analysis

Genetic Factors Influencing PRS Transferability

The transferability of PRSs across populations depends on several interconnected genetic factors that collectively influence how well genetic risk estimates generalize across ancestral groups:

• Heritability Differences: Array heritability (the proportion of phenotypic variation captured by GWAS SNPs) can differ across populations due to varying sociocultural factors, environmental exposures, and measurement errors [74]. Even within relatively homogeneous populations, heritability—and thus PRS predictive accuracy—can vary by demographic variables such as age, sex, and socioeconomic status [74].

• Allele Frequency and Effect Size Variations: Differences in causal allele frequencies and effect sizes across populations arise from demographic histories (genetic drift, population bottlenecks) and gene-environment interactions [74]. Though extensive genetic overlap exists across ancestries for many complex traits, widespread allelic effect heterogeneity has been observed [74] [76].

• Linkage Disequilibrium (LD) Pattern Variations: LD patterns differ markedly across populations, with African populations typically showing smaller LD blocks than European or East Asian populations [74]. Since PRS variants are often proxies for causal variants rather than causal themselves, LD differences significantly impact transferability from European-derived scores [74].

• Causal Variant Heterogeneity: Even when associations exist in the same genomic region across ancestries, they may be driven by different causal variants. Colocalization analyses between European and South Asian ancestry samples found evidence for causal variant sharing in only 26-61% of transferable loci across various cardiometabolic traits [76].

Conceptual Framework for Population Descriptors in Genetic Studies

Accurate population descriptors are essential for interpreting cross-population genetic analyses:

• Race and Ethnicity: Socially constructed classifications that should not be conflated with genetic ancestry. Race categorizes based on perceived physical traits, while ethnicity refers to shared cultural identity [74].

• Genetic Ancestry: A fixed characteristic of the genome representing segments inherited from ancestors, typically inferred from genetic similarity measures and reference populations [74].

• Global vs. Local Ancestry: Global ancestry estimates genome-wide contributions from proxy ancestral populations, while local ancestry identifies ancestral origins of specific chromosomal segments [74].

Table 1: Performance Metrics for PRS Transferability in Underserved Populations

Population	Trait	Best-Performing PRS Variance Explained (R²)	Compared to European Performance	Key Limitations
Thai [75]	LDL-C	9.8%	Reduced	Limited SNP retention, ancestry-related LD differences
Thai [75]	Type 2 Diabetes	AUC: 0.70	Reduced	30% of T2D PRSs significant vs. expected higher %
British Pakistani/Bangladeshi [76]	Lipids, Blood Pressure	High performance	Similar	LDL-C heritability significantly lower (0.06 vs 0.18)
British Pakistani/Bangladeshi [76]	BMI, CAD	Lower performance	Reduced	PAT ratio for CAD: 0.62
General [74]	Multiple traits	40-60% accuracy loss	40-60% reduction	European-centric discovery GWAS

Methodological Approaches for Assessing Transferability

Quantifying Genetic Correlation Across Populations

Genetic correlation analysis measures the proportion of genetic variance shared between traits or populations. For endometriosis, this approach has revealed significant genetic correlations with multiple conditions:

• Endometrial Cancer: Moderate but significant genetic correlation (r𝑔 = 0.23, P = 9.3×10⁻³) with evidence for significant SNP pleiotropy (P = 6.0×10⁻³) and concordance in effect direction (P = 2.0×10⁻³) [77].

• Uterine Leiomyomata (Fibroids): Cross-disease GWAS meta-analysis identified four loci shared between endometriosis and uterine fibroids, with epidemiological meta-analysis suggesting at least doubled risk for fibroid diagnosis among those with endometriosis history [78].

• Pain, Inflammatory and Gastrointestinal Conditions: Genetic correlation analyses provide evidence that genetic factors contributing to endometriosis are shared with migraine, asthma, gastro-oesophageal reflux disease, gastritis/duodenitis, and depression [73].

The standard method for genetic correlation estimation is LD Score regression, which uses GWAS summary statistics to estimate the genetic covariance between traits while accounting for LD structure [73] [77] [78].

Experimental Protocol: Transferability Assessment for Endometriosis PRS

Objective: Systematically evaluate the performance of endometriosis PRS in non-European populations.

Materials and Dataset Requirements:

• Target cohort with endometriosis cases/controls from underrepresented population
• Genotype data imputed to standard reference panel
• Clinical covariates (age, BMI, principal components for ancestry)

Methodology:

• PRS Calculation:

  • Obtain summary statistics from endometriosis GWAS [73]
  • Apply clumping (r² = 0.1, distance = 500kb) to select independent SNPs
  • Calculate scores using PRSice2 or LDpred2 with European LD reference
  • Alternatively, use multi-ancestry PRS construction methods [74]

• Association Testing:

  • Fit logistic regression: Endometriosis ~ PRS + age + BMI + PC1:10
  • Evaluate discrimination via Area Under Curve (AUC)
  • Estimate variance explained using Nagelkerke's R²

• Transferability Metrics:

  • Power-Adjusted Transferability (PAT) Ratio: (Observed transferable loci)/(Expected transferable loci given power) [76]
  • Variance Explained (R²): Proportion of phenotypic variance explained by PRS
  • Stratified Odds Ratios: Compare effect sizes across PRS quantiles

• Ancestry-Specific Analyses:

  • Estimate SNP-based heritability in target population using LD Score regression
  • Calculate cross-population genetic correlation using Popcorn [76]
  • Perform colocalization analysis at significant loci to assess causal variant sharing

Interpretation: Reduced performance (AUC, R²) indicates limited transferability. PAT ratio <1 suggests loci missing despite adequate power, potentially due to genetic heterogeneity [76].

Experimental Protocol: Cross-Population Mendelian Randomization for Endometriosis Comorbidities

Objective: Assess causal relationships between endometriosis and comorbid traits across diverse populations using Mendelian Randomization (MR).

Rationale: MR uses genetic variants as instrumental variables to test causal relationships, avoiding confounding [73]. Cross-population MR can reveal whether causal mechanisms are shared.

Methodology:

• Instrument Selection:

  • Identify genome-wide significant (P < 5×10⁻⁸) SNPs for exposure trait
  • Clump SNPs (r² = 0.001, distance = 10,000kb) to ensure independence
  • Extract SNP-outcome associations from target population GWAS

• MR Analysis:

  • Perform Inverse-Variance Weighted (IVW) MR as primary analysis
  • Conduct sensitivity analyses (MR-Egger, weighted median, MR-PRESSO)
  • Test for horizontal pleiotropy via MR-Egger intercept and Cochran's Q

• Cross-Population Comparison:

  • Repeat MR analysis in European and non-European populations separately
  • Compare effect estimates using interaction tests
  • Assess heterogeneity via meta-analysis approaches

Application: This approach has revealed putative causal relationships between endometriosis and depression, ovarian cancer, and uterine fibroids [73].

Current Evidence on Transferability in Endometriosis and Related Traits

Empirical Data on PRS Performance Across Ancestries

Direct evidence for endometriosis PRS transferability remains limited due to the lack of diverse GWAS. However, studies of related traits provide insights:

• Cardiometabolic Traits in Thai Populations: Evaluation of 64 PRSs for eight cardiometabolic traits showed variable performance, with lipid PRSs explaining up to 9.8% of variance in LDL-C, while PRSs for cardiovascular disease showed weaker predictive value and sometimes inverse associations [75].

• British Pakistani and Bangladeshi Populations: PRS performance was high for lipids and blood pressure but lower for BMI and coronary artery disease. The PAT ratio for CAD was 0.62, indicating fewer transferable loci than expected given statistical power [76].

• General Transferability Patterns: PRSs developed from multi-ancestry cohorts tend to perform comparably or better than those derived solely from European or East Asian populations across most traits [75].

Genetic Correlation Evidence for Endometriosis

Despite limited direct PRS evidence, genetic correlation analyses demonstrate shared genetic architecture between endometriosis and other traits across populations:

Table 2: Documented Genetic Correlations with Endometriosis

Trait	Genetic Correlation Estimate	Significance	Implications
Endometrial Cancer	r𝑔 = 0.23	P = 9.3×10⁻³	Shared biological etiology despite distinct GWAS loci [77]
Uterine Leiomyomata	Multiple shared loci	P < 5×10⁻⁸	Overlapping genetic origins [78]
Depression	Significant MR evidence	FDR < 0.05	Potential causal relationship [73]
Ovarian Cancer	Significant MR evidence	FDR < 0.05	Endometriosis as risk factor [73]
Migraine, Gastrointestinal	Significant genetic correlation	FDR < 0.05	Shared pathways contributing to comorbidity [73]

Interaction Between PRS and Comorbidities in Endometriosis

Emerging evidence suggests complex interactions between genetic risk and comorbid conditions:

• Women with endometriosis have significantly higher comorbidity burden, which correlates with endometriosis PRS in those without endometriosis but shows negative correlation in affected individuals [79].

• The absolute increase in endometriosis prevalence conveyed by several comorbidities (uterine fibroids, heavy menstrual bleeding, dysmenorrhea) is greater in individuals with high endometriosis PRS compared to low PRS [79].

• These interactions, consistent across UK Biobank and Estonian Biobank, highlight how polygenic risk modifies the effect of comorbid conditions on endometriosis susceptibility [79].

Table 3: Key Research Reagents and Computational Tools

Resource Category	Specific Tools/Methods	Function/Purpose	Considerations for Endometriosis Research
Statistical Genetics Software	LD Score Regression [73] [77]	Genetic correlation estimation	Requires GWAS summary statistics; accounts for LD structure
	SECA (SNP Effect Concordance Analysis) [77]	Assess SNP pleiotropy between traits	Uses P-value "bins" to extract independent SNPs
	PRSice2, LDpred2 [74]	Polygenic risk score calculation	LDpred2 accounts for LD; superior for European ancestry
Data Resources	GWAS Catalog	Access to summary statistics	Limited non-European endometriosis datasets available
	Biobanks with diverse participants (All of Us, Biobank Japan)	Multi-ancestry genetic studies	Underutilized for endometriosis research
	Trans-ancestry reference panels (1000 Genomes, HGDP)	Imputation and ancestry analysis	Improve genotype imputation in diverse populations
Methodological Approaches	Multi-ancestry meta-analysis [74]	Improve discovery across populations	Increases portability of resulting PRS
	Colocalization analysis [76]	Test for shared causal variants	Identifies biologically relevant mechanisms
	MR-Base [73]	Mendelian randomization framework	Enables causal inference for comorbidities

Advancements and Future Directions

Methodological Innovations for Improved Transferability

Several promising approaches are emerging to enhance PRS transferability:

• Multi-ancestry GWAS and PRS Construction: Combining data across ancestries in discovery GWAS significantly improves portability of resulting PRS compared to European-only scores [74].

• Ancestry-Specific Effect Size Estimation: Methods that estimate effect sizes specific to target populations can enhance prediction accuracy in underrepresented groups [74].

• Functional Annotation Integration: Incorporating functional genomic data can help prioritize causal variants that are more likely to be shared across populations [74].

Prioritizing Diverse Endometriosis Genetics Research

Addressing the diversity gap in endometriosis genetics requires coordinated effort:

• Expand Recruitment of Underrepresented Populations: Targeted recruitment of diverse participants in endometriosis genetic studies is essential to build adequate sample sizes for transferability assessments.

• Standardize Race and Ethnicity Reporting: Adherence to ICMJE guidelines for reporting race and ethnicity in endometriosis research would improve transparency and reproducibility [25].

• Develop Ancestry-Aware Clinical Tools: As PRSs move toward clinical application, developing frameworks that account for genetic ancestry will be crucial for equitable implementation.

The transferability of polygenic risk scores and genetic correlations across populations represents both a formidable challenge and critical opportunity in endometriosis research. Current evidence demonstrates substantial reduction in PRS performance when applied across genetic ancestries, threatening to exacerbate existing health disparities if unaddressed. Methodological frameworks for assessing transferability—including genetic correlation analysis, power-adjusted transferability ratios, and cross-population Mendelian randomization—provide robust approaches for evaluating and improving cross-population applicability. The significant genetic correlations between endometriosis and other gynecological conditions highlight shared biological mechanisms that may inform therapeutic development. However, realizing the promise of equitable precision medicine for endometriosis requires urgent investment in diverse genetic studies, multi-ancestry analytical methods, and ancestry-aware clinical implementation frameworks. Only through dedicated effort to include global genetic diversity can we ensure that advances in endometriosis genetics benefit all affected individuals regardless of ancestry.

Endometriosis, a chronic inflammatory condition affecting approximately 10% of reproductive-aged women globally, demonstrates significant heterogeneity in its genetic architecture across different populations [7] [53]. Despite the identification of numerous susceptibility loci through genome-wide association studies (GWAS), the functional characterization of these variants, particularly those specific to certain ethnic groups, remains limited. This gap critically impedes the development of personalized diagnostic and therapeutic strategies. The historical context of endometriosis research further complicates this landscape, as racial and ethnic biases have historically influenced both medical education and research focus, potentially leading to underdiagnosis in certain populations and limited genetic representation in studies [36]. Recent research confirms that specific risk alleles operate differently in the pathogenesis of endometriosis across distinct ethnic populations, underscoring the necessity of studying the genetic basis of endometriosis in diverse cohorts [5]. This technical guide provides a comprehensive framework for validating population-specific genetic variants, bridging the gap between statistical association and biological mechanism in the context of global ethnic diversity.

Landscape of Population-Specific Endometriosis Loci

Established and Novel Genetic Associations Across Populations

Recent GWAS efforts in diverse populations have revealed both shared and population-specific susceptibility loci for endometriosis. The table below summarizes key findings from recent studies in different ethnic groups.

Table 1: Population-Specific Endometriosis Susceptibility Loci

Population	Shared Loci	Novel/Population-Specific Loci	Key Genes	Study Details
Taiwanese-Han	3 of 5 loci	2 novel loci	WNT4, RMND1, CCDC170, C5orf66/C5orf66-AS2, STN1	2,794 cases; 27,940 controls [46]
European Descent	42 significant loci	-	ESR1, CYP19A1, HSD17B1, VEGF, GnRH	Large-scale meta-analysis [53]
Iranian	-	Variants associated with local demographics	MFN2, PINK1, PRKN	50 samples; association with geography/ethnicity [5]
Multiple	5 regulatory variants	6 enriched regulatory variants	IL-6, CNR1, IDO1, TACR3, KISS1R	19 endometriosis cases (WGS) [7]

Functional Potential of Associated Variants

The functional annotation of GWAS-identified variants reveals that the majority reside in non-coding genomic regions, suggesting they predominantly exert regulatory effects. A comprehensive analysis of 465 endometriosis-associated variants found that they most often influence gene expression rather than protein structure, functioning as expression quantitative trait loci (eQTLs) in tissue-specific patterns [6]. Notably, ancient regulatory variants, including some of Neandertal and Denisovan origin, have been implicated in endometriosis susceptibility, potentially interacting with modern environmental exposures like endocrine-disrupting chemicals (EDCs) to modulate disease risk [7]. This complex interplay between deep evolutionary genetic legacy and contemporary environmental factors creates a unique landscape for population-specific disease manifestation.

Methodological Framework for Functional Validation

Prioritization of Candidate Variants

The initial step in functional validation involves rigorous prioritization of candidate variants from GWAS signals. This process should integrate multiple data dimensions to identify the most promising targets for experimental follow-up.

Table 2: Variant Prioritization Criteria and Methods

Prioritization Criteria	Data Sources	Analytical Methods	Interpretation
Association Strength	GWAS summary statistics	p-value, odds ratio	p < 5×10-8 considered genome-wide significant [6]
Population Specificity	1000 Genomes, gnomAD	Population branch statistic (PBS), FST	Identifies variants under differential selection [7]
Regulatory Potential	GTEx, ENCODE, Roadmap	eQTL analysis, chromatin states	Tissue-specific regulatory effects (uterus, ovary) [6]
Linkage Disequilibrium	LDlink, 1000 Genomes	r2, D'	Defines haplotype blocks and independent signals [7]
Functional Annotation	Ensembl VEP, ANNOVAR	Variant consequence prediction	Non-coding vs. coding functional impact [6]

Computational and Experimental Validation Workflow

The functional validation of population-specific variants requires an integrated approach combining bioinformatic analyses with experimental techniques. The following diagram illustrates the comprehensive workflow from initial genetic discovery to mechanistic insight.

Diagram 1: Functional Validation Workflow (76 characters)

Core Experimental Protocols

Functional Genomic Characterization

Expression Quantitative Trait Loci (eQTL) Analysis: Cross-reference prioritized variants with tissue-specific eQTL data from resources like GTEx (v8), focusing on biologically relevant tissues including uterus, ovary, vagina, sigmoid colon, ileum, and peripheral blood [6]. Employ false discovery rate (FDR) correction (FDR < 0.05) to identify significant associations. The slope value provided by GTEx indicates the direction and magnitude of regulatory effect, where +1.0 represents a twofold increase in expression per alternative allele, while -1.0 reflects a 50% decrease [6].

Epigenomic Profiling: Utilize assays such as ATAC-seq, ChIP-seq (H3K27ac, H3K4me1), and DNase I hypersensitivity mapping to identify variants overlapping regulatory elements in endometriosis-relevant cell types (endometrial stromal cells, epithelial cells). Analyze population-specific chromatin accessibility patterns using data from the Roadmap Epigenomics Project and ENCODE.

In Vitro Functional Assays

Dual-Luciferase Reporter Assays: Clone reference and alternative alleles of candidate regulatory variants into reporter vectors (pGL4-based) upstream of a minimal promoter driving firefly luciferase expression. Transfect into endometriosis-relevant cell lines (e.g., 12Z, 22B) using appropriate transfection reagents (Lipofectamine 3000). Measure luciferase activity 48 hours post-transfection, normalizing to Renilla luciferase control. Perform statistical analysis across at least three biological replicates to assess allele-specific effects on transcriptional activity.

CRISPR/Cas9 Genome Editing: Design guide RNAs targeting prioritized regulatory regions and transfert into target cell lines using ribonucleoprotein (RNP) complexes. Generate both deletion mutants (for enhancer validation) and precise allele conversions (for SNP functional assessment). Validate edits by Sanger sequencing and assess functional consequences through RNA-seq, qPCR, and relevant phenotypic assays (proliferation, invasion, hormone response).

Functional Characterization of Taiwanese-Han Specific Loci

For the newly identified loci in Taiwanese-Han populations (C5orf66/C5orf66-AS2 and STN1), specific functional hypotheses should be tested. For the lncRNA genes C5orf66 and C5orf66-AS2, perform RNA immunoprecipitation (RIP) assays to identify interacting RNA-binding proteins (RBPs) and assess their impact on RNA metabolic processes, mRNA stabilization, and splicing [46]. For STN1, involved in telomere maintenance, evaluate telomere length and stability in endometrial cell lines following genetic perturbation.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for Functional Validation

Reagent/Category	Specific Examples	Application in Validation	Technical Notes
Genotyping & Sequencing	PCR probes, Sanger sequencing, WGS	Variant confirmation, carrier identification	Probe-based PCR for SNP genotyping [80]
Gene Expression Analysis	RT-qPCR kits, RNA-seq	Expression level quantification, splicing analysis	Normalize to reference genes (e.g., 18s rRNA) [5]
Epigenomic Profiling	ATAC-seq, ChIP-seq kits	Regulatory element identification	Focus on active enhancer marks (H3K27ac)
Genome Editing	CRISPR/Cas9 systems, sgRNAs	Precise genetic perturbation	RNP delivery for highest efficiency
Cell Culture Models	Endometrial cell lines (12Z, 22B), primary cells	Functional assays in relevant context	Characterize hormone response profiles
Protein Interaction	Co-IP kits, ELISA	Protein-protein, protein-RNA interactions	Validate lncRNA-RBP interactions [46]
Pathway Analysis	STRING, MSigDB	Biological context for discoveries	Use Hallmark gene sets [6]

Analytical and Statistical Considerations

Addressing Population Stratification

When working with population-specific variants, careful attention must be paid to statistical methods that account for population stratification and genetic ancestry. Utilize genetic principal components or linear mixed models to correct for stratification artifacts. For LD and haplotype analyses, employ population-specific reference panels from the 1000 Genomes Project or population-specific sequencing initiatives [7]. Compute population branch statistics (PBS) to quantify population differentiation, truncating negative values to zero for meaningful interpretation of selective pressure differences.

Multiple Testing Correction

Implement rigorous multiple testing corrections throughout the functional validation pipeline. For eQTL analyses, use false discovery rate (FDR) correction with a threshold of FDR < 0.05 [6]. For experimental validation involving multiple variants or conditions, apply Bonferroni or Benjamini-Hochberg corrections based on the number of independent hypotheses tested. In discovery-phase analyses, consider less stringent thresholds to maintain statistical power while acknowledging the exploratory nature of these analyses.

Pathway Mapping and Mechanistic Integration

Signaling Pathways Implicated by Population-Specific Variants

Population-specific variants in endometriosis converge on several core biological pathways. The following diagram illustrates key pathways and their interactions implicated by genetic findings across diverse populations.

Diagram 2: Endometriosis Pathways and Genetics (52 characters)

Integration with Clinical Phenotypes

Correlate functional genomic findings with detailed clinical phenotypes, including pain scores, infertility status, lesion characteristics (rASRM stage), and disease recurrence rates. For population-specific variants, assess whether they associate with distinct clinical presentations, such as the higher risks of developing deeply infiltrating/invasive lesions and associated malignancies observed in Taiwanese-Han populations [46]. Multivariate statistical approaches, including factor analysis of mixed data (FAMD) and redundancy analysis (RDA), can reveal associations between genetic variants, environmental factors, and clinical outcomes [5].

The functional validation of population-specific variants represents a crucial step toward equitable precision medicine in endometriosis. By moving beyond association signals to mechanistic understanding, researchers can identify novel therapeutic targets relevant to diverse patient populations and develop genetic risk prediction models that perform accurately across ethnic groups. This approach not only advances biological understanding but also directly addresses historical disparities in endometriosis research and clinical care. Future directions should include the development of multi-ethnic biobanks, increased application of advanced genome editing in disease-relevant cell models, and integration of genetic data with environmental exposure information to fully capture the complex etiology of this debilitating condition.

The pursuit of ethnically-inclusive biomarkers and drug targets represents a critical frontier in precision medicine. Despite known heritability and established genetic loci for conditions like endometriosis, genome-wide association studies (GWAS) have historically relied on cohorts of European ancestry, limiting the generalizability of findings. This whitepaper synthesizes current evidence demonstrating ethnic disparities in genetic architecture and clinical trial participation. We present quantitative analyses of allele frequency heterogeneity and diversity gaps in major studies, alongside structured methodologies for developing inclusive genomic research protocols. Our analysis confirms that expanding diversity in genetic research is scientifically necessary and ethically imperative to ensure equitable healthcare outcomes and robust drug development.

Genetic studies have revolutionized our understanding of disease etiology, yet their translational potential remains constrained by a critical lack of diversity. Endometriosis, a common gynecological disorder affecting 6-10% of reproductive-aged women, exemplifies this challenge [81] [52]. With an estimated heritability of 47-51% based on twin studies, endometriosis has a strong genetic component, and GWAS have successfully identified multiple risk loci [52]. However, the foundational discoveries predominantly stem from European-ancestry cohorts, creating inherent limitations in their global applicability.

The ethical and scientific imperative for diversity extends beyond endometriosis to all biomarker discovery and drug target identification. Recent analyses of clinical trial populations reveal significant underrepresentation of ethnic minorities, potentially compromising the generalizability of therapeutic findings [82]. Simultaneously, studies examining tumor genomic landscapes across diverse populations report differing prevalences of clinically actionable alterations, suggesting that biomarker-driven treatment strategies derived from predominantly White cohorts may not optimally serve all patient populations [83]. This whitepaper examines these disparities within the specific context of endometriosis genetics while providing frameworks for developing ethnically-inclusive research strategies applicable across disease states.

Quantitative Landscape: Disparities in Genetic Research and Clinical Translation

Diversity Gaps in Genomic Studies and Clinical Trials

Table 1: Ethnic Representation in Major Genetic and Clinical Studies

Study / Database	Primary Focus	Sample Size	White	Asian	Black/African American	Hispanic/Latino	Reference
Endometriosis Meta-Analysis	Genetic associations	17,045 cases / 191,858 controls	~93% (effective sample)	~7%	Not specified	Not specified	[52]
TAPUR Study	Targetable genomic alterations	3,448 registrants	72%	4%	11%	6%	[83]
Clinical Trial Perceptions Survey	Participation barriers	12,017 respondents	81%	6%	6%	15%	[82]

Note: Percentages may not sum to 100% due to rounding or "other" categories not shown.

The data reveal consistent underrepresentation of non-European populations in genetic research. The largest endometriosis meta-analysis to date, while including approximately 7% Japanese ancestry individuals, predominantly reflects European genetic architecture [52]. In clinical research settings, the TAPUR Study shows better but still imbalanced representation, with Black, Asian, and Hispanic participants collectively comprising only 21% of the cohort [83].

Ethnic Variations in Biomarker Prevalence

Table 2: Select Genomic Alterations with Differential Prevalence Across Ancestries

Gene	Alteration Association	Odds Ratio (95% CI)	P-value	Clinical Context	Reference
PDGFRA	Higher in Hispanic vs. Non-Hispanic	4.5 (2.0-10.3)	<0.05	Targetable alteration	[83]
JAK2	Higher in Asian vs. White	>4.0 (wide CI)	<0.05	Targetable alteration	[83]
MTAP	Lower in Black vs. White	0.3 (0.1-0.7)	<0.05	Potential drug target	[83]
SMARCB1	Higher in Hispanic vs. Non-Hispanic	4.9 (1.6-15.3)	<0.05	Cancer-associated gene	[83]

These findings demonstrate that clinically relevant genomic alterations show significant variability in prevalence across ethnic groups. Such differences underscore the risk of developing biomarker-stratified treatment approaches based on evidence from single-population studies, potentially leading to disparities in diagnostic accuracy and therapeutic efficacy for underrepresented groups [83].

Endometriosis GWAS Loci Heterogeneity Across Populations

Table 3: Replication Status of Endometriosis Risk Loci in Multi-Ancestry Context

Locus	Gene	Reported OR (European)	Replication in Japanese Ancestry	Notes on Cross-Ancestry Generalizability	Reference
1p36.12	WNT4	1.29 (1.18-1.40)	Confirmed	Associated with hormone signaling; replicated across populations	[81] [52]
9p21.3	CDKN2BAS	1.20 (1.13-1.29)	Population-specific effect	First identified in Japanese cohort; effect size varies	[52]
2q23.3	RND3-RBM43	1.20 (1.13-1.29)	Not confirmed	Identified in European cohort; lacking independent replication	[81] [52]
6q25.1	CCDC170/ESR1	1.09 (1.06-1.13)	Confirmed	Sex steroid hormone pathway; replicated across populations	[52]

The heterogeneous replication of endometriosis risk loci across ancestries highlights both shared genetic architecture and population-specific risk factors. Loci involved in fundamental biological processes like sex steroid hormone signaling (e.g., WNT4, ESR1) demonstrate greater cross-ancestry generalizability, while others show population-specific effects [52]. This heterogeneity presents both challenges for clinical translation and opportunities for discovering ancestry-specific biological insights.

Methodological Framework: Protocols for Inclusive Biomarker Research

Multi-Ancestry GWAS Protocol

Objective: To identify genetic variants associated with disease risk across diverse populations while accounting for potential ancestry-specific effects.

Detailed Workflow:

• Cohort Recruitment and Design:

  • Strategically recruit participants from multiple ancestral backgrounds (e.g., European, African, East Asian, Hispanic/Latino) with balanced case-control ratios within each group.
  • Collect detailed demographic, clinical, and environmental exposure data using standardized instruments across all recruitment sites.
  • For endometriosis studies, utilize surgical confirmation (rAFS classification) rather than self-report where possible to ensure phenotypic consistency [81].

• Genotyping and Quality Control:

  • Perform genome-wide genotyping using arrays designed for multi-ancestry imputation (e.g., the Illumina OmniExpress BeadChip used in endometriosis studies [81]).
  • Apply stringent quality control filters: call rate <0.98, Hardy-Weinberg Equilibrium p<0.001, minor allele frequency <0.01.
  • Conduct identity-by-descent analysis to remove related individuals (π>0.2) to avoid population stratification.

• Population Structure Analysis:

  • Use software such as ADMIXTURE to estimate individual ancestry proportions and principal components (PCs) [81].
  • Restrict analysis to individuals with ≥95% membership in specific ancestral groups if conducting ancestry-stratified analyses.
  • Include principal components as covariates in association tests to control for residual population stratification.

• Association Testing and Meta-Analysis:

  • Perform GWAS within each ancestral group separately using logistic regression adjusted for principal components.
  • Apply fixed-effects or random-effects meta-analysis approaches to combine results across ancestries.
  • Use heterogeneity tests (e.g., Cochran's Q) to identify loci with significantly different effect sizes across populations.

Biomarker Validation in Diverse Cohorts

Objective: To establish the clinical validity and utility of candidate biomarkers across diverse ethnic populations.

Detailed Workflow:

• Retrospective Cohort Identification:

  • Identify existing biobanks and cohort studies with diverse representation and appropriate phenotypic data.
  • For endometriosis, prioritize cohorts with surgical confirmation and detailed stage information (rAFS classification) [81] [52].

• Genotyping and Imputation:

  • Utilize dense reference panels (e.g., 1000 Genomes Project) for accurate imputation in diverse populations [52].
  • Calculate polygenic risk scores (PRS) using ancestry-specific effect sizes.

• Performance Assessment:

  • Evaluate biomarker performance (sensitivity, specificity, AUC) within each ancestral group separately.
  • Test for significant differences in effect sizes and predictive accuracy across populations.
  • Develop optimized PRS that incorporate cross-population genetic data.

Implementation Strategies: Overcoming Barriers to Diverse Research Participation

Addressing Practical and Logistical Barriers

Survey research has identified significant disparities in practical barriers to clinical trial participation across ethnic groups. Asian respondents expressed greater concern about time off work (22% vs 7% White respondents) and time required to participate (19% vs 7%) [82]. Black and Hispanic respondents reported higher levels of disruption related to technology use (30-31% vs 13% White) and completing study requirements at home (26-32% vs 15% White) [82]. These findings highlight the need for:

• Compensation structures that account for wage loss and additional expenses
• Flexible visit scheduling outside standard working hours
• Technology support programs for decentralized trial elements
• Simplified protocol designs that minimize participant burden

Building Trust Through Representative Research Ecosystems

Trust-building emerged as a critical factor, with Black (32%) and Hispanic (22%) respondents placing higher importance on diversity in clinical trial staff compared to White respondents (12%) [82]. Implementation strategies should include:

• Community-engaged recruitment through trusted local organizations
• Workforce diversity initiatives to ensure research teams reflect participant demographics
• Transparent communication about research objectives and data usage
• Cultural competency training for all research staff

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 4: Key Research Reagents for Ethnically-Inclusive Genomic Studies

Category	Specific Tool/Reagent	Function/Application	Implementation Considerations
Genotyping Platforms	Illumina OmniExpress BeadChip	Genome-wide variant detection	Select arrays with content optimized for multi-ancestry imputation [81]
Reference Panels	1000 Genomes Project Phase 3	Genotype imputation	Provides diverse haplotypes for improved imputation accuracy across populations [52]
Quality Control Tools	PLINK, ADMIXTURE	Data filtering, population structure analysis	Essential for identifying genetic outliers and controlling for stratification [81]
Analysis Software	METAL, REGENIE	Cross-ancestry meta-analysis, PRS calculation	Enables robust combination of results from diverse cohorts [52]
Biobank Resources	All of Us Research Program, UK Biobank	Diverse cohort samples with clinical data	Emerging resources with enhanced diversity for validation studies

The development of ethnically-inclusive biomarkers and drug targets requires fundamental changes in research approach, from study design through implementation. In endometriosis research, while notable progress has been made in identifying genetic risk factors, the limited ancestral diversity of discovery cohorts constrains their clinical utility across global populations. The quantitative evidence presented demonstrates both the pressing need for and viable pathways toward more inclusive research paradigms. By implementing the structured methodologies and implementation strategies outlined here, researchers can advance precision medicine to better serve all populations, ensuring that the benefits of genomic discovery are distributed equitably. Future efforts must prioritize diverse recruitment, trans-ancestry validation, and community engagement to realize the full potential of precision medicine for global populations.

Conclusion

The replication of endometriosis GWAS loci across diverse ethnic populations remains a significant challenge with profound implications for equitable healthcare and drug development. This analysis synthesizes key findings: the substantial genetic diversity gap in current research, promising methodological advances like combinatorial analytics that show improved cross-ancestry reproducibility, the critical need for standardized reporting and optimized study designs, and emerging frameworks for validating population-specific risk variants. Future directions must prioritize intentional inclusion of diverse cohorts in genetic studies, development of trans-ancestry analytical methods, and functional characterization of population-specific loci. Ultimately, overcoming these replication challenges is essential for realizing precision medicine in endometriosis care and ensuring that genetic discoveries benefit all populations equally, paving the way for more targeted and effective therapeutics.

References

• 1. Twenty years of genome-wide association studies: Health ... [https://www.nature.com/articles/s41431-025-01951-5]
• 2. Multi-ancestry genome-wide association study of ... [https://pubmed.ncbi.nlm.nih.gov/40950499/]
• 3. The phenotypic and genetic association between ... [https://pubmed.ncbi.nlm.nih.gov/40262193/]
• 4. Identification and Validation of Novel Combinatorial ... [https://pubmed.ncbi.nlm.nih.gov/40832379/]
• 5. Gene expression and demographic factors associated with ... [https://mefj.springeropen.com/articles/10.1186/s43043-025-00256-3]
• 6. Regulatory Effects of Endometriosis-Associated Genetic Variants [https://pmc.ncbi.nlm.nih.gov/articles/PMC12385710/]
• 7. Endometriosis - on the intersection of modern ... [https://www.nature.com/articles/s41431-025-01977-9]
• 8. All of Us Research Program year in review: 2024 [https://www.sciencedirect.com/science/article/pii/S0002929725003131]
• 9. A genome-wide association study identified 10 novel genomic ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12510315/]
• 10. Genetic variants underlying risk of endometriosis [https://pmc.ncbi.nlm.nih.gov/articles/PMC4132588/]
• 11. Insights into Assessing the Genetics of Endometriosis - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3410033/]
• 12. Ethnic-specific genetic susceptibility loci for endometriosis ... [https://www.nature.com/articles/s10038-024-01270-5]
• 13. Integration of genome-wide association study and ... [https://www.nature.com/articles/s41598-020-79515-4]
• 14. Multiomic insight into the involvement of cell aging related ... [https://www.nature.com/articles/s41598-025-96711-2]
• 15. Integrative -omics analyses uncover key pathways from a ... [https://pubmed.ncbi.nlm.nih.gov/39649588/]
• 16. Mapping the regulatory genetic landscape of complex traits ... [https://www.nature.com/articles/s41467-025-60834-x]
• 17. Genome-Wide Association Study Link Novel Loci to ... [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058257]
• 18. A multi-tissue atlas of allelic-specific expression reveals the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12123890/]
• 19. A Framework for Promoting Diversity, Equity, and Inclusion in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9223088/]
• 20. Bridging genomics' greatest challenge: The diversity gap [https://www.sciencedirect.com/science/article/pii/S2666979X24003537]
• 21. The Importance of Diversity in Genetic Research [https://www.baylorgenetics.com/blog/the-importance-of-diversity-in-genetic-research/]
• 22. Identification and Validation of Novel Combinatorial ... [https://sciety-discovery.elifesciences.org/articles/by?article_doi=10.1101/2025.08.13.25333595]
• 23. Identification and Validation of Novel Combinatorial ... [https://www.medrxiv.org/content/10.1101/2025.08.13.25333595v2]
• 24. Combinatorial Risk Scores | Disease Risk [https://precisionlife.com/building-combinatorial-risk-scores-to-predict-personal-disease-risk/]
• 25. Race and ethnicity reporting in endometriosis literature [https://pmc.ncbi.nlm.nih.gov/articles/PMC12489416/]
• 26. Optimization of multi-ancestry polygenic risk score disease ... [https://www.nature.com/articles/s41598-025-02903-1]
• 27. Systematic review of genome-wide association studies on ... [https://www.sciencedirect.com/science/article/pii/S0301211520306394]
• 28. A multi-ancestry polygenic risk score improves risk prediction ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10353935/]
• 29. eQTL analysis: A bridge from genome to mechanism [https://www.sciencedirect.com/science/article/pii/S2352304225003393]
• 30. The case for increasing diversity in tissue-based functional ... [https://www.nature.com/articles/s41467-022-30650-8]
• 31. Multi-omics analysis for identifying cell-type-specific and bulk ... [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06739-1]
• 32. Trans-eQTLs Can Be Used to Identify Tissue-Specific Gene ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12384777/]
• 33. Genome-wide meta-analysis identifies novel risk loci for ... [https://www.nature.com/articles/s41467-025-57483-5]
• 34. Population Stratification in Genetic Association Studies [https://pmc.ncbi.nlm.nih.gov/articles/PMC6007879/]
• 35. Evaluating multi-ancestry genome-wide association methods [https://www.sciencedirect.com/science/article/pii/S0002929725003167]
• 36. Revisiting the impact of race/ethnicity in endometriosis - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC9066945/]
• 37. Biobanking and gynecologic oncology [https://www.sciencedirect.com/science/article/abs/pii/S0748798325001416]
• 38. Unexpected findings in the exploration of African American ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4026340/]
• 39. Biases in Race and Ethnicity Introduced by Filtering Electronic ... [https://medinform.jmir.org/2025/1/e67591]
• 40. homologous rodent models - PMC - PubMed Central - NIH [https://pmc.ncbi.nlm.nih.gov/articles/PMC12237519/]
• 41. WERF Endometriosis Phenome and Biobanking ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12237513/]
• 42. GWAS meta-analysis identifies five susceptibility loci for ... [https://www.sciencedirect.com/science/article/pii/S2352396425002749]
• 43. Prevalence and Time of Diagnosis of Endometriosis across ... [https://www.medrxiv.org/content/10.1101/2021.07.28.21261303v1]
• 44. Preparing a Manuscript for Submission to a Medical Journal [https://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html]
• 45. Diversity Action Plans to Improve Enrollment of Participants [https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-action-plans-improve-enrollment-participants-underrepresented-populations-clinical-studies]
• 46. Ethnic-specific genetic susceptibility loci for endometriosis ... [https://pubmed.ncbi.nlm.nih.gov/38982179/]
• 47. traditional, hybrid, and digital recruitment results from a non ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12504426/]
• 48. Sample Size Calculation in Genetic Association Studies [https://pmc.ncbi.nlm.nih.gov/articles/PMC9863799/]
• 49. Sample size, power and effect size revisited: simplified and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7745163/]
• 50. Statistical Power Analysis - Sage Research Methods [https://methods.sagepub.com/ency/edvol/the-sage-encyclopedia-of-communication-research-methods/chpt/statistical-power-analysis]
• 51. Power to Detect What? Considerations for Planning and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11193916/]
• 52. Meta-analysis identifies five novel loci associated with ... [https://www.nature.com/articles/ncomms15539]
• 53. New Insights into Genetics of Endometriosis—A ... [https://www.mdpi.com/2075-4418/13/13/2265]
• 54. A Bayesian approach to implicit L2 learning: Web-based ... [https://www.sciencedirect.com/science/article/pii/S2772766125000631]
• 55. an analysis of the global burden of disease study 2021 and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12570807/]
• 56. Non-Hormonal Strategies in Endometriosis: Targets with ... [https://www.mdpi.com/2077-0383/14/14/5091]
• 57. Social Determinants of Health and Lifestyle Risk Factors ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11658798/]
• 58. Global, regional, and national burdens of endometriosis ... [https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1562196/full]
• 59. Environmental Risk Factors for Endometriosis: An Umbrella ... [https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.680833/full]
• 60. The health-promoting lifestyle and its relationship with the ... [https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-025-03696-1]
• 61. New Insights into Genetics of Endometriosis—A ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10340419/]
• 62. Article Leveraging local ancestry and cross ... [https://www.sciencedirect.com/science/article/pii/S0002929725002411]
• 63. Admixed and single-continental genome segments of the ... [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-025-03672-w]
• 64. Integrated genetic and geographic ancestry prediction via ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12570655/]
• 65. Simulating variance heterogeneity in quantitative genome ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-018-2061-1]
• 66. a meta-analysis application considering heterogeneity ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9847376/]
• 67. Dissecting the shared genetic architecture between ... [https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1359236/full]
• 68. Beyond endometriosis GWAS: from Genomics to ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5693320/]
• 69. Genetic Characterization of Endometriosis Patients [https://www.mdpi.com/1422-0067/21/5/1765]
• 70. Genomic Evidence Supports the Recognition of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8983833/]
• 71. Improved analyses of GWAS summary statistics by ... [https://www.nature.com/articles/s41467-021-27438-7]
• 72. SumStatsRehab: an efficient algorithm for GWAS summary ... [https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-022-04920-7]
• 73. Insights from Mendelian randomization and genetic ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10477944/]
• 74. Principles and methods for transferring polygenic risk ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10961971/]
• 75. Transferability of polygenic risk scores for metabolic and ... [https://www.nature.com/articles/s41525-025-00532-1]
• 76. Transferability of genetic loci and polygenic scores for ... [https://www.nature.com/articles/s41467-022-32095-5]
• 77. Genetic overlap between endometriosis and endometrial ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5943470/]
• 78. Genome-wide association and epidemiological analyses ... [https://www.nature.com/articles/s41467-019-12536-4]
• 79. Interaction between genetic risk and comorbid conditions ... [https://www.sciencedirect.com/science/article/pii/S2666247725000594]
• 80. Gene–environment Interaction of GWAS Loci and ... [https://www.xiahepublishing.com/m/1555-3884/GE-2025-00056]
• 81. Genome-Wide Association Study Link Novel Loci ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3589333/]
• 82. Promoting Diversity through an Understanding of Barriers and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12018620/]
• 83. Prevalence of targetable genomic alterations among a diverse ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12229528/]